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Abstract 
The work described in this thesis concerns the design, synthesis, DNA binding and 
biological activity of palladium(II) supramolecular cylinders that might be capable 
of recognizing a DNA four-way junction. 
An introduction to DNA structure will be presented, as well as the different binding 
modes of natural and synthetic agents that can recognise and bind to DNA. Since 
this work is focused on the design of large metallo-structures, the general 
principles of supramolecular chemistry will be summarised with particular 
emphasis on metallo-supramolecular structures. 
Palladium(II) supramolecular cylinders have already been reported and these 
show promising cytotoxicity against different cancer cell lines. However, these 
complexes present poor solubility in aqueous solutions. It is therefore the aim of 
this thesis to improve the water solubility of palladium(II) supramolecular cylinders 
without significantly changing their structure or quenching their cytotoxic activity. 
The DNA binding properties of the newly synthesised palladium(II) complexes will 
be presented. Several spectroscopic techniques, such as circular and linear 
dichroism and ethidium bromide displacement assays, as well as electrophoresis 
experiments were carried out and these will be discussed. 
Initial DNA four-way junction experiments and cytotoxicity studies will also be 
discussed.
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Chapter 1. Introduction 
 
 
This thesis focuses on the design and synthesis of novel metallo-supramolecular 
structures that might potentially bind DNA structures. To set out the scene, a short 
introduction on DNA is presented in this chapter, as well as the different known 
binding modes that natural and synthetic agents use to recognize DNA structures. 
A brief insight into metallo-supramolecular chemistry is also given and reviewed. 
 
1.1.  Introduction to DNA 
DNA is the acronym for deoxyribonucleic acid. It is the key component of 
chromosomes and provides information about how to build proteins. In 
chromosomes, DNA is tightly packed and complexed with a histone (8 protein 
units) forming a DNA-protein complex called a nucleosome.(1) DNA is a polymer 
formed by deoxyribonucleotides that are connected through phosphodiester 
bonds. These deoxyribonucleotides are made up of three components: a five 
carbon sugar (2’-deoxy-D-ribose), a nitrogenous base that can be a pyrimidine 
(cytosine or thymine) or a purine (adenine or guanine) and a phosphate group 
(Figure 1.1). 
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Figure 1.1: Polynucleotide chain of DNA. 
 
In cells, DNA forms a double helix when two polynucleotide strands coil 
around a common axis.(2) The strands are antiparallel with opposite polarity; one 
goes from 5' to 3' whereas the complementary strand goes from 3' to 5' (Figure 
1.2).(3) In standard DNA, the bases are not randomly arranged. Adenine (A) is 
always paired with a thymine (T) on the complementary strand and vice versa, and 
guanine (G) is always paired with cytosine (C) and vice versa. The paring occurs 
via hydrogen bonds, two for A-T and three for G-C, holding the two strands of the 
duplex together.(4) 
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Figure 1.2: The antiparallel nature of the DNA double helix. 
 
The primary structure of nucleic acids is the sequence of nucleoside 
monophosphates. As a result of the base pairing, the nucleic acid assumes a form 
which is called the secondary structure, such as A-DNA, Z-DNA and B-DNA 
(Figure 1.3). The latter is the form that predominates in the aqueous environment 
of the cell. The tertiary structure is the three-dimensional shape of how the entire 
linear polymer is folded.  
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Figure 1.3: Comparison of the A-DNA (PDB 440D)(5) (left), B-DNA (PDB 1BNA)(6) (centre) 
and Z-DNA (PDB 2DCG)(7) (right) forms of the DNA double helix. 
 
B-DNA is a right handed duplex and is present in more than 90% of known 
DNA sequences. Under ideal conditions, the diameter of the B-DNA helix is 2 nm. 
The distance required to complete one helical turn (360º) or pitch is 3.54 nm. As 
there are 10.4 base pairs in each turn of the helix, the distance between each 
base pair is 0.34 nm. The pairing of the non-symmetric bases and their stacking, 
at a 36º torsion angle, gives a small, narrow and shallow (minor) groove and a 
large, wide and deep (major) groove.(8)  
A-DNA is a right handed helix with major and minor grooves equal in width 
due to the particular orientation of its base pairs. To this date, there is no evidence 
of the presence of this DNA form in any living organism, however it can be found 
in double-stranded RNA and DNA-RNA hybrids.(1) 
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Z-DNA is a left handed helix where pyrimidine bases alternate with purine 
bases in anti and syn conformations, respectively. As a result of this, the 
sugar-phosphate backbone of Z-DNA forms a zigzag pattern, where the major 
groove is barely apparent and the minor groove is deep and narrow.(1) 
 
1.2.  DNA recognition modes 
In the 1960’s five different modes of molecular recognition of DNA were 
established: major groove recognition, minor groove recognition, intercalation 
between the base pairs, backbone binding and binding to the bases.(9) The first 
four binding modes are non-covalent and the interaction is mainly electrostatic or 
via hydrogen bonding, while the last one forms covalent bonds to the DNA bases. 
Recently new ways have been reported for recognition of other DNA structures 
(vide infra). 
 
1.2.1. Major groove recognition 
The DNA major groove is targeted by many proteins and large synthetic or 
semi-synthetic agents. However, since most synthetic drugs are relatively small for 
the major groove, little research has been focused in the recognition of the DNA 
major groove.(10) 
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1.2.1.1. Major groove recognition by proteins 
Proteins can recognize both DNA grooves, but tend to bind in the DNA major 
groove due to the dimensional difference between the grooves.(11)  
Proteins interact with DNA by electrostatic attraction, hydrogen bonding, 
bridging water molecules and Van der Waals contacts. The protein surfaces that 
interact with the DNA are enriched with positive charges from lysine and arginine 
aminoacids. This positive charge acts as the main force for the protein–DNA 
interaction, approaching the negatively charged DNA phosphate backbone. Even if 
dominant, this attraction is not sequence-specific as the negative charge from the 
DNA backbone is all over the DNA. Sequence-specificity is dictated by hydrogen 
bond interactions. In 90% of the cases, proteins act as the hydrogen bond donor 
group and DNA as the acceptor group.(12) 
Van der Waals contacts also contribute in some degree to 
sequence-specificity as the right geometry and shape are required for a perfect 
contact. Only the -helix domain of the protein interacts with the DNA major 
groove. The -helix must be tilted to sit in the major groove as -helices normally 
have 3 turns or more (Figure 1.4b). If it stays parallel to the groove it will not fit 
(Figure 1.4a).(13)  
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Figure 1.4: Docking of -helix domain of proteins in the DNA major groove. Purple area 
highlights the available region for protein interaction. 
 
Proteins that are found to recognize the DNA major groove are 
helix-turn-helix proteins, zinc finger proteins, leucine zipper proteins(9) and 
enzymes from prokaryotic and eukaryotic organisms.(14) 
Zinc finger proteins (typically Cys2His2) usually contain several units or 
fingers that make simultaneous contacts along the DNA. Each finger possesses a 
 domain with a zinc metal ion tetrahedrally coordinating two cysteins of the 
antiparallel -sheet and two histidines of the -helix (Figure 1.5).(14,15) 
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Figure 1.5: Crystal structure of the zinc finger domain of KLF4 bound in the DNA major 
groove (PDB 2WBU).(15) 
 
 
1.2.1.2. Major groove recognition by oligonucleotides 
Oligonucleotides (synthetic or natural) can recognize the major groove of DNA via 
hydrogen bonding to the purine bases, forming a triple stranded DNA or 
Hoogsteen motif (H-DNA) (Figure 1.6).(16)  
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Figure 1.6: Example of a Hoogsteen G:C·C+ base contact. 
 
This can be used to artificially control the gene expression via the antigene 
approach. The third strand can be designed to bind in a specific sequence of the 
duplex DNA of a given gene and inhibit it.(17) However there are some limitations; 
for example not all diseases have DNA targeting sequences to form a triple helix, 
or nucleases can digest the oligonucleotide before it arrives in the cell.(18) Also, 
oligonucleotides do not selectively bind DNA, they can also bind RNA.(9) 
 
1.2.1.3. Major groove recognition by peptide nucleic acids (PNAs) 
In 1991 Nielsen et al.(19) reported the formation of a neutral oligonucleotide by 
replacing the sugar phosphate backbone with a polyamide (peptide-like backbone) 
and called them PNAs (Figure 1.7).  
They usually invade the DNA double helix and displace one DNA strand to 
form (DNA)(PNA)2 triplexes (Figure 1.7).
(20) 
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Figure 1.7: General structure of a PNA (left) and PNA complexed with DNA forming a 
(DNA)(PNA)2 triplex (PDB 1PNN)
(20) (right). 
 
 
1.2.1.4. Major groove recognition by calix[n]arenes 
A calix[n]arene is a macrocyclic oligomer formed by hydroxyalkylation of a phenol 
and an aldehyde. They have a hydrophobic cavity that can hold small molecules or 
ions. Metallacalix[n]arenes are calix[n]arenes in which the methylene has been 
replaced by a metal ion and the phenol ring by a bent nitrogen heterocycle.(21) 
Calix[n]arenes and metallacalix[n]arenes are known to give a variety of host-guest 
interactions.(22,23)  
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Recently it has been proposed that metallacalix[4]arenes (Figure 1.8) can 
bind in the major groove of DNA via non-covalent interactions, as seen by different 
spectroscopic techniques and AFM studies.(24) 
 
Figure 1.8: Crystal structure of a platinum-calix[4]arene (CCDC 146631).(25) 
 
Positively charged dimeric calix[4]arenes (Figure 1.9) have also been 
shown to interact with the DNA major groove, via hydrogen bond interactions 
between the top cationic moieties of the calix[4]arene and the DNA bases and the 
negatively charged phosphate backbone. Minor groove insertion and intercalation 
are precluded due to the large dimensions of the dimeric calix[4]arene 
(3 nm x 1 nm).(26,27)  
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Figure 1.9: Dimeric calix[4]arene shown to recognize the DNA major groove. 
 
 
1.2.2. Minor groove recognition 
The driving forces for the interaction between the DNA minor groove and natural 
and synthetic agents are electrostatic interactions with the phosphate backbone at 
the walls of the groove, van der Waals contacts, hydrophobic interactions and 
hydrogen bonding.(28) A crescent shape of the minor groove binder is a 
requirement for effective van der Waals contacts. Some sequence specificity is 
observed in hydrogen bond interactions between the base pairs and the minor 
groove agent. Some selectivity is also evident towards AT rich regions as they 
have an overall negative charge and produce a narrower and deeper groove than 
GC rich regions.(11,29) 
The most common examples of minor groove binders are distamycin A, and 
netropsyn (natural molecules), diarylamidines (DAPI, berenil, and pentamidine) 
and bis-benzimidazoles (Hoechst 33258) (Figure 1.10).(29)  
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Figure 1.10: Structures of some minor groove binders. 
 
 
1.2.2.1. Minor groove recognition by natural agents 
Distamycin A is a natural cationic minor groove binder. It is an antibiotic with an 
oligopeptide structure with three pyrrole rings. It shows high affinity for AT rich 
regions in the DNA minor groove. It can be found as a 1:1 complex (30) as well as 
an antiparallel 2:1 complex(31,32) (Figure 1.11).  
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Figure 1.11: Distamycin A complexed with DNA in a 1:1 ratio (PDB 1JTL)(30) (left) and in a 
2:1 ratio (PDB 1JUX)(32) (right). 
 
When acting as a stacked dimer, distamycin A is able to bend five or six AT 
base pairs. This results in a change in the directionality of the curvature. As a 
monomer, distamycin A bends the DNA towards the minor groove, while when 
acting as a dimer it bends the DNA towards the major groove. This could be used 
for the modulation of DNA transcription, as by altering the major groove shape 
some of these transcription factors might have a reduced affinity to DNA.(33) 
 
Chapter 1 
Introduction 
15 
 
1.2.2.2. Minor groove recognition by synthetic agents 
During many years research has been focused on the design of synthetic minor 
groove binders which consequently had clinical application as anti-cancer, 
anti-viral and anti-bacterial agents.  
Pentamidine is an antimicrobial drug used for the treatment of severe 
pneumonia in HIV-positive patients and sleeping sickness.(9) A temporary caged 
aza-pentamidine (Figure 1.12) has been shown to be activated by light via 
cleavage of its protecting groups. This results in a control of its DNA binding 
properties and its antifungal activity triggered by light.(34) 
 
Figure 1.12: Caged aza-pentamidine (protecting groups shown in blue). 
 
As well as electrostatic interactions with the phosphate backbone at the 
walls of the groove, van der Waals contacts, hydrophobic interactions and 
hydrogen bonding, water mediated binding interactions have also been detected in 
minor groove binders. The phenylamidine group of a DAPI derivative interacts via 
hydrogen bonding with the N3 of an adenine through a water molecule in the 
minor groove.(35,36) 
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Figure 1.13: DAPI analogue binding in the DNA minor groove (left) and water mediated 
hydrogen bond contact (in pink) of DAPI analogue (right) (PDB 2B0K).(35) 
 
Dervan and co-workers have created polyamides analogous to the natural 
distamycin A minor groove binder. These polyamides, which have an imidazole in 
place of a pyrrole, follow the same binding principle of the distamycin A dimer 
discussed above. The heterocyclic rings of one strand interact via -stacking with 
the amide groups on the other strand. Also, the new imidazole nitrogen introduced 
into the ring can form hydrogen bonds with the NH2 of guanine bases.
(37,38) 
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Figure 1.14: Structure of polyamide (left) and two polyamide strands in the DNA minor 
groove (PDB 407D)(38) (right). 
 
Analogous polyamide linked dimers have been shown to span eleven to 
sixteen base pairs in the minor groove(39) (traditional minor groove binders 
recognize only three or four base pairs). 
 
1.2.2.3. Minor groove recognition by proteins 
Proteins usually bind in the major groove due to their relatively large size; however 
they can also bind in the minor groove. TATA binding proteins are an example.(40) 
In the recognition process, the minor groove opens up and the DNA double helix is 
unwound by 120º and bent by 80º, compressing the major groove. The interaction 
occurs between the -sheet domains of the protein and the hydrophobic regions of 
the groove (Figure 1.15).(41) 
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Figure 1.15: TATA-binding protein recognizing the DNA minor groove (PDB 1TGH).(41) 
 
 
1.2.3. Intercalation 
In 1961 Lerman suggested that small planar polycyclic, electron-deficient, 
aromatic molecules can recognize DNA through intercalation, using the 
hydrophobic cavity between two base pairs. Face-face - interactions are formed 
between the aromatic rings of the intercalator and the heterocyclic rings of the 
bases above and below it. The van der Waals contacts formed between the 
intercalator and the bases sandwiching the intercalator are more favourable than 
similar contacts between the bases themselves.(42) This interaction can be 
reinforced by ionic forces between a positive charge in the intercalator and the 
negatively charged sugar phosphate backbone of the DNA. Transcription, 
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replication and DNA repair processes can be inhibited due to the structural 
modifications caused by the intercalator binding, such as unwinding of the DNA 
double helix.(43) Usually the size of these drugs is around two to three 
six-membered rings.  
Examples include; proflavine, ellipticine, ethidium bromide, doxorubicin, 
daunomycin and daunorubicin (Figure 1.16). 
 
Figure 1.16: Structures of some intercalator agents. 
 
A positive charge can be introduced in an intercalating drug by 
incorporating a transition metal.(44-46) The first example of these intercalators is 
based on a square planar platinum(II) terpyridine unit synthesized by Lippard 
(Figure 1.17).(47)  
Chapter 1 
Introduction 
20 
 
 
Figure 1.17: Platinum terpyridine intercalator drug. 
 
Metals are attractive not only for the fact that they can impart a positive 
charge to the drug, but also other characteristics such as luminescence 
(e.g. ruthenium(II) polypyridine complexes) and DNA cleavage properties 
(e.g. rhodium(III) centres acting through photoinduced oxidation) are important. 
Recently, a ruthenium complex (-[Ru(bpy)2(dppz)]
2+) synthesised by 
Barton and co-workers has been crystallised with a DNA helix that bears two 
adenine:adenine (A:A) mismatches.(48) The crystal structure reveals that the 
ruthenium complex is able to intercalate through the minor groove between the 
mismatched bases via metalloinsertion and between the non-mismatched bases 
via metallointercalation (Figure 1.18). Binding at the mismatched site results in the 
mismatched adenine bases being pushed out of the helical core (in dark grey in 
Figure 1.18) and an enhanced luminiscence.(49) 
The related -[Ru(phen)2(dppz)]
2+ complex has shown perpendicular and 
canted intercalation in a non-mismatched DNA duplex.(50) 
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Figure 1.18: -[Ru(bpy)2(dppz)]
2+ complex (bottom right) inserted in a mismatched A:A 
DNA double helix (left) and metalloinsertion and metallointercalation of ruthenium drug 
(top right) (PDB 4E1U).(49) 
 
Another approach used in the design of intercalating drugs is the 
combination of two intercalators, forming bis-intercalators. These are linked by a 
flexible chain that is suficiently long enough to allow the two intercalators to insert 
into two sites on the same DNA duplex.(9) 
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The bis-intercalator in Figure 1.19 shows a rapid formation of the 
mono-intercalated adduct that is then slowly converted into the thermodynamically 
more stable bis-intercalated adduct.(51) 
 
Figure 1.19: Structure of iridium bis-intercalator. 
 
 
1.2.4. Backbone binding 
The sugar-phosphate DNA backbone has a hard oxygen-rich polyanion surface 
that can interact with metal cations from groups I and II. Also, proteins with 
cationic residues like arginine can interact by hydrogen bonding. 
Farrell has developed an octacationic trinuclear platinum backbone binder 
that can bind along the phosphate backbone or stretch across the minor groove 
making hydrogen bond contacts (shown in pink in Figure 1.20) with the phosphate 
backbones on either side.(52-54) 
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Figure 1.20: Farrell’s octacationic backbone binder (PDB 2DYW).(52) 
 
1.2.5. Binding to the DNA bases 
This is the most common form of DNA recognition used by clinical drugs. It 
involves a covalent link between the drug and DNA. It shows certain sequence 
preference to N7 of guanine bases in the major groove and to a lesser extent to 
adenine bases. 
The most renowned compound that recognizes DNA by binding to its bases 
is cis-diamminedichloroplatinum(II), known as cisplatin. Cisplatin is the most 
successful anticancer agent in the clinic. It is very effective against testicular 
cancer and plays an important role in the treatment of ovarian, head, neck, 
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cervical and bladder cancers, as well as melanomas and lymphomas.(55) Cisplatin 
forms bifunctional DNA cross-links, with the 1,2-intrastrand GG crosslink between 
adjacent guanines being the most significant one.(56) The binding of cisplatin to 
guanine bases causes the DNA to bend or kink at around 45º, affording a wider 
and flatter minor groove opposite the platination site (Figure 1.21).(57,58) This 
specific structural motif is believed to be the cause of cell death. One hypothesis 
suggests that HMG-domain proteins (nuclear high-mobility group proteins) 
recognize this motif and therefore the DNA repair processes cannot occur. The 
other hypothesis, which is not exclusive, is based on the fact that HMG-domain 
proteins are kept away from their natural binding site and this causes cell stress 
which ends up in cell death.(55) 
 
Figure 1.21: Kinking of DNA double helix upon cisplatin binding (left) and coordination of 
cisplatin to N7 (dark blue) of two adjacent guanines (hydrogen bonding to phosphate 
backbone in pink) (right) (PDB 1AIO).(57) 
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Following the success of cisplatin, five other platinum based derivatives 
entered into the clinic; oxaliplatin and carboplatin (worldwide) and nedaplatin, 
lobaplatin and heptaplatin (regionally) (Figure 1.22).(59,60) They work in a similar 
fashion to cisplatin, however their reactions are much slower. These DNA binding 
kinetics cause less toxic effects which is important since one of the main 
drawbacks of cisplatin are its side effects and toxicity.(61) 
 
Figure 1.22: Platinum-based drugs. 
 
 
1.2.6. Recognition of other DNA structures 
Synthetic molecules not only recognize the double helix of DNA. Higher order 
structures, such as nucleosomal DNA, triplex and tetraplex DNA and DNA 
junctions, can also be targeted. 
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1.2.6.1. Nucleosomal DNA 
Dervan’s polyamides that bind in the minor groove can also bind higher order 
structures such as nucleosomes.(62) Nucleosomes are found in chromosomes, 
where DNA is wrapped around small basic proteins called histones.(63) This 
wrapping yields two sections of double helical DNA that are adjacent to each 
other. Therefore, two linked polyamides are able to bind to two adjacent minor 
grooves in the nucleosome (Figure 1.23).(62) 
 
Figure 1.23: DNA wrapped around histone proteins (pink) in the nucleosome (left), linked 
polyamide recognizing nucleosomal DNA (protein structure removed for clarity) (right) 
(PDB 1S32)(62) and structure of linked polyamide (bottom). 
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1.2.6.2. Triplex DNA 
Triplex DNA is not as stable as duplex DNA, even when there is specificity on 
sequence recognition of the third oligonucleotide strand. This is due to the 
electrostatic repulsion of the three phosphate backbones.(64) Therefore, 
triplex-binding ligands have been used to increase the oligonucleotides binding 
strength on triplex formation. These ligands are able to bind to triple helices and 
not to double helices, or they show a strong preference for triplex over duplex 
DNA. Several triplex binders have now been described, such as 
benzopyridoindoles, coralyne chloride, disubstituted amidoanthraquinones and 
naphthylquinolines(65) (Figure 1.24). These binders are able to intercalate between 
bases that form Hoogsteen motifs. 
 
Figure 1.24: DNA triplex-binding ligands. 
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Triplex DNA structures are of great interest as they might help to 
understand cellular processes such as DNA transcription and gene expression. 
The formation of a triplex with a synthetic modified oligonucleotide strand, the so 
called antigene approach (see section 1.2.1.2), and the stabilization of triplex with 
triplex binders are two different approaches to attempt to interfere with the 
transcription of genes.(66,67)  
 
1.2.6.3. Tetraplex (or quadruplex) DNA 
In 2009, Elisabeth H. Blackburn, Carol W. Greider and Jack W. Szostak were 
awarded the Nobel Prize in Physiology or Medicine “for the discovery of how 
chromosomes are protected by telomeres and the enzyme telomerase”.(68-70) 
Telomeres are formed of short repetitive nucleotide regions (quadruplex) at 
the end of the chromosomes. In normal cells, telomeres shorten after each 
replication cycle as DNA polymerase cannot fully replicate the end sequence. This 
eventually leads to cell death. However, in cancerous cells the telomeric ends are 
stabilized by the action of the over-expressed enzyme telomerase. Telomerase is 
able to catalyze the synthesis of telomeric DNA. This means that there is not DNA 
loss during replication in cancerous cells. It is believed that the inhibition of 
telomerase in tumour cells would cause cell death. For this reason, quadruplex 
DNA has emerged as a new target for anti-cancer drugs.(11,71) 
The quadruplex or tetraplex is made up of four strands and its DNA 
structure is rich in guanine bases (G-quadruplex). The G-quadruplex structure is 
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based on a planar tetrad with an electron-rich -surface, where the strands are 
held together by Hoogsteen hydrogen bonds. The orientation of the strands can 
vary (parallel or folded and antiparallel) giving different structures according to the 
directionality of the strands and the connectivities of loop regions at their ends 
(Figure 1.25). The stability of these structures lies in base-stacking interactions.(72) 
 
 
Figure 1.25: G-tetrad structure. 
 
In 1991 Zahler demonstrated that K+-stabilized G-quadruplex structures 
(Figure 1.26) could inhibit telomerase,(73) therefore great interest emerged in the 
design of small organic molecules that are able to bind to G-quadruplex and thus 
inhibit telomerase and disrupt telomeres. 
G-tetrad  
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Figure 1.26: K+-stabilized G-quadruplex DNA (left) and K+ contacts with guanines (in pink) 
and Hoogsteen hydrogen bonds between guanines (in red) (right) (PDB 2GWE).(74) 
 
Recently, a tetra-substituted naphthalene diimide compound functionalized 
with positively charged N-methyl-piperazine side chains has been shown to bind 
and thermally stabilize the 3’-ends of human telomeric G-tetrads of quadruplexes. 
The four side chains interact with the grooves of the quadruplex while the 
naphthalene core interacts via - stacking to the DNA bases (Figure 1.27). It has 
also been found to be a potent inhibitor of cell growth.(75) 
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Figure 1.27: Tetra-substituted naphthalene diimide quadruplex binder (bottom right) bound 
to a human telomeric G-tetrad; side view (left) and top view (top right) (PDB 3T5E).(75) 
 
Metal-containing ligands are also able to bind G-quadruplexes.(76,77) 
Sleiman has shown that Fujita’s platinum molecular square(78) (Figure 1.28) is an 
excellent stabilizer of the G-quadruplex motif, and it significantly binds selectively 
to the tetraplex over duplex DNA.(79) 
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Figure 1.28: Structure of Fujita’s platinum molecular square. 
 
 
1.2.6.4. DNA junctions  
A DNA junction is a branched structure consisting of several double strands 
converging at one point.  
DNA three way junctions are structures transiently formed during DNA 
replication (in the replication fork). They are intermediates during triplet repeat 
expansions (myotonic dystrophy I, Huntington’s disease) and during phage genetic 
recombination. They are also present in inverted terminal repeats of certain viral 
genomes.(80,81) 
Sasaki has reported a bidentate minor groove binder that can recognize a 
DNA three-way junction structure. Two Hoechst 33258 are connected by a 
polyether linker at their convex side. Strong binding occurs when each Hoechst 
33258 molecule interacts with the A3T3 minor groove regions of the arms of the 
junction (Figure 1.29).(82) 
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Figure 1.29: Structure of Sasaki’s bidentate minor groove binder (left) and schematic 
representation of a DNA-3WJ (PDB 1EKW)(83) and Sasaki’s binder (right). 
 
In 2006, Hannon et al. reported the first synthetic molecule able to bind to 
the central hydrophobic cavity of a DNA three-way junction. This dinuclear iron(II) 
complex is cylindrical in shape and is of the perfect size to sit in the central cavity 
of the junction without perturbing the DNA structure. Two types of interactions are 
observed; - stacking to the DNA bases and electrostatic attraction between the 
cationic cylindrical molecule and the negatively charged phosphate DNA backbone 
(Figure 1.30).(81) 
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Figure 1.30: Crystal structure of dinuclear iron(II) complex (CCDC 622770)(84) (left) and 
complex bound at the heart of a DNA three-way junction (PDB 2ET0).(81) 
 
One of the most studied junctions is the four-way junction or Holliday 
junction. It is accepted to be the central intermediate during homologous genetic 
recombination. This process is important in DNA repair mechanisms and the 
restart of failed replication forks.(85) It also provides genetic diversity which is 
essential for the evolution of the species.(86) Holliday junctions are also involved in 
replication processes of bacteriophage T4 as they allow viral integration.(87) Double 
strand breaks can occur in two homologous double helices due to different factors 
such as radiation and the DNA repair process starts. The nicked strands are able 
to invade the homologous strands and these are then covalently linked to the 
original strands at the nicked site, forming a Holliday junction. This Holliday 
junction migrates away from the original nicked site across the strands in a 
process called branch migration. As a result of this, DNA strands are swapped 
producing heteroduplex regions, which results in an exchange of genetic material. 
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At some point, migration of the Holliday junction ends and resolves the entangled 
DNA strands into two separate ones. The junction bends and forms the X-stacked 
Holliday junction. If one of the DNA helices rotates by 180º, a process called 
isomerisation, the result is the open form of the Holliday junction. Endonucleases 
can cut at different points producing non-crossover products, where only two 
strands have exchanged genetic material, or crossover products, where all the 
strands have new genetic material (Figure 1.31).(87,88) 
 
Figure 1.31: Homologous recombination process. 
 
The structure of a DNA four-way junction was found to be dependent on the 
type and concentration of cations in solution (Figure 1.32). At low salt 
concentration, the four-way junction adopts the open form where the arms of the 
junction are fully extended. An H-shaped structure gives the minimal electrostatic 
repulsion between the negatively charged phosphate backbones. In the presence 
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of metal ions, a more compact structure is formed where the four arms are paired 
and stacked with each other. Group II metals, such as calcium and magnesium 
are able to fold the four-way junction structure at concentrations greater than 
100 M. Group I metals, such as sodium and potassium, require very high 
concentrations to partially fold the junction structure. Metal complexes 
([Co(NH3)6]
3+) and polyamines (spermine) are more efficient, as they are able to 
promote folding of the Holliday junction structure at concentrations ranging from 
2 to 25 M.(87,89) 
  
Figure 1.32: Holliday junction structures: open form (PDB 1Z1G)(90) (left) and X-stacked 
form (PDB 3T8P)(91) (right). 
 
Holliday junctions can be recognized by a number of proteins in cells which 
direct branch migration and resolution during the homologous recombination 
process. The binding is structurally selective, however proteins can also distort the 
junction structure upon binding.(92,93) 
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Cardin has developed a family of compounds based on alkyl-chain-linked 
dimers of acridine with varying spacer length. These compounds are able to bind 
across the centre of the junction ejecting two adenines at either side of the junction 
crossover (Figure 1.33).(94) 
 
 
Figure 1.33: Bis-acridine intercalator bound to a DNA-4WJ (PDB 2GWA).(94) 
 
In section 1.2., the different binding modes that natural and synthetic agents 
employ to recognize DNA has been discussed. It is noted that correct structural 
design of synthetic DNA binders is required for molecules to succeed in the DNA 
recognition process. In this way, intercalators need to have aromatic rings at the 
correct site to be able to sandwich between the DNA base pairs. If higher order 
DNA structures or the DNA major groove are the target, large molecules need to 
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be synthesised. Metallo-supramolecular chemistry is able to generate these large 
molecules. The main principles of this chemistry and some metallo-supramolecular 
structures are reviewed in the next section.  
 
1.3. Metallo-supramolecular chemistry 
Traditionally molecular chemistry is based on molecules formed by atoms linked 
by strong bonds, such as covalent bonds. In supramolecular chemistry molecules 
are used to build bigger aggregates by intermolecular interactions using weak 
bonds such as hydrogen bonds, Van der Waals interactions, electrostatic 
interactions, hydrophobic interactions or - stacking interactions of aromatic 
units.(95,96) Supramolecular chemistry is inspired by the formation and interactions 
observed in proteins and oligonucleotides, reviewed above.(97) This new chemistry 
concept was first defined by Jean-Marie Lehn in 1978 who received the Nobel 
Prize in Chemistry in 1987.(95) Since then, supramolecular chemistry has been 
extensively studied and the different nanosized motifs synthesised have led to 
several applications, such as sensing,(98,99) electronics,(100,101) molecular 
motors,(102) environmental control,(103) diagnostic and chemotheraupetic agents(104) 
and catalysis.(105) 
It was in 1994 when Constable introduced the term metallo-supramolecular 
chemistry to describe those assemblies that are built by employing metals (M) and 
their interaction with donor groups of organic molecules (ligands, L). The nature of 
M and L determines the strength of the interaction M-L.(106) 
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One of the most important properties of this type of chemistry is the 
self-assembly process(107) used in the synthesis of these arrays (metal-directed 
self-assembly); only the ligand and the metal are needed to yield the aggregate, 
due to a molecular recognition process giving only one product, the most stable 
one. The product can be designed by studying the steric and electronic 
characteristics of the building blocks and finding a balance between rigidity and 
flexibility. The starting materials contain the molecular information for the selective 
binding.(108) 
Different architectures can be formed by studying the characteristics of the 
ligands and the metals. The metal has to be selected according to its coordination 
number and geometry, and the ligand for the relative position and number of its 
donor atoms.(109,110) In this way, a vast number of structures can be formed; linear 
and zigzag coordination polymers, molecular squares, rectangles, hexagons, 
triangles, windows, lattices, ladders, square tiles and cubes, adamantanoid and 
dodecahedral cages, double-stranded, triple-stranded, quadruple-stranded and 
circular helicates and rotaxanes and catenates.(111-113) Some of these structures 
will be discussed below based on the number of metals and geometry adopted. 
 
1.3.1.  [M2L2] architectures 
Self-assembly directed by metal-coordination has led to the preparation of 
molecular squares that are able to host different guests in their internal cavities. 
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This is the case of the platinum metallacycle formed from 2,7-diazapyrenium 
(Scheme 1.1).(114) 
 
Scheme 1.1: Synthesis of Pt(II) rectangular metallacycle of 2,7-diazapyrenium based 
ligand. 
 
This metallacycle can host different environmental pollutants which are 
polycyclic aromatic hydrocarbons (PAH) of two or more fused rings (Figure 1.34). 
The molecular recognition process is based on - interactions between the 
pyrenes of the metallacycle and the guests (pyrene and triphenylene), as well as 
hydrophobic forces.(114) 
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Figure 1.34: Pt(II) metallacycle hosting a pyrene (CCDC 783766)(114) (left) and a 
triphenylene (CCDC 783768)(114) (right). 
 
It has been shown recently that this platinum metallacycle can coil the DNA 
and is able to block the amplification of DNA in a PCR assay. It also shows high 
cytotoxicity against five different cancer cell lines. These results show a potential 
use of this compound as an anticancer agent.(115) 
Double helices can also be formed in an [M2L2] architecture. Helices in 
general attract the attention of supramolecular chemists for their analogy to DNA, 
and as a simple model to understand the self-assembly and molecular recognition 
processes. Helices can also be used to easily introduce chirality into molecules 
that can be used for several applications, such as catalysis or opto-electronics.(116) 
Helices can be formed as a result of the wrapping of two or more multitopic 
ligands around a central core of metal centres. Alternatively, helices can be 
formed as a result of the aggregation of smaller supramolecular units. These two 
types of helices are observed in Ward’s silver helicate.(117) A double helicate is 
formed by the self-assembly of bidentate pyrazolyl-pyridine ligands coordinating 
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silver metal centres. These molecular complexes associate into larger polymeric 
arrays by silver-silver contacts (Figure 1.35).  
 
Figure 1.35: Polymeric double stranded helicate with Ag-Ag contacts (in magenta) 
(CCDC 862638).(117) 
 
Three of these double helices can associate to form a larger triple helicate 
with a quasi-cylindrical shape. The centre of the triple helix is occupied by 
perchlorate counter-ions (yellow) (Figure 1.36).(117) 
 
Figure 1.36: Triple helix of double helicates; long-side view (left) and end-on view (right) 
(CCDC 862638).(117) 
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1.3.2.  [M2L3] architectures 
A triple helix can also be formed when three ligands wrap around to metal centres. 
Hannon and co-workers have synthesised an imine based ligand that is able to 
coordinate octahedral metals to form triple helices. This bidentate ligand is formed 
by the conjugation of two pyridyl-imine units to an aryl ring. Consequently the 
imine bond is stable to hydrolysis. When coordinated to iron centres a racemate of 
triple helices is formed.(118) The two enantiomers can be resolved by cellulose 
column chromatography with a 20 mM NaCl solution as eluent.(119) This helicate is 
stabilized by inter-strand face-edge -stacking interactions between the phenylene 
rings of the spacer units (Scheme 1.2).(118) 
 
Scheme 1.2: Synthesis of iron(II) triple helicate. Crystal structure shows M enantiomer. 
(CCDC 622770).(84) 
 
This helicate is able to coil and bend DNA by binding around the major 
groove.(120) It can also recognize the central cavity of DNA and RNA three-way 
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junctions (vide supra).(81,121) It is proposed that the helicate can interact with the 
loops and grooves of telomeric G-quadruplex DNA.(122) Recently, it has been 
demonstrated that this triple helicate can act as an amyloid-inhibitor which could 
be used to treat Alzheimer’s disease, as the accumulation of amyloid- peptides is 
a sign of this illness.(123) The helicate is also a potent inhibitor of cellular 
proliferation in several cancerous cell lines. It induces cytostasis and apoptosis in 
myeloid leukemia cells and it is not genotoxic.(124) It is also able to displace Taq 
DNA polymerase from DNA which indicates that it might be able to interfere with 
DNA transaction processes (e.g. DNA replication). Its ruthenium analogue is also 
able to inhibit the polymerase chain reaction (PCR). However, due to the instability 
of the iron cylinder at the high temperatures which are required to performed a 
PCR experiment, this inhibition was not observed in the case of the iron 
cylinder.(125) 
 
1.3.3.  [M2L4] architectures 
The first saturated tetra-stranded helicate was reported by Steel in 1998. The use 
of square planar metal centres and monodentate ligands was crucial. The 
tetra-stranded complex was initially obtained via isolation of a dimeric complex, 
which reorganized and crystallised in the presence of hexafluorophosphate salts to 
yield the tetra-stranded helicate. Within the central cavity a hexafluorophosphate 
counter-ion is encapsulated (Scheme 1.3). This anion makes weak contacts with 
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the palladium(II) metal centres acting as a bridging ligand. This was also the first 
example of encapsulation of a polyatomic anion by a helicate.(126) 
 
Scheme 1.3: Synthesis of the first tetra-stranded helicate. 
 
Another interesting tetra-stranded palladium(II) complex has been designed 
by Clever. This tetra-stranded cage forms an interlocked dimer upon prolonged 
heating, and can host three tetrafluoroborate counter-ions (Scheme 1.4). The 
dimeric species has a strong chloride-anion binding ability and two of the 
tetrafluoroborate counter-ions can be displaced by chlorides, leaving the central 
tetrafluoroborate counter-ion strongly bound.(127) 
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Scheme 1.4: Formation of an interlocked dimer from a tetra-stranded cage 
(CCDC 844925).(127) 
 
These dimerization and encapsulation behaviours have also been seen in 
similar tetra-stranded cages.(128) 
 
1.3.4.  [M3L3] architectures 
One of the crucial requirements to yield a specific supramolecular assembly is the 
length, symmetry and flexibility of the ligands.(129) In this way, shorter bidentate 
ligands would form [M2L2] species while longer bidentate ligands would form [M3L3] 
supramolecules. This is observed in Würthwein nickel supramolecular square and 
triangle formation (Figure 1.37).(130) 
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Figure 1.37: Ligand structures (top) and crystal structures of [Ni2L2] (CCDC 854333)
(130) 
(bottom left) and [Ni3L3] (CCDC 854334)
(130) (bottom right). 
 
 
1.3.5.  [M4L4] architectures 
As mentioned above, in 1995 Fujita synthesised a platinum molecular square 
[Pt4L4] which was later shown to bind G-quadruplex DNA. One year after, Fujita 
presented his results on its palladium analogue (Figure 1.38). If the ligand length 
was increased by addition of different spacer units between the pyridine rings, a 
supramolecular double-walled triangle [Pd3L6] was formed as a minor product.
(131) 
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Figure 1.38: Crystal structure of Fujita’s Pd(II) molecular square (CCDC 753499).(131) 
 
 
1.3.6.  [M4L8] architectures 
Fujita explored then the introduction of a biphenyl unit between the coordinating 
pyridines in his ligand design. This ligand was reacted with naked palladium(II) 
ions ([Pd(NO3)2]) resulting in a dynamic equilibrium between a double-walled 
triangle [Pd3L6] and a tetrahedron [Pd4L8]. This equilibrium could be driven to one 
or the other structure depending on the counter-ion used. In the presence of 
nitrate anions the ratio between the double-walled triangle and the tetrahedron 
was 1:1. When using triflates, the double-walled triangle was formed as the major 
product. The formation of the pure tetrahedron was achieved when employing an 
aromatic anion, such as p-tosylate. This is due to the -stacking of the -surface of 
the anion to the phenyl rings on the spacer (Figure 1.39).(132) 
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Figure 1.39: Crystal structure of Fujita’s palladium(II) tetrahedron (CCDC 297117).(132) 
 
 
1.4. Closing remarks 
In summary, an overview of supramolecular chemistry has been given and 
some metallo-supramolecular structures have been used as examples. The 
emphasis was focused into structures that will be involved in the next chapter. The 
main characteristics of DNA and how it can be recognized by natural and synthetic 
agents has also been discussed. Recognition of duplex DNA via its major groove 
and minor groove, and by intercalation, phosphate binding and covalent binding to 
the DNA bases has been presented. Recognition of higher order DNA structures 
has also been summarized. The thesis aims are to create a large, water soluble 
supramolecular agent that might recognize the Holliday junction. The design 
features and approach to achieve this are described in chapter 2. Therefore, an 
understanding of the different modes in which a drug can interact with DNA is 
important in the evaluation of how the synthesised compounds interact with DNA 
and this will be discussed in chapter 3. 
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Chapter 2. Towards Solubilization of 
Palladium(II) Tetra-Stranded Cylinders 
 
 
2.1. Introduction 
As stated in Chapter 1, Hannon et al. have developed a triple-stranded helicate 
that is able to bind in the DNA major groove. Still more exciting, this cylindrical 
drug is of the perfect size and shape to fit in the central cavity of a Y-shaped DNA 
three-way junction (Figure 2.1).(81)  
 
Figure 2.1: Crystal structure of Hannon’s iron(II) cylinder bound in the central cavity of a 
DNA 3WJ; front view (left) and side view (right) (PDB 2ET0).(81) 
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Inspired by this breakthrough, Hannon and co-workers aimed to develop a 
tetra-stranded cylinder that might be capable of recognizing and binding within the 
central cavity of a DNA four-way junction (Figure 2.2). A DNA four-way junction, or 
Holliday junction, is an intermediate during homologous recombination and is 
important in DNA repair and the restart of failed replication forks (see section 
1.2.6.4.).(85) A potentially four-way junction binding drug might be able to stop DNA 
repair processes. One of the applications could be that when a cancer patient 
receives radiotheraphy, or is administered an alkylating anticancer drug like 
cisplatin, DNA strand breaks are produced and the Holliday junction-binding drug 
might stop normal DNA repair processes, causing the death of the tumour. 
 
Figure 2.2: Graphical representation of a potentially four-way junction binding drug in the 
central cavity of a DNA 4WJ (PDB 1Z1G).(90) 
 
The molecular design was inspired by that of the triple-stranded cylinder to 
ensure a similar interaction upon binding. It has been shown that each of the three 
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strands of the iron(II) cylinder interact with the bases of each of the three DNA 
strands at the centre of the trigonal cavity of the junction.(81) Therefore, it was 
hoped that a tetra-stranded cylinder will bind to the square central cavity of a DNA 
four-way junction in a similar fashion. For the triple stranded cylinder, an 
octahedral metal centre such as iron(II) was the metal of choice. In the case of the 
tetra-stranded molecule, a square planar metal was selected as this will give the 
square disposition of ligands that might be required to bind the square cavity of the 
DNA four-way junction. Palladium(II) was the first choice due to its reactivity, 
however other metals were also explored (vide infra). In terms of ligand design 
(Figure 2.3), the triple stranded iron(II) cylinder has three bidentate ligands with 
pyridine-imine units to satisfy the octahedral requirements of the iron(II) centres. In 
order to obtain a tetra-stranded complex in a square planar configuration, 
monodentate ligands are required. A pyridine unit was selected as there is a great 
number of examples of polypyridyl complexes.(110) The diphenyl spacer unit was 
maintained as it was shown to play an important role in DNA three-way junction 
recognition, with - stacking to the DNA bases.(81) It will also allow a dinuclear 
species since coordination of the two pyridines from the same ligand to the same 
metal centre cannot occur. 
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Figure 2.3: Structure of the bidentate ligand (Lim) used for the triple-stranded iron(II) 
cylinder (left) and structure of a monodentate ligand (L) used for tetra-stranded 
palladium(II) cylinders (right). 
 
It is worth mentioning that a DNA four-way junction is a more challenging 
target than a DNA three-way junction as the four-way junction can exist as two 
isomeric forms depending on the ion concentration. These forms are the 
X-stacked form, where the two arms interact with each other by stacking; and the 
open form, where the four DNA strands are spread out due to the electrostatic 
repulsion of the phosphate backbones (see section 1.2.6.4.).(87) 
Following these principles for molecular design, Hannon, Ryabova and 
Kaur synthesised several of these tetra-stranded complexes.(133,134) The crystal 
structure of the simplest one, [Pd2L4][(BF4)4], is shown in Figure 2.4, which 
confirms the formation of the tetra-stranded palladium(II) complex. This cylinder 
crystallises with a plane of symmetry through the centre of the four ligands and is 
therefore achiral. This is a consequence of the rigidity of the ligand, which results 
in an increase in the diameter of the cylinder compared to the chiral triple-stranded 
iron(II) cylinder.(133) 
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Figure 2.4: Crystal structure of the palladium(II) cylinder [Pd2L4][(BF4)4].
(133) 
 
The platinum(II) cylinder of the same ligand was also synthesised. The 
crystal structure revealed that these palladium and platinum cylinders are 
structurally identical. However, the synthesis of the platinum(II) complex was not 
straightforward and several purification cycles via HPLC were needed.(133,134) 
When using silver(I) as metal centre a tetra-stranded cylinder was not 
formed. Instead, two metallo-supramolecular polymers that display a zigzag 
architecture were obtained. The first silver(I) polymer presented an almost linear 
two-coordinate environment with a 1:1 metal to ligand stoichiometry. The second 
silver(I) polymer showed a three-coordinate environment for silver centres and a 
distorted trigonal planar geometry.(133) This is due to the varied coordination 
numbers (from two to six) and various geometries (linear, trigonal, tetrahedral and 
octahedral) that silver can adopt, and consequently a wide variety of 
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metallo-supramolecular arrays can be obtained. The final structure that will be 
formed is affected by the ligand composition, the counter ion and solvent, and the 
metal to ligand ratio used.(135) 
In order to investigate the effects of increasing the ligand size LTriple was 
also synthesised by Hannon and Kaur (Figure 2.5). In LTriple, ethynyl bonds have 
been incorporated between the central phenyl rings and the pyridine binding units. 
The cylindrical structure is analogous to that of [Pd2L4][(BF4)4], except that it is 
significantly larger. It remains an achiral molecule as the triple bond retains the 
rigidity of the ligand system.(133,134) 
 
Figure 2.5: Structure of ligands used in the first generation of compounds. 
 
The last ligand system explored by Hannon and Kaur was LEt (Figure 2.5). 
The central methylene unit was replaced by an ethylene, hoping to confer ligand 
flexibility. This minor change in the ligand design led to two products upon 
complexation with palladium(II), a double-walled triangle [Pd3L
Et
6][(BF4)6] and a 
tetrahedron [Pd4L
Et
8][(BF4)8]. Similar palladium(II) architectures have been 
described by Fujita and co-workers and reviewed in Chapter 1.(131,132) The 
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double-walled triangle was the major product and was crystallised from the crude 
mixture (Figure 2.6).(133) 
 
Figure 2.6: Crystal structure of the palladium(II) double-walled triangle 
[Pd3L
Et
6][(BF4)6].
(133) 
 
These complexes were tested against different human cancer cell lines in 
order to assess their cytotoxicity. The first complex [Pd2L4][(BF4)4] showed 
considerable cytotoxicity against ovarian A2780 and A2780cis (resistant to 
cisplatin) and breast T47D cancerous cells (Table 2.1). The IC50 values obtained 
via an MTT assay for three days were comparable or better to those obtained for 
cisplatin.(133,134)  
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Table 2.1: IC50 values (M) for palladium(II) cylinder [Pd2L4][(BF4)4] and cisplatin.
(133) 
 
Preliminary toxicological studies showed that this cylinder was also 
non-mutagenic and non-genotoxic.(133) These exciting results place this 
palladium(II) cylinder as a promising anticancer agent. The drawback of this 
compound is its low water solubility that prevented more detailed DNA binding 
studies.(133) 
 
2.2. Research aims 
Encouraged by the promising cytotoxicity, the challenge now is to improve the 
solubility of these compounds without significantly modifying their structure or 
quenching their activity against cancerous cells, and this is the focus of this 
chapter. It has been shown in the first generation of compounds that modifications 
on the length of the spacer unit affect the self-assembly process, therefore a single 
atom spacer will be kept between the phenyl rings. Additional bonds, such as the 
triple bond of LTriple, will not be considered either, as that palladium(II) complex 
was not toxic against cancerous cells. 
 
 
A2780 A2780cis T47D 
 
[Pd2L4][(BF4)4] 8.1 ± 1.3 10.3 ± 1.2 5.6 ± 0.5 
 
Cisplatin 4.5 ± 0.8 16.0 ± 1.8 28.3 ± 1.7 
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2.3. Results and discussion 
In this chapter four different strategies are explored towards the solubilization of 
the first generation of tetra-stranded palladium(II) cylinders (Figure 2.7). 
i) Modification of the spacer atom of the diphenyl unit (X). 
ii) Exchange of the counter-ion of the complex (Y). 
iii) Addition of potentially solubilizing groups at the edges of the pyridine 
rings (R). 
iv) Increase of the complex charge (+). 
 
Figure 2.7: Molecular design for second generation of palladium(II) cylinders. 
 
These four different approaches are discussed below and exemplified with new 
synthesised cylinders. A fifth strategy where the general design is affected is also 
explored. 
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2.3.1. Modification of the spacer unit 
In general, Hannon et al. have used a diphenylmethane spacer unit in their 
helicating ligands.(118) This carbon spacer unit could be modified to improve the 
solubility properties of the complexes and to potentially increase their DNA binding 
affinity. For this study, oxygen, nitrogen and sulfur were the chosen atoms for the 
central unit of the spacer group, as these are electron-rich atoms that can interact 
with solvent molecules or with the DNA bases. Oxygen had already been used as 
spacer group in the first generation of compounds and the solubility of this 
complex was slightly increased in organic solvent/water mixtures. 
In addition, it was thought that introduction of some functionality at the 
edges of the pyridine rings would be appropriate at this early stage too. Therefore, 
methyl ether groups were added at position 3† of the pyridine ring. This functional 
group was selected as 3-bromo-5-methoxypyridine is commercially available and 
will allow a straightforward synthetic route due to the low reactivity of the methyl 
ether group. This group also has the potential to be modified at a later stage. 
Position 3 of the pyridine ring was selected so as to add a substituent 
without substantially affecting the general structure of the ligand. Positions 2 and 6 
were ruled out due to their proximity to the metal binding site. Position 4 was also 
undesirable as a substituent in this position might interfere with the DNA binding. 
 
                                            
†
 Position 3 refers to the new numbering that the ligand will receive once the methyl ether group is 
introduced. It is formally position 5 in the parent ligand. 
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2.3.1.1. Molecular design of ligand LOMe 
Prior to the modification of the spacer unit with oxygen, nitrogen and sulfur, ligand 
LOMe with a carbon spacer unit was synthesised so that the consequences of the 
addition of the methyl ether group could be assessed. In order to access ligand 
LOMe the following retrosynthetic analysis was considered (Scheme 2.1). 
 
Scheme 2.1: Retrosynthetic analysis for ligand LOMe. 
 
5-(Methoxypyridin-3-yl)boronic acid 1 and bis(4-bromophenyl)methane 2 
are not commercially available and need to be synthesized as building blocks for 
ligand LOMe. 1 and 2 can then react via Suzuki cross-coupling reaction to form 
LOMe. The Suzuki coupling reaction was chosen over other C-C bond formation 
reactions, such as Negishi coupling, due to the low toxicity of the boronic acid 
precursor required and the easy elimination of the boron-containing side products. 
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2.3.1.2. Synthesis of 5-(methoxypyridin-3-yl)boronic acid (1) 
5-(Methoxypyridin-3-yl)boronic acid 1 was formed via metalation of 
3-bromo-5-methoxypyridine with n-butyllithium under an argon atmosphere at low 
temperature, achieved with a dry ice-acetone cooling bath. It is reported in the 
literature that the relative acidity of bromopyridines in THF can result in 
deprotonation of bromopyridines when the lithium-halogen exchange occurs.(136) 
To avoid this side reaction, extremely low temperatures (-100 ºC) are needed 
otherwise low yields are obtained. To prevent the deprotonation, an 
inverse-addition mode was performed. n-Butyllithium was added to toluene in a 
dry purged flask and then 3-bromo-5-methoxypyridine was added forming a brown 
precipitate. It is known that lithium-halogen exchange requires a coordinating 
solvent such as THF to disassociate the n-butyllithium aggregate. However, when 
using non-coordinating toluene the lithiation reaction occurs, therefore it is thought 
that the nitrogen of the pyridine is able to activate this exchange.(136) THF was 
added to the brown precipitate slowly, in order to keep the temperature below 
-70 ºC. When the organolithium intermediate was formed it was quenched by 
addition of triisopropyl borate and finally a 2 M HCl solution. Once neutralized, 
sodium chloride was added to the aqueous phase in order to enhance the partition 
of the boronic acid into the organic phase and therefore the yield (76%) (Scheme 
2.2). 
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Scheme 2.2: Synthesis of 5-(methoxypyridin-3-yl)boronic acid 1. 
 
Characterization of boronic acids is often complicated due to the formation 
of cyclic and linear anhydrides and semi-anhydrides when dehydrated. For 
example, p-toluene boronic acid can form its pure anhydride when warming it in 
anhydrous solvents such as carbon tetrachloride or chloroform.(137) Infrared 
spectroscopy (IR) can easily distinguish both species (boronic acid and anhydride) 
or a mixture of both (semi-anhydride) (Figure 2.8). In the case of 1, the IR spectra 
showed no OH band at around 3300 cm-1, indicating the absence of the boronic 
acid. However, it presented a strong and sharp band around 720 cm-1 which 
corresponds to the presence of the anhydride species. A band around 1412 cm-1 
was also detected which confirmed the B-O linkage. 
 
Figure 2.8: Structures of boronic acid and its anhydride. 
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The electron impact (EI+) mass spectrum did not show the presence of the 
molecular ion, however a peak at m/z 167 Da was observed and assigned to the 
compound where one of the hydroxyl groups has been substituted by a methoxy 
group. This is also observed when boronic acids are heated in the presence of 
methanol to yield the corresponding methyl boronate and free boronic acid.(138) 
During the mass spectrometry experiment the sample was dissolved in methanol 
and due to the high temperature of the instrument source the substitution 
occurred. The boron’s isotopic pattern consisting of 10B (20% distribution) and 11B 
(80% distribution) is also observed. 
A similar effect is also observed when performing a 1H NMR experiment in 
deuterated methanol. Boronic acid 1 degrades or interconverts with time and this 
becomes more evident after 20 hours in the NMR tube (Figure 2.9). 
 
Figure 2.9: 1H NMR spectra of 1 at t = 5 min and at t = 20 h (300 MHz, MeOD). 
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Boronic acid 1 was not further characterized and was used directly in the 
Suzuki coupling reaction. This is a common practice when using unstable boronic 
acids. 
An alternative method was also investigated so that the boronic acid 1 
could be isolated and not its anhydride. This was based on a modified literature 
protocol(139) where the borylation occurs in situ. The initial bromopyridine and 
triisopropylborate are placed together in a dry purged flask and n-butyllithium is 
added dropwise. This is based on the assumption that the lithium-halogen 
exchange is much faster than the reaction of n-butyllithium and triisopropylborate. 
Hence, the formed lithiopyridine reacts rapidly with the borate source so that it 
cannot undergo side reactions.(139) 
By following this procedure the boronic acid 1 was isolated in 48% yield as 
the water soluble HCl salt, as confirmed by EI+-MS with a peak at m/z 189 Da. 
The infrared spectrum presents a broad band at 3194 cm-1 which indicates the 
presence of the boronic acid. However, a sharp band at 693 cm-1 is also present. 
This band is assigned to the presence of the anhydride. Therefore, the isolated 
product might be a mixture of boronic acid and anhydride, the so-called 
semi-anhydride. 
Both boronic acids synthesised by the two different methods discussed 
above (inverse addition mode and in situ reaction) were reacted with 2 under the 
same reaction conditions in a Suzuki coupling. Conversion and yields were 
comparable. Therefore, since 1 was synthesised in a higher yield following the first 
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method, the inverse addition mode, this was the chosen protocol to synthesise 
successive batches of 1. 
 
2.3.1.3. Synthesis of the spacer building block 2 
The second building block necessary to synthesise ligand LOMe was prepared in 
two steps following a slightly modified literature protocol (Scheme 2.3).(140) 
 
Scheme 2.3: Two step synthesis of the carbon spacer building block. 
 
The mono-substituted lithium salt of 1,4-dibromobenzene was formed by 
addition of n-butyllithium under argon atmosphere and low temperature. This 
mixture was then added to 4-bromobenzaldehyde to form the intermediate alcohol 
3. Alcohol 3 was then reduced with sodium borohydride in trifluoroacetic acid, 
followed by quenching of the carbocation with water to yield 2. Alcohols that can 
form relatively stable carbocations in trifluoroacetic acid media can be reduced to 
the corresponding hydrocarbons due to the propensity of trifluoroacetic acid to 
stabilize carbocations. This particular secondary carbocation is also stabilized by 
the adjacent electron-rich phenyl rings. Both compounds 2 and 3 were fully 
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characterized, with the 1H and 13C NMR, EI+-MS and IR data in agreement with 
that reported in the literature.(140) 
 
2.3.1.4. Synthesis of ligand LOMe 
Once the building blocks were formed, the synthetic route towards the formation of 
ligand LOMe continued. Synthesis of ligand LOMe was first attempted following the 
previous reported protocol for the first generation of compounds.(133) 
5-(Methoxypyridin-3-yl)boronic acid 1 and bis(4-bromophenyl)methane 2 were 
reacted in a Suzuki cross-coupling reaction using Pd(PPh3)4 as catalyst and 
Na2CO3 as base in a 1:1 mixture of water and THF (Scheme 2.4). 
 
Scheme 2.4: Synthesis of ligand LOMe using Pd(PPh3)4 as catalyst. 
 
This protocol led to the formation of triphenylphosphine oxide. This side 
product made the purification of ligand LOMe more complex as both (ligand and 
triphenylphosphine oxide) were co-eluting on silica column chromatography and 
further purification (a second work up) was required to isolate the pure ligand LOMe. 
The yield was acceptable (60%), however this protocol was time consuming and 
therefore ineffective. 
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A new strategy was then applied based on a modified literature 
procedure.(141) The Pd(PPh3)4 catalyst was substituted by Pd2(dba)3, avoiding the 
formation of triphenylphosphine by-products (Scheme 2.5). 
 
Scheme 2.5: Synthesis of ligand LOMe using Pd2(dba)3 as catalyst. 
 
As confirmed by thin layer chromatography, ligand LOMe was formed as the 
predominant product; however starting materials and some side products were 
present too. Ligand LOMe was purified by silica flash column chromatography in 
66% yield.  
ESI+ mass spectrometry and 1H NMR spectroscopy confirmed the 
formation of ligand LOMe. The 1H NMR spectrum in deuterated chloroform reveals a 
single set of resonances characteristic of a symmetric ligand (Figure 2.10). 
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Figure 2.10: 1H NMR spectrum of ligand LOMe (300 MHz, CDCl3). 
 
Formation of the desired ligand LOMe was also confirmed by X-ray 
crystallography as shown in Figure 2.11. Crystals of LOMe were grown by slow 
evaporation of a solution of ligand LOMe in deuterated chloroform. The coordinating 
pyridine rings are nearly on the same plane with a small angle of 5º with respect to 
one another. This forces the phenyl rings to twist by 58º with respect to each other 
and by 37º with respect to the pyridine rings. The methyl ether groups at the sides 
of the pyridine rings are both pointing towards the outer edge of the ligand. This 
will be different upon formation of the complex (vide infra). 
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Figure 2.11: Crystal structure of ligand LOMe. 
 
2.3.1.5. Synthesis of the palladium(II) complex [Pd2L
OMe
4][(BF4)4] 
The first generation of palladium(II) complexes were synthesised overnight at 
room temperature using tetrakis(acetonitrile)palladium(II) tetrafluoroborate as the 
palladium source.(133) When employing this procedure a mixture of two compounds 
was isolated on a 10:1 ratio based on their relative 1H NMR signal intensities, with 
the desired tetra-stranded complex being the major product (Figure 2.12).  
 
Figure 2.12: 1H NMR spectrum of isolated crude mixture of [Pd2L
OMe
4][(BF4)4] 
(300 MHz, CD3CN). 
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This mixture could not be purified by washing with different solvents as 
performed on the first generation. This same reaction was monitored via 1H NMR 
spectroscopy in deuterated acetonitrile. It was observed that the formation of the 
tetra-stranded cylinder occurred within minutes and that the amount of the second 
product decreased with time (Figure 2.13). 
 
Figure 2.13: 1H NMR spectra of the reaction between LOMe and [Pd(CH3CN)4][(BF4)4] in 
CD3CN (300 MHz, CD3CN). 
 
It was also noticed that if the 1H NMR of the isolated [Pd2L
OMe
4][(BF4)4] 
crude mixture was carried out in deuterated dimethyl sulfoxide, the ratio 10:1 
progressively balanced to 1:1 after four days (Figure 2.14). 
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Figure 2.14: 1H NMR of [Pd2L
OMe
4][(BF4)4] crude mixture when the ratio of the two 
components becomes 1:1 (500 MHz, DMSO-d6). 
 
This change occurred without any observed precipitate and without a 
change in the amount of material as the overall integrals were constant (relative to 
the solvent), showing that there was an interconversion and not a degradation of 
the first major compound. It was then decided to monitor the reaction in deuterated 
dimethylsulfoxide by 1H NMR spectroscopy (Figure 2.15). The formation of the two 
compounds occurred within minutes and the ratios were constant with time. 
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Figure 2.15: 1H NMR spectra of the reaction of LOMe and [Pd(CH3CN)4][(BF4)4] in 
DMSO-d6 (300 MHz, DMSO-d6). 
 
Unfortunately, this second species was not detected by ESI-MS despite 
numerous attempts. Only the desired tetra-stranded complex was observed. This 
could imply that the two species are isomers or that the second species did not fly 
in the mass spectrometer. 
In order to better understand the nature of this second species an NMR 
diffusion experiment was performed. The DOSY NMR (diffusion-ordered 
spectroscopy) in deuterated dimethyl sulfoxide showed two species with different 
translation diffusion coefficients (Figure 2.16). 
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This implies that there are two different molecules of different size and 
shape that therefore diffuse with different coefficients. These two clearly different 
species may be assigned to a tetra-stranded box-like [Pd2L
OMe
4][(BF4)4] and a 
double-walled triangular [Pd3L
OMe
6][(BF4)6] species.  
 
Figure 2.16: DOSY NMR for [Pd2L
OMe
4][(BF4)4] crude (400 MHz, DMSO-d6). 
 
Similar findings were previously reported by Hannon et al. in copper 
helicates.(142) These copper helicates were formed via reaction of ligand Lim-Me 
(Figure 2.17) and [Cu(CH3CN)4][PF6] in methanol yielding two different 
compounds as shown by 1H NMR and ESI+-MS.  
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Figure 2.17: Structures of ligands Lim-Me and Lim-Et. 
 
These compounds were identified as a dimeric helix [Cu2L
im-Me
2][(PF6)2] 
which corresponded to the major species and a triangular helical trimer 
[Cu3L
im-Me
3][(PF6)3] as the minor species (Figure 2.18). The trimer was entropically 
disfavoured when reacting Lim-Et (Figure 2.17) with [Cu(CH3CN)4][PF6].
(143) 
 
Figure 2.18: Crystal structures of [Cu2L
im-Et
2][(PF6)2] dimer (CCDC 231266)
(143) (left) and 
[Cu3L
im-Me
3][(PF6)3] trimer (CCDC 187879)
(142) (right). 
 
The diffusion coefficients for the [Cu2L
im-Me
2][(PF6)2] dimer and 
[Cu3L
im-Me
3][(PF6)3] trimer in deuterated dichloromethane were found to be 
1.1 · 10-9 m2s-1 and 9.6 · 10-10 m2s-1 respectively.(142) These can be related to those 
obtained in deuterated dimethyl sulfoxide for the palladium [Pd2L
OMe
4][(BF4)4] 
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dimer (4.2 · 10-10 m2s-1) and the palladium [Pd3L
OMe
6][(BF4)6] trimer 
(3.5 · 10-10 m2s-1). The larger species in solution will move more slowly giving a 
smaller diffusion coefficient. A larger structure, such as [Pd4L
OMe
8][(BF4)8], can be 
discarded as this species will present two different environments for each four 
ligands. This type of supramolecular motif has been reported by Fujita (see section 
1.3.6.)(132) and has also been observed as a minor product in the first generation of 
compounds when using ligand LEt.(133) 
NOE NMR experiments were also performed on this two-component 
mixture. When exciting at both H9 protons, two different NOE contacts for the CH2 
spacer unit (H11) were evident (Figure 2.19). A singlet was observed for the dimer 
and two doublets were observed for the trimer. 
 
Figure 2.19: NOE 1H NMR spectra of [Pd2L
OMe
4][(BF4)4] crude with selective excitation on 
H9 of both species present in solution (500 MHz, DMSO-d6). 
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These two different resonances have been observed and assigned to the 
presence of a chiral and an achiral CH2 spacer unit in previous work in the Hannon 
group.(143) In that case this splitting was observed in a double-stranded copper 
cylinder due to the flexibility of the ligand Lim and the lability of the copper metal 
ions. These kind of complexes can adopt two conformations in solution that are in 
equilibrium leading to two isomeric structures: a helicate (rac-isomer) or a 
metallo-cyclophane or box architecture (meso-isomer). The box isomer appears 
when the ligand is too flexible to impose the same stereochemistry at both copper 
centres. The difference between both is the manner in which the ligands wrap 
around the axis defined by the metal ions (shown in orange); over and over in the 
box and over and under in the helix (Figure 2.20).  
 
Figure 2.20: Schematic representation of copper box and helix cylinders. 
 
In the helicate, both protons in the CH2 spacer unit are equivalent and 
therefore resonate as a singlet in the 1H NMR, whereas in the box they are 
different. One proton points into the cavity of the box while the other one points 
towards the exterior of the box (Figure 2.21). This is shown in the 1H NMR as a 
pair of doublets. 
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Figure 2.21: Copper box (left) and helicate (right) showing the positions of the CH2 
protons. 
 
The same effect will apply to the palladium trimer structure. One of the 
protons of the methylene spacer unit will be pointing towards one of the other 
ligands on the same edge of the triangle, and the other could be pointing out of the 
triangle (Figure 2.22). A coupling constant of 13 Hz was observed for the pair of 
doublets which is in complete agreement to that observed for the 
copper-cyclophane. 
 
Figure 2.22: Trimer (left) and dimer (right) showing the position of the CH2 protons. 
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Double-walled triangular species have also been identified in the first 
generation of palladium(II) complexes with LEt (see section 2.1.) and when 
exchanging the tetrafluoroborate counter-ions of the parent palladium(II) cylinder 
with trifluoroacetic anions. It was crystallized from a crude mixture however, once 
again, the molecular ion for this species was not able to be observed via 
ESI-MS.(133) 
Variable temperature 1H NMR experiments were performed on the 1:1 
mixture of compounds in deuterated dimethyl sulfoxide (Figure 2.23).  
 
Figure 2.23: Variable temperature 1H NMR of [Pd2L
OMe
4][BF4)4] crude mixture 
(400 MHz, DMSO-d6). 
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It was observed that the trimeric species nearly disappeared when 
increasing the temperature. This means that the species with lower nuclearity is 
favoured at high temperature. When the sample was cooled down, the trimeric 
species started to appear again however it needed 4 days to equilibrate to the 1:1 
ratio. It is then clear that there is an equilibrium between these two species. The 
tetra-stranded complex is favoured at higher temperatures and the triangle 
formation occurs with time in dimethyl sulfoxide. This might be due to the lability of 
the Pd-N bond. 
Different HPLC purification methods on reverse-phase columns were 
explored in order to isolate both compounds separately and properly characterize 
both species. An acetonitrile-water gradient from 100% water to 100% acetonitrile 
over 40 minutes gave an analytical HPLC chromatogram with trimer, dimer and 
free ligand eluting together at around 30 minutes; hence it was impossible to 
separate them. Increasing the polarity of the solvent system was explored in order 
to separate these two species. It was known from the first generation of complexes 
that when using trifluoroacetic acid to increase the polarity of the solvent system, 
the tetrafluoroborate counter-ion was exchanged during the course of the HPLC 
run. This led to the formation of trimeric species,(133) therefore trifluoroacetic acid 
was discounted. A good separation was achieved instead by incorporating a 
0.05% solution of tetrabutylammonium tetrafluoroborate salt in both acetonitrile 
and water solvents. A ramp over 40 minutes from water to acetonitrile yielded two 
main peaks. These two peaks were collected separately and analyzed via 
1H NMR. The first peak corresponded to the ligand and the second to the 
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tetra-stranded complex. This tetra-stranded complex contained a significant 
amount of tetrabutylammonium salt. The sample was passed through a desalting 
column resulting in a decrease of the salt concentration but complete removal 
could not be achieved. This might be due to the “large” size of the 
tetrabutylammonium salt for this kind of size exclusion column. However, a 
“smaller” salt (tetramethylammonium tetrafluoroborate) was also employed without 
success.  
The trimer could not be identified from any of the smaller peaks from the 
HPLC chromatogram via ESI-MS (a sufficient amount for a 1H NMR experiment 
could not be collected). Free ligand was not observed in any of the previous NMR 
studies, however it was present in the HPLC analysis. This could indicate that the 
trimer is decomposing during the HPLC purification process to yield the free 
ligand. 
Since HPLC could not be used to fully purify the tetra-stranded palladium(II) 
cylinder, a new strategy needed to be applied. Variable temperature 1H NMR 
showed that the desired tetra-stranded complex was the more stable species at 
high temperatures. It was therefore decided to perform the reaction with heat 
instead of at room temperature. Ligand LOMe was coordinated to palladium(II) by 
adding tetrakis(acetonitrile)palladium(II) tetrafluoroborate to a hot solution of ligand 
LOMe in acetonitrile. The mixture was heated at 80 ºC for 6 hours. Diethyl ether was 
added to the solution to precipitate a white solid in 78% yield. The 1H NMR shows 
peaks corresponding to only one species, which corresponds to the peaks of the 
dimeric species seen previously in the crude mixture. If compared to the free 
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ligand, there is a downfield shift of the protons close to the nitrogen upon 
coordination of the palladium metal centre due to a deshielding effect, caused by a 
reduced electron density of these protons, especially for protons  to the nitrogen 
(H2 and H6) (Figure 2.24). The proton assignment was performed with the aid of a 
2D-COSY and a 2D-NOESY. The NOESY experiment proved to be particularly 
useful as contacts between H6 and H8 as well as contacts between H2 and H12 
were observed. 
 
Figure 2.24: Comparison of 1H NMR spectra in CD3CN of L
OMe (top) and 
[Pd2L
OMe
4][(BF4)4] (bottom)
‡. 
 
                                            
‡
 Please note that assignment of the protons of L
OMe
 was performed with the aid of a NOESY 
experiment in CDCl
3
. Ligand L
OMe
 was not soluble enough to perform the NOESY experiment in 
CD
3
CN. It has been assumed that the positions of the protons have not significantly changed even 
if the chemical shifts are slightly different. This will be the case for all L
X-OMe
 ligands in this section. 
 
Chapter 2 
Towards Solubilization of Palladium(II) Tetra-Stranded Cylinders 
82 
 
It was also observed that the 1H NMR spectrum suffered variations in the 
chemical shifts of H6 and H2 protons depending on the concentration selected to 
perform the experiment (Figure 2.25). These are the protons closest to the 
coordinating nitrogen donors and thus this could indicate some lability of the Pd-N 
bond. 
 
Figure 2.25: Stacked 1H NMR spectra of [Pd2L
OMe
4][(BF4)4] at different concentrations 
(300 MHz, CD3CN). 
 
MALDI-TOF was employed to attempt to characterize the tetra-stranded 
complex. It showed a peak for the molecular ion [(Pd2L
OMe
4)+3BF4]
+ at 
m/z 2003 Da and another peak at m/z 778 Da that could be assigned to 
[(Pd2L
OMe
4)+BF4+NaBF4]
3+. The other peaks could not be assigned to any other 
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species related to the tetra-stranded complex. This might be due to the interaction 
of the complex with the matrix, 2,4,6-Trihydroxyacetophenone (THAP), so that the 
spectra cannot be interpreted. Other matrixes were employed (gentisic acid and 
6-aza-2-thiothymine) with no success. It has also been observed previously that 
the detection of high charge species of this kind is very rare via MALDI-TOF, with 
the molecular ion being the only possible species found. 
ESI+-MS gave a more useful result, as [Pd2L
OMe
4]
4+, [Pd2L
OMe
4(BF4)]
3+, 
[Pd2L
OMe
4(BF4)2]
2+ and [Pd2L
OMe
4(BF4)3]
+ species could be detected. Some free 
ligand was also observed due to the breakage of the complex during ionization. 
Low cone voltages (10-15 eV) are normally used to minimize this kind of side 
product, however sometimes they are inevitable. In contrast to the iron(II) triple 
stranded cylinders, the cationic species were always present together with their 
counter-ions. This might indicate a strong attraction of the tetrafluoroborate 
counter-ions to the palladium(II) metal centres.  
The infrared spectrum showed a characteristic band at 1032 cm-1 for the 
non-coordinated BF4
- anions. 
19F NMR spectroscopy was also used to determine whether the four 
tetrafluoroborate counter-ions are equivalent or not. The 19F NMR showed two 
peaks (Figure 2.26). These two peaks are very close to each other and therefore 
cannot be due to different environments of the anions within the molecule. This 
splitting is due to the boron isotopes (10B and 11B). The abundance of these 
isotopes is 20% and 80% respectively and that is the ratio observed between the 
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relative intensity of their NMR signals. These observations have been previously 
reported by Levinger et al.(144) The chemical shifts are also in good agreement with 
that of free tetrafluoroborate anions in acetonitrile solutions.(127) 
 
Figure 2.26: 19F NMR of [Pd2L
OMe
4][(BF4)4] (300 MHz, CD3CN). 
 
Colourless crystals of this pure tetra-stranded complex suitable for X-ray 
diffraction were obtained by the slow diffusion of diethyl ether into a solution of the 
complex in acetonitrile. The X-ray crystal structure confirms the formation of the 
tetra-stranded, dinuclear palladium(II) complex (Figure 2.27). Each metal centre 
occupies a four-coordinate, square planar environment with Pd-N bond distances 
of 2.023(8) - 2.039(8) Å and N-Pd-N angles of 88.3(3) - 92.1(3)º. The two 
palladium centres are related by an inversion centre at the centre of the cavity 
such that only half of the molecule is crystallographically unique, with a symmetry 
relation of -x,-y,-z+2. There is also an approximate plane of symmetry through the 
four ligands which yields an achiral structure, as was also seen in the first 
generation of palladium(II) cylinders. 
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Figure 2.27: Crystal structure of [Pd2L
OMe
4][(BF4)4], side view (left) and top view (right). 
Hydrogen atoms, solvent molecules and counter-ions have been omitted for clarity. 
 
The four ligands bridge the two palladium(II) centres resulting in a Pd···Pd 
separation of 12.4 Å. Within the ligands, the phenyl rings are twisted with respect 
to one another by 59º and 65º and with respect to the pyridine rings by 33º and 
37º. The twisting of the phenyl rings in the complex is greater than that observed 
for the ligand (59º and 65º versus 58º). This results in a wider angle between the 
coordinating pyridines (9º and 13º in the complex and 5º in the ligand). The 
disposition of the four ligands around the two palladium(II) metal centres yields a 
central cavity (Figure 2.28).  
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Figure 2.28: Spacefill representation of [Pd2L
OMe
4][(BF4)4] (left). Hydrogen atoms, solvent 
molecules and counter-ions have been omitted for clarity. Capped sticks representation of 
[Pd2L
OMe
4][(BF4)4] (right). 
 
This cavity is home to two tetrafluoroborate counter-ions and four water 
molecules (Figure 2.28), that interact with each other via hydrogen bonds with 
donor-acceptor distances of 2.782(12) - 3.233(11) Å (Figure 2.29). 
 
 
 
 
Figure 2.29: Views of the interaction between encapsulated tetrafluoroborate counter-ions 
and water molecules. 
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The other two tetrafluoroborate counter-ions are outside the cavity along 
the axis of the palladium centres. Each of these anions interacts with another 
tetrafluoroborate anion of the next molecule in the crystal packing via weak 
hydrogen bonds with acetonitrile molecules (Figure 2.30). 
 
Figure 2.30: Crystal packing of two [Pd2L
OMe
4][(BF4)4] molecules. 
 
The overall length of this cylinder is greater than that observed for the first 
generation palladium(II) complex due to the introduction of the methyl ether group 
(C···C 19.7 Å and 15.0 Å : H··H 21.2 Å and 16.6 Å, respectively). The new 
palladium(II) complex is also bigger than its predecessor in terms of its diameter 
(C···C 14.4 Å : H··H 15.6 Å compared to C···C 13.7 Å : H··H 14.9 Å, measured 
from the central methylene spacer unit of one ligand to the opposite ligand). This 
difference in diameter arises from the different twisting observed on the spacer 
phenyl rings. In the parent palladium(II) cylinder the phenyl rings twist with respect 
to one another by 71º and 74º, while in the newly synthesised complex the twist is 
59º and 65º.  
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This novel palladium(II) cylinder is soluble in dimethyl sulfoxide as is the 
parent analogue. However, it shows better solubility in acetonitrile and acetone, as 
well as organic solvent/water mixtures. 
 
2.3.1.6. Synthesis of ligands LO-OMe, LNH-OMe and LS-OMe 
In order to improve the solubility of the newly synthesised palladium(II) complex 
[Pd2L
OMe
4][(BF4)4], the CH2 spacer unit was substituted by O, NH and S to form 
ligands LO-OMe, LNH-OMe and LS-OMe respectively. Analogous retrosynthetic analysis 
was performed for the formation of the new ligands (Scheme 2.6). 
 
Scheme 2.6: Retrosynthetic analysis of ligands LX-OMe (X = O, NH, S). 
 
Bis(4-bromophenyl) ether and bis(4-bromophenyl)amine are commercially 
available, while bis(4-bromophenyl)sulfide was synthesised in 80% yield via 
bromination of diphenyl sulfide in dichloromethane (Scheme 2.7). Flash column 
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chromatography on silica gel with hexane as eluent was used to separate the 
monobrominated product from the desired bis(4-bromophenyl)sulfide 4. 
 
Scheme 2.7: Synthesis of bis(4-bromophenyl)sulfide 4. 
 
Synthesis of LO-OMe, LNH-OMe and LS-OMe ligands was also achieved via 
Suzuki coupling reaction following the Pd2(dba)3 protocol used for the synthesis of 
ligand LOMe (Scheme 2.8). 
 
Scheme 2.8: Synthesis of ligands LO-OMe, LNH-OMe and LS-OMe. 
 
High resolution ESI+-MS confirms the formation of LO-OMe, LNH-OMe and 
LS-OMe ligands with the presence of the corresponding protonated molecular ions. 
As expected the 1H NMR spectra (Figure 2.24) are very similar to each 
other with nearly a complete overlay of the pyridine protons (H2, H6 and H4). The 
main differences are in the phenyl protons (H8 and H9) due to the effect of the 
different spacer units (CH2, O, NH and S). The peak corresponding to the CH2 
protons at 4.09 ppm is obviously missing in the three spacer modified ligands, and 
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in the case of ligand LNH-OMe, the proton assigned to the NH from the spacer 
appears at 6.12 ppm.  
 
Figure 2.31: 1H NMR spectra of the four methyl ether ligands: LOMe, LO-OMe, LNH-OMe and 
LS-OMe (300 MHz, CDCl3). 
 
Colourless crystals of LO-OMe suitable for X-ray diffraction were obtained via 
slow evaporation of a deuterated chloroform solution of LO-OMe (Figure 2.32). This 
structure is very similar to that seen for its analogue LOMe. The two pyridine rings 
are nearly coplanar with a small angle of 4º. Also the phenyl rings are twisted with 
respect to one another by 61º and with respect to the pyridine rings by 38º. 
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Figure 2.32: Crystal structure of ligand LO-OMe. 
 
 
2.3.1.7. Synthesis of the palladium(II) complexes [Pd2L
O-OMe
4][(BF4)4], 
[Pd2L
NH-OMe
4][(BF4)4] and [Pd2L
S-OMe
4][(BF4)4]. 
As for the palladium complex of ligand LOMe, complexation of ligands LO-OMe, 
LNH-OMe and LS-OMe was achieved by heating the corresponding ligand and 
tetrakis(acetonitrile)palladium(II) tetrafluoroborate for 6 hours at 80 ºC. 
Formation of the complexes was confirmed by NMR, ESI+-MS and IR as 
was also verified for [Pd2L
OMe
4][(BF4)4]. In the case of the 
1H NMR, the complexes 
show bigger differences between each other compared to their ligands on their 
own (Figure 2.33). This indicates the different donor character of the different 
ligands upon coordination.  
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Figure 2.33: 1H NMR spectra of the four methyl ether palladium(II) complexes: 
[Pd2L
OMe
4][(BF4)4], [Pd2L
O-OMe
4][(BF4)4], [Pd2L
NH-OMe
4][(BF4)4] and [Pd2L
S-OMe
4][(BF4)4] 
(300 MHz, CD3CN). 
 
Doubly and triply charged species are observed in the electrospray mass 
spectra for [Pd2L
O-OMe
4][(BF4)4] and [Pd2L
NH-OMe
4][(BF4)4]. A mass spectrum for 
[Pd2L
S-OMe
4][(BF4)4] could not be obtained. This could be due to poor solubility or a 
lack of ionization of the species in the spectrometer.  
A band around 1030 cm-1 was observed for all three complexes in their 
infrared spectra corresponding to the non-coordinated tetrafluoroborate anions.  
13C NMR spectra were recorded in deuterated acetonitrile for all methyl 
ether complexes, except for [Pd2L
S-OMe
4][(BF4)4] due to its low solubility in 
acetonitrile. It was decided not to use deuterated dimethyl sulfoxide as it would be 
[Pd2L
OMe
4][(BF4)4] 
[Pd2L
NH-OMe
4][(BF4)4] 
[Pd2L
S-OMe
4][(BF4)4] 
[Pd2L
O-OMe
4][(BF4)4] 
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very difficult to recover the solid from this solvent. Table 2.2 shows a comparison 
of the different chemical shifts observed in the 13C NMR spectra. Small shifts are 
observed for carbons C8 and C9 on changing the spacer unit. Downfield shifts 
occur upon complexation for carbons C6 and C2. Overall, few changes are noted 
in the 13C NMR spectra and little information can be obtained. 
Table 2.2: 13C NMR chemical shifts (ppm) for methyl ether ligands and their complexes. 
 C6 C2 C4 C9 C8 OCH3 CH2 
LOMe 140.9 136.1 119.2 129.8 127.6 55.8 41.4 
[Pd2L
OMe
4][(BF4)4] 141.8 138.0 124.7 130.8 128.8 57.7 41.1 
LO-OMe 140.8 136.1 119.1 119.7 128.9 55.8 - 
[Pd2L
O-OMe
4][(BF4)4] 141.3 137.8 124.3 120.7 130.4 57.8 - 
LNH-OMe 140.5 135.6 118.7 118.4 128.4 55.8 - 
[Pd2L
NH-OMe
4][(BF4)4] 141.0 137.0 122.6 119.5 129.2 57.6 - 
 
Suitable yellow crystals for x-ray diffraction were obtained by slow diffusion 
of diethyl ether into an acetonitrile solution of [Pd2L
NH-OMe
4][(BF4)4]. The X-ray 
crystal structure confirms that the tetra-stranded, dinuclear palladium(II) complex 
has been formed (Figure 2.34).  
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Figure 2.34: Crystal structure of [Pd2L
NH-OMe
4][(BF4)4], side view (left) and top view (right). 
Hydrogen atoms, solvent molecules and counter-ions are omitted for clarity, except the 
hydrogen of the NH group. 
 
Each metal centre has a four-coordinate, square planar geometry with Pd-N 
bond distances of 2.021(7) - 2.042(6) Å and N-Pd-N angles of 88.3(3) - 91.8(3)º. 
An inversion centre at the centre of the palladium complex relates the two metal 
centres so that only half of the molecule is crystallographically unique with a 
symmetry relation of -x,-y,-z+2. There is also an approximate plane of symmetry 
through the four ligands which yields an achiral structure, as was also seen in 
[Pd2L
OMe
4][(BF4)4]. The four ligands bridge the two palladium(II) centres resulting 
in a Pd···Pd separation of 13.5 Å, which is 1.1 Å greater than the intermetallic 
distance observed in [Pd2L
OMe
4][(BF4)4]. This is a result of the substitution of the 
carbon central unit by nitrogen. Within the ligands, the phenyl rings are twisted 
with respect to one another by 45º and with respect to the pyridine rings by 21º 
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and 35º. The coordinating pyridines are nearly coplanar (5º and 12º). The 
disposition of the four ligands around the two palladium metal centres yields a 
central cavity. This cavity is home to two tetrafluoroborate counter-ions and two 
acetonitrile molecules that interact with each other via weak hydrogen bonds 
(Figure 2.35).  
 
Figure 2.35: Capped sticks representation of [Pd2L
NH-OMe
4][(BF4)4] (left) and interaction 
between encapsulated counter-ions and acetonitrile molecules (right). 
 
The other two tetrafluoroborate counter-ions are outside the cavity along 
the axis of the palladium centres. They also interact with each other via weak 
hydrogen bonds through acetonitrile molecules as seen for [Pd2L
OMe
4][(BF4)4] 
(Figure 2.36).  
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Figure 2.36: Crystal packing of two [Pd2L
NH-OMe
4][(BF4)4] molecules. 
 
Hydrogen bond contacts are also observed between a tetrafluoroborate anion and 
the NH groups of two palladium cylinders, with donor-acceptor distances of 
2.919(13) – 3.207(16) (Figure 2.37). 
 
Figure 2.37: Hydrogen bond interaction between a BF4 counter-ion and NH group of two 
[Pd2L
NH-OMe
4][(BF4)4] molecules. 
 
This hydrogen bond interaction combined with the weak interaction 
between anions along the axis of the palladium centres can be seen in the crystal 
packing of four cylinders as depicted in Figure 2.38. 
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Figure 2.38: Crystal packing of 4 molecules of [Pd2L
NH-OMe
4][(BF4)4]. 
 
This cylinder is slightly longer than its analogous [Pd2L
OMe
4][(BF4)4] (C···C 
20.2 Å : H··H 21.5 Å), which makes it less wide, with a diameter of N···N 12.9 Å : 
H··H 14.6 Å measured from the central amine spacer unit of one ligand to the 
opposite ligand). These differences are a consequence of the different twisting 
angles within the ligands. 
 
2.3.1.8. Solubility of spacer modified tetra-stranded palladium(II) complexes 
The variation of the element at the spacer diphenyl unit yielded four novel 
compounds that are soluble in dimethyl sulfoxide and fairly soluble in acetonitrile, 
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with [Pd2L
O-OMe
4][(BF4)4] and [Pd2L
NH-OMe
4][(BF4)4] being easier to solubilise. In 
addition, the cylinder with the NH spacer is partially soluble in methanol. The 
S-modified complex is barely soluble in acetonitrile, therefore it will not be studied 
further. 
 
2.3.2. Exchange of the counter-ion of the complex 
The second strategy that was explored was the exchange of the counter-ions of 
the complex. 
Nitrate salts are generally water soluble since the negative charge is 
distributed among the three oxygen atoms, facilitating water solvation. Chloride 
salts are also known to be water soluble compounds and are generally used in 
water soluble cationic drugs (e.g. Hannon’s triple-stranded cylinder). Only silver, 
lead and mercury present insoluble chloride salts in a two element compound 
combination. It has also been demonstrated that some platinum complexes 
present an increase in water solubility when using triflates 
(trifluoromethanesulfonate) as counter-ion.(145) These three different anions were 
chosen to explore the solubility of the tetra-stranded palladium(II) cylinders. The 
tetrabutylammonium salt of the different anions (nitrate, chloride and triflate) was 
used to exchange the original tetrafluoroborate counter-ion. The exchange can be 
performed by addition of a saturated solution of the corresponding 
tetrabutylammonium salt into either a concentrated solution of the crude reaction 
mixture or into an acetonitrile solution of the pure redissolved palladium(II) 
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tetrafluoroborate complex. In both cases, the palladium(II) complex with the 
exchanged counter-ion precipitates out of the acetonitrile solution and can be 
isolated by filtration. 
This strategy of exchange of the counter-ion was investigated for the 
[Pd2L
OMe
4][(BF4)4] complex. The complex was dissolved in the minimum amount 
of acetonitrile and an excess of tetrabutylammonium nitrate, chloride or triflate in 
acetonitrile solutions was added dropwise. The complexes precipitated and were 
collected via filtration. They were all redissolved in deuterated acetonitrile and their 
1H NMR spectra compared (Figure 2.39). For BF4
- and CF3SO3
- the concentration 
was 1.5 mM. In the case of NO3
- and Cl- a concentration of 1.5 mM could not be 
reached due to the lower solubility in acetonitrile and a precipitate was observed in 
the NMR tube.  
It is noticeable that the protons next to the nitrogen of the pyridine, H2 and 
H6, are displaced downfield when exchanging the counter-ion. This result might 
indicate the close presence of the counter-ion to the metal centre which holds the 
positive charge, or even a very weak bond on the sometimes observed fifth 
position of the palladium coordination sphere. Therefore, the proximity of different 
counter-ions to those H2 and H6 protons affects their chemical shift. This is in 
agreement with the observed location of a tetrafluoroborate counter-ion on the 
outer side of both palladium(II) centres in the crystal structure of the 
[Pd2L
OMe
4][(BF4)4] complex. 
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Figure 2.39: 1H NMR spectra of [Pd2L
OMe
4][(X)4] where X = BF4
-, NO3
-, CF3SO3
- and Cl- 
(300 MHz, CD3CN). 
 
The 1H NMR data also suggests the decomposition of the complex when 
changing the tetrafluoroborate anion to chloride, yielding the ligand. This might be 
due to the lability of the Pd-N bond and the formation of a stronger bond with 
chloride to yield PdCl2 or [PdCl4]
2-. 
The newly formed [Pd2L
OMe
4][(NO3)4] and [Pd2L
OMe
4][(CF3SO3)4] 
complexes were also analyzed by mass spectrometry and infrared spectroscopy. 
Different ESI+-MS methods were tested in order to obtain a spectrum, however it 
was impossible to ionize these complexes and make them fly through the 
[Pd2L
OMe
4][(BF4)4] 
[Pd2L
OMe
4][(BF4)4] + NBu4CF3SO3 
[Pd2L
OMe
4][(BF4)4] + NBu4Cl 
[Pd2L
OMe
4][(BF4)4] + NBu4NO3 
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spectrometer. This is something commonly observed in nitrate salts. This was also 
observed for the triflate complex. 
The infrared spectra of these complexes shows a lack of the characteristic 
tetrafluoroborate band at 1032 cm-1 and the appearance of nitrate and triflate 
bands at 1317 cm-1 and 1027 cm-1, respectively.  
Once the complexes were analysed, their solubility was studied. When 
exchanging to nitrate counter-ions, the complex becomes more soluble in organic 
solvents such as chloroform. The solubility of the triflate complex in acetonitrile 
increased considerably, however it remains insoluble in pure water. As mentioned 
above, the chloride complex could not be achieved. It was also reported for the 
first generation of compounds that when using a Dowex-Cl resin to exchange the 
tetrafluoroborate anions to chloride, the complex decomposed into a complicated 
mixture.(133) 
An interesting approach to achieve an increase in solubility by exchanging 
the counter-ions was reported by Kuroda and co-workers.(146) They observed that 
their tetra-stranded palladium(II) receptor can form a 1:2 host:guest complex with 
p-toluenesulfonate (OTs-) or 2-naphthalenesulfonate (ONs-) via anion 
encapsulation. A first generation sulfonate dendrimer was able to increase the 
complex solubility in low polar solvents. Chiral induction was also achieved with 
d- or l-camphor sulfonate (Figure 2.40). These encapsulation processes occurred 
via - stacking, hydrogen bonding between host and guest and Pd2+ ··· O3SR
- 
interactions. 
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Figure 2.40: Crystal structure of Kuroda’s palladium(II) tetra-stranded host with 
encapsulated d-camphor sulfonate (CCDC 827758).(146) 
 
The crystal structures of the synthesised palladium(II) cylinders presented 
above showed encapsulation of two of the four counter-ions. In order to study the 
interaction of these complexes with different counter-ions, an anion titration NMR 
experiment was performed. Titration of a deuterated acetonitrile solution of 
tetrabutylammonium trifluoromethanesulfonate into a [Pd2L
OMe
4][(BF4)4] 
deuterated acetonitrile solution presented the spectra shown in Figure 2.41. 
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Figure 2.41: 1H NMR spectra of titrations of NBu4OTf into [Pd2L
OMe
4][(BF4)4] 
(300 MHz, CD3CN) 
 
A downfield shift of the -pyridyl protons H6 ( 0.08 ppm) and H2 
( 0.16 ppm) is observed. This shift suggests that the substitution of anions 
occurs initially on the outside of the complex as H2 presents a higher shift 
increment. In Kuroda’s palladium(II) complex, H2 did not experience a downfield 
shift while H6 was moved substantially by 0.25 – 0.83 ppm. 
Greater interaction with the outer triflate counter-ions was shown for the 
[Pd2L
NH-OMe
4][(BF4)4 complex. Shifts of 0.04 ppm for H6 and 0.15 ppm for H2 were 
observed. This might be due to the interaction of the triflate anion with the NH 
group of the spacer unit as seen in the crystal structure of [Pd2L
NH-OMe
4][(BF4)4 
(see Appendix). 
[Pd2L
OMe
4][(BF4)4] 
[Pd2L
OMe
4][(BF4)4] + 1 eq.NBu4OTf 
[Pd2L
OMe
4][(BF4)4] + 2 eq.NBu4OTf 
[Pd2L
OMe
4][(BF4)4] + 3 eq.NBu4OTf 
[Pd2L
OMe
4][(BF4)4] + 4 eq.NBu4OTf 
[Pd2L
OMe
4][(BF4)4] + 5 eq.NBu4OTf 
[Pd2L
OMe
4][(BF4)4] + 6 eq.NBu4OTf 
[Pd2L
OMe
4][OTf4] 
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- stacking interactions of anion guests were assessed by titration of 
tetrabutylammonium p-toluenesulfonate (NBu4OTs) into a [Pd2L
OMe
4][(BF4)4] 
deuterated acetonitrile solution. Downfield shifts of 0.87 and 0.48 ppm were 
observed for H2 and H6 respectively. An upfield shift ( 0.08 ppm) was also 
observed for H4 (Figure 2.42). These results indicate exchange of the counter-ions 
outside the cavity. - stacking interactions sandwiching the tosilate counter-ion 
between cylinders might be occurring, rather than - stacking between the 
strands and anions inside the cavity. 
In contrast to Kuroda’s guest, the newly synthesised palladium(II) 
supramolecular cylinders tend to exchange their outer counter-ions as these are 
readily available. Intermolecular interactions might be observed between anions 
and cylinders. 
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Figure 2.42: 1H NMR spectra of titrations of NBu4OTs into [Pd2L
OMe
4][(BF4)4] 
(300 MHz, CD3CN) 
 
 
2.3.3. Addition of potentially solubilizing groups at the edges of the pyridine 
rings 
As discussed above, position 3 of the pyridine ring was chosen to introduce some 
functionality into the molecule in order to achieve an increase in the solubility of 
the palladium(II) complexes. Alcohol groups, glycol chains and alkyl-chained 
pyrrolidines were the motifs explored and are discussed below. 
 
[Pd2L
OMe
4][(BF4)4] 
[Pd2L
OMe
4][(BF4)4] + 1 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 2 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 3 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 4 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 5 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 6 eq.NBu4OTs 
[Pd2L
OMe
4][(BF4)4] + 10 eq.NBu4OTs 
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2.3.3.1. Molecular design of LOH 
The methyl ether was introduced at position 3 of the pyridine rings on the spacer 
modified ligands, as well as on the methylene spacer cylinder, in order to start to 
introduce some functionality to the new cylinders. This methyl ether group can 
potentially be cleaved to further increase the solubility of the new complexes. 
Once the methyl ether is cleaved the ligands will have a hydroxyl functional group 
at each side. These hydroxyl groups might be able to hydrogen-bond to water 
molecules. 
 
2.3.3.2. Synthesis of ligands LOH, LO-OH and LNH-OH 
Ligands LOH, LO-OH and LNH-OH were accessed using a Lewis acid, such as boron 
tribromide or aluminium trichloride, for the o-demethylation. Aluminium trichloride 
proved to be the most successful Lewis acid for this deprotection in conjunction 
with ethanethiol. Initially the Lewis acid forms a complex with the ethereal oxygen 
atom via a dative bond. Then, the divalent sulfur acts as a soft nucleophile 
attacking the methyl electron deficient carbon of the oxonium species via an SN2 
mechanism. Hydrolysis leads to the deprotected alcohol (Scheme 2.9). 
 
Scheme 2.9: Synthesis of ligands LOH, LO-OH and LNH-OH. 
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The reaction went to completion after 2 days. More reactive species such 
as aluminium tribromide or chloroaluminate ionic liquids could be used in the 
future for a shortened reaction time, however these were not investigated. 
Yields for the deprotection of LOMe and LO-OMe were acceptable, however 
very poor yields were obtained when trying to deprotect LNH-OMe. This yield was 
even lower when attempting a scale up of the reaction. This may be due to the fact 
that during the course of the reaction acidic species are produced that may 
protonate the NH at the spacer yielding a salt. During the work up the reaction 
mixture was neutralized to recover the salt into solution, however the high water 
solubility of ligand LNH-OH made difficult this isolation difficult. Fortunately, yellow 
crystals suitable for X-ray diffraction were obtained by slow evaporation of 
deuterated methanol (Figure 2.43).  
 
Figure 2.43: Crystal structure of LNH-OH. 
 
Ligand LNH-OH possesses a mirror plane located through the central NH 
group such that only half of the ligand is crystallographically unique with a relation 
given by x,-y+1/2,z. The phenyl rings are twisted with respect to one another by 23º 
and with respect to the pyridine rings by 28º. Even if twisted, this bending is 
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smaller to that observed for the methyl ether ligands (LOMe and LO-OMe). This 
causes an angle of 36º between the pyridine rings, while in the methyl ether 
ligands, these rings were nearly co-planar. 
Columns of LNH-OH molecules are connected via - stacking interactions 
between the pyridine rings with a distance between the planes through the 
pyridine rings of 3.36 and 3.40 Å (Figure 2.44). 
 
Figure 2.44: Columns of LNH-OH connected via - stacking between the pyridine rings. 
 
Hydrogen bonding between ligands is also observed. Each nitrogen of each 
pyridine unit of one ligand interacts with the hydroxyl groups of another ligand with 
a distance of 2.829(4) Å between donor and acceptor (Figure 2.45). 
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Figure 2.45: Hydrogen bonding (shown in purple) between LNH-OH ligands. 
 
The interaction via hydrogen bonding and - stacking in the crystal 
packing of ligand LNH-OH is shown in Figure 2.46. 
 
Figure 2.46: Crystal packing of ligand LNH-OH. 
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The three ligands were characterized by NMR, ESI+-MS and IR. The 
1H NMR is shown in Figure 2.47. As for the methyl ether ligands, all hydroxyl 
ligands present a very similar 1H NMR spectrum. The main difference is the 
chemical shifts of the phenylene protons from the spacer unit due to the presence 
of the different heteroatoms. The protons from the hydroxyl groups and the proton 
from the amine group of ligand LNH-OH cannot be observed as these 1H NMR 
experiments were performed in deuterated methanol, therefore these protons are 
exchanged with the deuterium of the solvent. 
 
Figure 2.47: 1H NMR spectra of ligands LOH, L O-OH and L NH-OH (300 MHz, MeOD). 
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1H NMR of LNH-OH was recorded in deuterated dimethyl sulfoxide to confirm 
the presence of the hydroxyl and amine groups (Figure 2.48). These protons 
appear as broad singlets and integrate for two and one protons respectively. 
 
Figure 2.48: 1H NMR of ligand LNH-OH (300 MHz, DMSO-d6). 
 
The infrared spectra of all hydroxyl ligands show a broad band above 
3000 cm-1 which indicates the presence of the hydroxyl groups and confirms that 
the deprotection of the methyl ether group has taken place. 
Electrospray mass spectrometry in positive ionization mode also confirms 
the formation of these ligands with the presence of their molecular ion. 
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2.3.3.3. Synthesis of [Pd2L
OH
4][(BF4)4] and [Pd2L
O-OH
4][(BF4)4] 
Formation of the palladium(II) complexes of the deprotected ligands occurred as 
for the parent methyl ether analogues. The hydroxyl ligands were heated at 80 ºC 
and tetrakis(acetonitrile)palladium(II) tetrafluoroborate was added. After 6 hours 
the complexes were formed and isolated by precipitation with diethyl ether. 
Formation of [Pd2L
NH-OH
4][(BF4)4] complex could not be achieved due to lack of 
sufficient material, as the yield for the formation of the ligand was very low. 
It seemed that the palladium complex [Pd2L
OH
4][(BF4)4] was soluble in 
acetonitrile and methanol, however when performing some NMR experiments in 
these deuterated solvents the spectra were noisy, hence difficult to integrate. 
Therefore, deuterated dimethyl sulfoxide was used to record its 1H NMR. This 
spectrum and that of the LOH ligand are shown in Figure 2.49. A downfield shift is 
observed in the palladium(II) complex spectrum indicating complexation of ligand 
LOH. 
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Figure 2.49: 1H NMR spectra comparison between LOH (top) and [Pd2L
OH
4][(BF4)4] 
(bottom) (300 MHz, DMSO-d6). 
 
Colourless crystals suitable for X-ray diffraction were obtain by slow 
diffusion of diethyl ether into an acetonitrile solution of complex [Pd2L
OH
4][(BF4)4] 
(Figure 2.50).  
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Figure 2.50: Crystal structure of [Pd2L
OH
4][(BF4)4]; side view (left) and top view (right). 
 
Unfortunately, the data that were collected were quite poor and therefore 
positions and exact distances between atoms could not be accurately determined. 
However, a few observations can be drawn as there is certainly evidence of the 
overall structure of the complex. In contrast to the structure observed for 
[Pd2L
OMe
4][(BF4)4], this crystal structure suggests the formation of a helicate. The 
two palladium centres are no longer equivalent as there is not an inversion centre 
in the centre of the molecule. However, there is a four-fold rotation axis through 
the centre of the molecule. This results in only one crystallographically unique 
ligand that is four times repeated. The palladium to ligand bonds of the two metal 
centres are twisted by 45º, while they were parallel to each other in the palladium 
complex [Pd2L
OMe
4][(BF4)4]. In other words, the ligand strands are twisted by 45º 
around the metal-metal axis. Since the ligands are achiral, a racemic mixture of 
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minus (M) and plus (P) helical enantiomers should be present. This can be a 
consequence of the different twisting angles observed in ligands LOMe and LNH-OH. 
The fact that the pyridine rings are not co-planar in the hydroxyl ligands might 
force the complex to adopt a helical form. This could be a result of the 
intermolecular forces observed in ligand LNH-OH, such as - stacking and 
hydrogen bonding interactions arising from the OH groups. Unfortunately, due to 
the quality of the cylinder data, this hypothesis cannot be confirmed. However, it is 
not uncommon to observe helical structures in tetra-stranded palladium(II) 
complexes as these have been reported before in the literature.(147) 
In an attempt to observe this helical nature in solution, titrations of 
-TRISPHAT (Figure 2.51) into deuterated dimethyl sulfoxide solutions of 
[Pd2L
OH
4][(BF4)4] were performed. -TRISPHAT is an NMR shift reagent that can 
be used to detect (and in some cases separate) isomers in solution by formation of 
diastereomeric ion pairs with cationic molecules, such as helicates.(148) 
 
Figure 2.51: Structure of -TRISPHAT. 
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No change was observed in the 1H NMR spectra of these titrations. 
Therefore, verification of the helical nature of this helicate in solution was not 
possible. This could be due to the necessity of using dimethyl sulfoxide to dissolve 
the complex (less polar solvent mixtures are normally required for this 
experiment).(149) It may also be that the helical nature of this complex is just an 
artefact of the solid state. 
 
The palladium complex [Pd2L
O-OH
4][(BF4)4] was slightly soluble in 
acetonitrile, acetone, nitromethane and methanol, however when dissolved in 
dimethyl sulfoxide a gelatinous solution was formed. This made its 
characterization very complicated, however the 1H NMR spectrum shown in Figure 
2.52 in deuterated methanol could be recorded. Downfield chemical shift of 
pyridine protons is again observed upon complexation. 
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Figure 2.52: 1H NMR spectra comparison between LO-OH (top) and [Pd2L
O-OH
4][(BF4)4] 
(bottom) (300 MHz, MeOD). 
 
 
2.3.3.4. Molecular design of LO-Glycol 
Continuing with the strategy of the addition of potentially solubilizing groups at the 
edges of the pyridine ring, it was thought that a glycol chain may be appropriate. It 
was hoped that the oxygen atoms of the glycol chain may have a higher 
interaction with water molecules. This type of synthetic strategy has been 
extensively used in the literature.(150-154) 
Diethylene glycol methyl ether was chosen as the glycol chain to add to the 
edges of the pyridine ring. A longer chain or polyethylene glycol could have also 
 
Chapter 2 
Towards Solubilization of Palladium(II) Tetra-Stranded Cylinders 
118 
 
been used, however a monodisperse complex was desired. The retrosynthetic 
analysis is shown in Scheme 2.10. 
 
Scheme 2.10: Retrosynthetic analysis for the synthesis of ligand LO-Glycol. 
 
The first disconnection once again leads to two Suzuki coupling substrates. 
Bis(4-bromophenyl) ether was chosen to act as spacer unit as it is commercially 
available and showed a slight increase in solubility for the methyl ether cylinder 
[Pd2L
O-OMe
4][(BF4)4]. A boron derivative needed to be synthesised to be able to 
perform the Suzuki coupling. This compound could be accessed from the bromo 
Chapter 2 
Towards Solubilization of Palladium(II) Tetra-Stranded Cylinders 
119 
 
derivative as seen for previous ligands. Finally, this bromo derivative can be 
formed via a coupling reaction to introduce the glycol chain into the pyridine ring. 
 
2.3.3.4. Synthesis of 3-bromo-5-(2-(2-methoxyethoxy)ethoxy)pyridine (5) 
In order to introduce the glycol functionality into the pyridine ring, a Mitsunobu 
reaction was used following a modified literature protocol.(155) 
Initially, diethyl azodicarboxylate (DEAD) in combination with triphenylphosphine 
were employed as deprotonating agents of the pyridinol. It has been reported(156) 
that when replacing the alkoxy groups (OEt) of the diethyl azodicaboxylate 
molecule with strong electron donating groups, such as secondary amines, the 
basicity of the hydrazo anion intermediate is increased. Therefore, 
1,1’-(azodicarbonyl)dipiperidine (ADD), depicted in Figure 2.53, was used in 
conjunction with tri-n-butylphosphine.  
 
Figure 2.53: Mitsunobu coupling agents. 
 
These coupling reagents led to higher yields of the Mitsunobu reaction. The 
crude material was purified by column chromatography on silica gel to yield 
3-bromo-5-(2-(2-methoxyethoxy)ethoxy)pyridine 5 in 90% yield (Scheme 2.11). 
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Scheme 2.11: Mitsunobu coupling to yield 5. 
 
The synthesis of the glycolated pyridine 5 has been recently reported by 
coupling diethylene glycol methyl ether to 3,5-dibromopyridine in 35% yield 
(Scheme 2.12).(157) Sodium hydride was used to abstract the hydrogen from the 
hydroxyl group so that the glycol molecule is able to react with the bromopyridine. 
This synthetic approach was initially attempted, however poor yield led to the 
search of new strategies, such as the Mitsunobu coupling discussed above. 
 
Scheme 2.12: Reported synthesis of 5. 
 
Glycol-modified pyridine 5 was characterized by NMR, ES+-MS and IR to 
confirm its formation. 
 
2.3.3.5. Synthesis of 3-(2-(2-methoxyethoxy)ethoxy)-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pyridine (6) 
The next step towards the formation of ligand LO-Glycol was to synthesise a suitable 
boron derivative for the final Suzuki coupling reaction. Several attempts to form the 
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boronic acid of the glycol modified pyridine 5 by using the previously reported 
methods always resulted in low yields. Therefore, it was decided to synthesise the 
boronate ester of the glycolated pyridine 5 following a modified literature 
protocol.(158) Bis(pinacolato)diboron was used as boron source and potassium 
acetate as base. In this case, [1,1’-bis(diphenylphosphino)ferrocene]-
dichloropalladium(II) complex with dichloromethane was the catalyst of choice. 
The reaction proceeded in anhydrous dimethylformamide as the reaction is 
accelerated in polar solvents. Reaction materials were reacted for one hour at 
160 ºC and then tert-butyl methyl ether was added to produce a precipitate. The 
filtrate was concentrated under reduced pressure and used without further 
purification in the next step (Scheme 2.13). 
 
Scheme 2.13: Synthesis of glycolated boronate ester 6. 
 
2.3.3.6. Synthesis of ligand LO-Glycol 
Suzuki coupling of bis(4-bromophenyl) ether and the synthesised glycolated 
boronate ester 6 was performed under the same conditions of those reported for 
the methyl ether ligands above (Scheme 2.14). This Suzuki coupling protocol 
proves to be very powerful as it is valid for boronic acids and boronate esters as 
starting materials.  
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Scheme 2.14: Synthesis of ligand LO-Glycol. 
 
Ligand LO-Glycol was fully characterized by NMR, mass spectrometry and 
infrared spectroscopy. 
The 1H NMR spectrum confirms the symmetry of the ligand and the 
successful coupling of the spacer unit to the glycolated pyridine (Figure 2.54). 
Proton assignment was performed with the aid of a 2D-COSY and 2D-NOESY. 
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Figure 2.54: 1H NMR spectra of ligand LO-Glycol (300 MHz, CDCl3). 
 
The infrared spectrum shows two strong bands at 1130 and 1111 cm-1. 
These bands are assigned to the presence of the ether groups on the spacer unit 
and on the glycol chain, respectively. 
High resolution mass spectrometry confirmed the formation of ligand 
LO-Glycol with the presence of an adduct formed by the molecular ion and sodium at 
m/z 583 Da. 
 
2.3.3.7. Synthesis of [Pd2L
O-Glycol
4][(BF4)4] 
An equivalent synthetic protocol previously used for the synthesis of tetra-stranded 
palladium(II) complexes was employed for the synthesis of [Pd2L
O-Glycol
4][(BF4)4]. 
The reaction proceeded at 80 ºC and quantitative formation of the palladium(II) 
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cylinder was achieved after six hours. Precipitation and washing with diethyl ether 
afforded [Pd2L
O-Glycol
4][(BF4)4] in 70% yield. 
1H NMR spectroscopy confirms the formation of the palladium(II) complex 
with a downfield chemical shift of the protons close to the metal binding site, that is 
H2 and H6 and H4 to a lesser extent (Figure 2.55). 
 
Figure 2.55: 1H NMR spectra of LO-Glycol (top) and [Pd2L
O-Glycol
4][(BF4)4] (bottom) 
(300 MHz, CD3CN). 
 
The 19F NMR spectrum presents two peaks at -150.87 and -150.92 ppm 
with integrals of two and eight respectively. These correspond to the different 
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fluorine environments created by the two different boron isotopes (10B and 11B) as 
discussed above. 
2.3.3.8. Molecular design of ligand LO-Pyrr 
The last group that was added at the edges of the pyridine ring was an 
alkyl-chained pyrrolidine. This kind of motif, along with charged amines,(159) are 
used in the literature in order to improve the water solubilization of metal 
complexes such as G-quadruplex targeting drugs(160,161) as well as progesterone 
derivatives.(162) The principle lies in the fact that the cyclic tertiary amines will be 
protonated at physiological pH.  
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Scheme 2.15: Retrosynthetic analysis for the synthesis of ligand LO-Pyrr. 
 
The retrosynthetic analysis that was followed was analogous to that of the 
glycol ligand previously discussed (Scheme 2.15). First, a Mitsunobu reaction to 
couple the pyrrolidine motif onto the pyridine ring is required, followed by the 
formation of the boronate ester of the modified pyridine, and finally a Suzuki 
coupling reaction with bis(4-bromophenyl) ether to yield ligand LO-Pyrr. 
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2.3.3.9. Synthesis of 3-bromo-5-(2-(pyrrolidin-1-yl)ethoxy)pyridine (7) 
Formation of pyridine 7 occurred smoothly under Mitsunobu conditions using 
1,1’-(azodicarbonyl)dipiperidine (ADD) in combination with tri-n-butylphosphine 
based on a modified literature protocol (Scheme 2.16).(155) Purification of this 
ligand was achieved via column chromatography on activated neutral aluminium 
oxide. Due to the high polarity of the molecule, it was not possible to use silica with 
any solvent. Even with aluminium oxide, highly polar solvents were necessary to 
elute the product. 
 
Scheme 2.16: Synthesis of 7. 
 
Pyrrolidine-modified pyridine 7 was characterized by NMR, ES+-MS and IR 
to confirm its formation. 
 
2.3.3.10. Synthesis of 3-(2-(pyrrolidin-1-yl)ethoxy)-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pyridine (8) 
The boronate ester 8 was synthesised following the same protocol applied for the 
formation of its glycolated analogue 6, and it was used in the next step without 
further purification (Scheme 2.17). 
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Scheme 2.17: Synthesis of 8. 
 
 
2.3.3.11. Synthesis of ligand LO-Pyrr 
The Suzuki coupling of 8 with bis(4-bromophenyl) ether was also performed under 
the same conditions used for all previous Suzuki coupled ligands (Scheme 2.18).  
 
Scheme 2.18: Synthesis of ligand LO-Pyrr. 
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The purification of the crude mixture was even more challenging as two 
pyrrolidine motifs were present in the molecule. Two aluminium oxide columns 
were needed to obtain the final pure LO-Pyrr ligand. This resulted in low yields due 
to the high interaction between the ligand and the stationary phase. 
The 1H NMR spectrum confirms the formation of ligand LO-Pyrr with a single 
set of signals (Figure 2.56). Assignment of the different protons was performed 
with the aid of a 2D COSY and a 2D NOESY. 
 
Figure 2.56: 1H NMR spectrum of ligand LO-Pyrr (300 MHz, CDCl3). 
 
Electrospray mass spectrometry provided further evidence of the formation 
of ligand LO-Pyrr with the presence of the molecular ion at m/z 551.4 Da. 
 
 
Chapter 2 
Towards Solubilization of Palladium(II) Tetra-Stranded Cylinders 
130 
 
2.3.3.12. Synthesis of [Pd2L
O-Pyrr
4][(BF4)4] 
When reacting ligand LO-Pyrr with [Pd(CH3CN)4][(BF4)2] at 80 ºC, as performed for 
the formation of the complexes above, a complex mixture was obtained. The initial 
yellow solution became brown after one hour. This behaviour was not observed for 
any of the previous complex-forming reactions. Since some sort of degradation 
might be occurring, the reaction was then performed at room temperature 
overnight to evaluate whether the pyrrolidine motif is sensitive to temperature. A 
yellow solution was obtained and it was concentrated under reduced pressure and 
precipitated with diethyl ether. The obtained solid was analyzed by NMR 
spectroscopy.  
 
Figure 2.57: 1H NMR spectrum of the crude [Pd2L
O-Pyrr
4][(BF4)4] (300 MHz, CD3CN). 
 
The 1H NMR spectrum shown in Figure 2.57 presents broad signals for the 
different proton peaks, indicating that the palladium(II) cylinder was not isolated as 
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its pure form. However, the relative intensities of the NMR signals indicate the 
correct ratio of protons expected. In addition a downfield shift, as seen for previous 
complexes, is also observed. 
Unfortunately, any purification method attempted was unsuccessful. 
Therefore, [Pd2L
O-Pyrr
4][(BF4)4] could not be obtained as its pure form. 
 
2.3.3.13. Solubility of complexes with added groups at the edges 
The strategy of functionalizing the complexes with the addition of different motifs at 
the edges of the pyridine ring proved to be the most successful. Hydroxyl 
complexes [Pd2L
OH
4][(BF4)4] and [Pd2L
O-OH
4][(BF4)4] showed a slight increase in 
their solubility in methanol compared to their methyl ether analogues. However, 
gelatinous solutions were also obtained. This might be due to the presence of 
eight hydroxyl groups located on the outside of the hydrophobic cylinder. The best 
improvement was achieved with the synthesis of [Pd2L
O-Glycol
4][(BF4)4] as this new 
complex is highly soluble in methanol, however it remains insoluble in water. 
Unfortunately, synthesis of the promising [Pd2L
NH-OH
4][(BF4)4] and 
[Pd2L
O-Pyrr
4][(BF4)4] complexes could not be achieved.  
 
2.3.4. Increase of the complex charge 
The last strategy investigated to attempt to increase the water solubility of these 
tetra-stranded palladium(II) cylinders was to increase the overall charge of the 
complex. All the above complexes are 4+ charged. This charge is imparted by the 
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two palladium(II) centres. While maintaining the same dinuclear complex with the 
same metal centres, the charge could be increased by a slight modification of the 
ligands. This was performed by substitution of the diphenyl spacer unit by two 
pyridine units. Since these pyridine rings are linked to each other from the nitrogen 
atom by the methylene spacer, each ligand will be doubly charged (Figure 2.58). 
Reaction with palladium(II) may yield a tetra-stranded dinuclear species with a 12+ 
charge. 
 
Figure 2.58: Proposed doubly charged ligand. 
 
These type of charged ligands have been previously reported by Quintela et 
al..(163) The reaction of these charged ligands with protected palladium(II) metal 
centres yielded water soluble dinuclear palladium(II) complexes, which were used 
as macrocycles for catenane formation or as host of PAH as discussed in section 
1.3.1.(114,163,164) 
In order to achieve this doubly charged ligand LN+, an asymmetric bipyridine 
needed to be synthesised and this could be accessed via Suzuki coupling of a 
bromopyridine and a pyridine boronic acid, as shown in the retrosynthetic analysis 
in Scheme 2.19. 
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Scheme 2.19: Retrosynthetic analysis of doubly charged ligand LN+. 
 
 
2.3.4.1. Synthesis of 3,4'-bipyridine (9) 
The synthesis of the asymmetric bipyridine was performed via Suzuki coupling 
following an analogous procedure to that reported above (Scheme 2.20). 
 
Scheme 2.20: Synthesis of asymmetric bipyridine 9. 
 
Characterization of bipyridine 9 was successfully performed by NMR 
spectroscopy, MS spectrometry and IR spectroscopy which confirmed its 
formation. 
 
2.3.4.2. Synthesis of ligand LN+ 
Once the asymmetric bipyridine was synthesised it was coupled with 
dibromethane yielding the 2+ ligand LN+ with two bromo counterions (Scheme 
2.21). 
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Scheme 2.21: Synthesis of charged ligand LN+·2Br-. 
 
Three different permutations (A, B and C) for the coupling of bipyridine 9 
and dibromethane are possible (Figure 2.59). 
 
Figure 2.59: Possible coupling combinations 
 
The analysis of the 1H NMR spectrum was enough to determine whether 
one of the possible A, B and C products had formed or a mixture of two or three of 
them was present at the same time. 
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Figure 2.60: 1H NMR spectrum of ligand LN+ (300MHz, D2O). 
 
The simple spectrum with seven different signals rules out the possibility of 
having formed a mixture of compounds. In addition, B could not have been formed 
as B is an asymmetric ligand and more signals should have been present. The 
highest downfield shifted protons should be those  to the positively charged 
nitrogen of the pyridine ring. Since this signal accounts for two protons in the NMR 
spectrum shown in Figure 2.60 and only two protons with the same environment 
can produce such a signal, A was confirmed as the only product. 
Interestingly, after a month in the NMR tube it was observed that the central 
methylene proton disappeared. This could be due to its exchange with the 
deuterium of the NMR solvent. 
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2.3.4.3. Attempted synthesis of [Pd2L
N+
4][(BF4)4] 
When attempting to synthesise the palladium(II) complex of LN+·2Br-, the cylinder 
was not formed. This is probably due to the formation of PdBr2. Similar results 
were observed for the exchange of the tetrafluoroborate counter-ion of 
[Pd2L
OMe
4][(BF4)4] complex by chloride. In both cases, the palladium-halogen 
bond seems to be stronger than the palladium-pyridine one. 
To solve this problem, the bromide counter-ions of ligand LN+·2Br- were 
exchanged by hexafluorophosphates (LN+·2PF6
-) and these by nitrates in order to 
obtain a water soluble ligand (LN+·2NO3
-). Ligand LN+·2Br- was dissolved in water 
and a saturated aqueous solution of ammonium hexafluorophosphate was added 
to precipitate a white solid. This solid was collected by filtration and washed with 
water and diethyl ether. Confirmation of the exchange was readily observed by 
infrared spectroscopy with the presence of a strong band at 805 cm-1 which 
corresponds to the free hexafluorophosphate counter-ions. Ligand LN+·2PF6
- was 
then dissolved in acetonitrile and a saturated solution of tetrabutylammonium 
nitrate in acetonitrile was added to precipitate a white solid. Filtration of the solid 
and washing with acetonitrile and diethyl ether afforded ligand LN+·2NO3
-. Its 
infrared spectrum presented a strong band at 1320 cm-1 confirming the successful 
counter-ion exchange. 
Unfortunately, complex formation did not occur with the nitrate ligand 
LN+·2NO3
- either. This result might be due to the impossibility of four doubly 
charged ligands approaching two palladium(II) metal centres. This problem was 
not observed in Quintela’s system as protected palladium(II) starting materials 
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were used. However, for a tetra-stranded complex to be formed, naked 
palladium(II) reagents are a requirement. 
 
2.3.5. Exploring a new ligand system 
Multi-step and time consuming reactions were required to modify and synthesise 
the palladium(II) tetra-stranded cylinders discussed above. Therefore, a new 
ligand system was explored.  
In 2010, Crowley and co-workers reported the synthesis of a tetra-stranded 
palladium(II) saturated helicate with triazole rings coordinating to the palladium(II) 
metal centres. This ligand was synthesised via a CuAAC click chemistry 
reaction.(165)  
 
Scheme 2.22: Synthesis of Crowley’s tetra-stranded helicate (CCDC 762916).(165) 
 
This complex was used as inspiration to develop a new ligand system, in 
which the pyridine rings are replaced by 1,2,3-triazole rings. This could lead to a 
new library of compounds via an easy synthetic route.  
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The 1,3-dipolar cycloaddition reaction between azides and terminal alkynes 
was initially studied by Huisgen.(166) Its Cu(I)-catalyzed version has been recently 
renamed as the “click” reaction. The CuAAC or click reaction can produce, under 
mild reaction conditions, 1,4-substituted-1,2,3-triazoles in excellent yields.(167) 
1,2,3-Triazoles can be used in coordination chemistry as they have the potential to 
act as N donor ligands.(165) Therefore, CuAAC reactions and triazoles represent a 
new powerful tool and ligand architecture for the design of metallo-supramolecular 
arrays. Triazole ligands formed via click reaction also present a simple synthetic 
route to new functionalized scaffolds, which are harder to obtain in polypyridine 
chemistry with multiple reaction steps as shown above. 
 
2.3.5.1. Molecular design of ligand LClick-Bn 
Ligand LClick-Bn was designed by incorporation of the triazole motif of Crowley’s 
click ligand into the diphenyl spacer-ligand used in this study and in Hannon’s 
helicates. The retrosynthetic analysis proposed for the synthesis of ligand LClick-Bn 
is shown in Scheme 2.23. 
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Scheme 2.23: Retrosynthetic analysis for the synthesis of ligand LClick-Bn. 
 
Suitable building blocks (10 and 11) needed to be synthesised to perform 
the CuAAc click reaction to form ligand LClick-Bn. 
In order to synthesise 11, the following retrosynthetic analysis was 
proposed (Scheme 2.24). The triple bond functionality will be introduced by 
coupling a protected acetylene onto the aromatic spacer unit. Subsequent removal 
of the protecting group will lead to the free arylacetylene. 
 
Scheme 2.24: Retrosynthetic analysis for the synthesis of 11. 
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2.3.5.2. Synthesis of bis(4-iodophenyl)methane (13) 
Bis(4-iodophenyl)methane 13 was synthesised as a precursor for the synthesis of 
the biarylacetylene 11. 4,4'-Methylenedianiline was dissolved in concentrated 
sulfuric acid and was diazotized by addition of sodium nitrite. Care was taken to 
maintain the temperature below 5 ºC as diazonium salts in solution are unstable 
above that temperature with elimination of nitrogen gas (N2). The diazonium salt 
was then poured into a warmed solution of potassium iodide to form compound 13 
by nucleophilic aromatic substitution (Scheme 2.25). Work up and purification by 
column chromatography as stated in a previous reported protocol(168) yielded 13 in 
47% yield. 
 
Scheme 2.25: Synthesis of 13. 
 
NMR, IR and particularly mass spectrometry aided the identification of 
compound 13. The molecular ion at m/z 420 Da and fragments corresponding to 
the loss of one (m/z 293 Da) and both iodines (m/z 166 Da) were observed in 
electron impact mass spectrometry. 
 
2.3.5.3. Synthesis of bis[4-[(trimethylsilyl)ethynyl]phenyl]methane (12) 
Introduction of the one end protected acetylene unit into the aryl molecule 13 was 
performed via a palladium-copper-catalyzed cross-coupling reaction as depicted in 
Scheme 2.26 following a Sonogashira mechanism.(168) The palladium(0) catalyst is 
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generated in situ from palladium(II) acetate and triphenylphosphine. Copper iodide 
acts as an activator of the alkyne group to produce copper(I) acetylide at the free 
end. Triethylamine acts as a solvent and as a base forming triethylamine 
hydroiodide with the substracted hydrogen iodide. 
 
Scheme 2.26: Synthesis of 12. 
 
Compound 12 was characterized by NMR, where peaks corresponding to 
the methyl groups of the protecting group were observed in 1H and 13C NMR. The 
1H NMR spectrum shows a single peak integrating for 18 protons at 0.29 ppm and 
the13C NMR a single peak at 0.2 ppm. EI+-MS shows the molecular ion at 
m/z 360 Da and a fragment at m/z 345 Da corresponding to the loss of one methyl 
group. The infrared spectra presents two characteristic bands for the vibrations of 
the Si-CH stretching at 2957 cm-1 and 1246 cm-1 and one very strong broad band 
for the Si-C bending at 836 cm-1. 
Characterization of compound 12 was performed after it was purified by 
column chromatography on silica gel. This purification step proved to be very 
important as a copper-free compound is mandatory for the success of the 
subsequent deprotecting step. Since the deprotection occurs in basic alcohol 
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media, the presence of copper iodide salts produced the Glaser coupling product 
14, as detected by EI+-MS with a peak at m/z 430 Da (Scheme 2.27). 
 
Scheme 2.27: Formation of Glaser coupling product 14. 
 
 
2.3.5.4. Synthesis of bis(4-ethynylphenyl)methane (11) 
Removal of the trimethylsilyl protecting group was performed under inert 
atmosphere in a mixture of methanol and diethyl ether with anhydrous potassium 
carbonate (Scheme 2.28). 
 
Scheme 2.28: Synthesis of 11. 
 
The free alkyne group was observed by 1H NMR with a peak at 3.07 ppm 
accounting for two protons and corresponding to the terminal alkyne proton. 
Infrared spectroscopy also aided the identification of the compound with a very 
strong sharp band at 3274 cm-1 assigned to the C≡CH vibration. These data were 
compared to those reported in the literature.(168) 
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2.3.5.5. Synthesis of ligand LClick-Bn 
LClick-Bn ligand can be formed in a one-pot, multi-component click reaction 
(Scheme 2.29). Due to the explosive potential of low molecular weight azides, 
benzyl azide 10 was prepared in situ and was not isolated. The benzyl group was 
the substituent chosen for this ligand, for analogy to that presented by Crowley 
and co-workers in 2010. 
 
Scheme 2.29: Synthesis of ligand LClick-Bn. 
 
Benzyl bromide and sodium azide were dissolved in dimethylformamide 
and heated at 65 ºC for two hours. After cooling to room temperature, an aqueous 
solution of copper sulfate, L-ascorbic acid, sodium carbonate and alkyne 11 were 
added, followed by stirring for 48 hours. As copper azides and acetylides are 
explosive when dried, a solution of EDTA/NH4OH (1 M) was poured into the crude 
reaction mixture once the reaction had concluded. Column chromatography on 
silica gel afforded the pure ligand LClick-Bn. 
Infrared spectroscopy proved very useful for the identification of ligand 
LClick-Bn as the azide band at around 2095 cm-1 and the alkyne bands at 2150 and 
3300 cm-1 were absent. The characteristic singlet of the triazole unit was also 
observed in the 1H NMR spectrum (Figure 2.61). 
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Figure 2.61: 1H NMR spectrum of ligand LClick-Bn (300 MHz, CDCl3). 
 
Colourless crystals suitable for X-ray diffraction were successfully grown by 
slow evaporation of deuterated dichloromethane. The crystal structure confirms 
the formation of the symmetric ligand LClick-Bn (Figure 2.62). 
 
Figure 2.62: Crystal structure of ligand LClick-Bn. 
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The phenyl rings are twisted about the central methylene spacer by 75º with 
respect to one another and by 20º and 25º with respect to the 1,2,3-triazole rings. 
The phenyl rings of the benzyl groups are twisted with respect to the triazole rings 
by 57º and 61º. The triazole rings are twisted by 67º with respect to each other. No 
intermolecular interactions are observed. 
 
2.3.5.6. Attempted synthesis of [Pd2L
Click-Bn
4][(BF4)4] 
When reacting the newly synthesised LClick-Bn ligand with [Pd(CH3CN)4][(BF4)2] at 
80 ºC, a complex mixture was formed. Reaction at room temperature overnight 
produced the same result. The 1H NMR spectrum presents broad signals that are 
difficult to assign or integrate. However, a downfield chemical shift of the 
characteristic triazole proton is observed. Unfortunately, mass spectrometry was 
unable to confirm the formation of the complex in its crude form. This crude 
mixture could not be purified by any of the common methods. 
2.3.5.7. Molecular design of ligand LClick-OH 
Since the palladium(II) complex of ligand LClick-Bn could not be formed or isolated 
as its pure form, a new ligand system was investigated. A smaller group was 
thought to be more convenient as the benzyl groups are quite bulky groups and 
might interfere with the coordination process of the palladium(II) to the 
1,2,3-triazole rings. An alcohol chain was the chosen motif to be added at position 
4 of the triazole moieties. This alcohol group might also infer better water solubility 
properties into the ligand and complex. The retrosynthetic analysis for the 
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formation of LClick-OH is shown in Scheme 2.30. As for the previous ligand system, 
a CuAAC reaction between an azide and the triple bond spacer 11 should yield the 
desired LClick-OH ligand. 
 
Scheme 2.30: Retrosynthetic analysis of ligand LClick-OH. 
 
 
2.3.5.8. Synthesis of ligand LClick-OH 
By following the same protocol reported above for ligand LClick-Bn, ligand LClick-OH 
was formed in a one-pot click chemistry reaction between 2-bromoethanol and 
triple bond spacer 11 in 83% yield (Scheme 2.31). 
 
Scheme 2.31: Synthesis of ligand LClick-OH. 
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Purification of this ligand was achieved by recrystallization of the crude 
mixture from hot methanol. The 1H NMR spectrum confirmed the formation of the 
1,4-disubstituted trizole ligand (Figure 2.63). 
 
Figure 2.63: 1H NMR spectrum of ligand LClick-OH (300 MHz, DMSO-d6). 
 
Electrospray mass spectrometry provided further evidence for the formation 
of ligand LClick-OH with a peak at m/z 413.2 Da corresponding to the sodium adduct. 
 
2.3.5.9. Attempted synthesis of [Pd2L
Click-OH
4][(BF4)4] 
Upon reaction of ligand LClick-OH with [Pd(CH3CN)4][(BF4)2] a broad 
1H NMR 
spectrum was obtained, therefore it was not possible to integrate the different 
peaks or unambiguously detect the triazole proton. All purification methods 
attempted proved unsuccessful. 
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2.3.5.10. Molecular design and synthesis of ligand LClick-Glycol 
Since [Pd2L
O-Glycol
4][(BF4)4] proved to be the most readily soluble complex, a 
glycol chain was added at position 4 of the triazole ring. Ligand LClick-Glycol was 
synthesised following an analogous protocol employed for the click reactions 
reported above (Scheme 2.32). 
 
Scheme 2.32: Formation of LClick-Glycol ligand. 
 
Formation of the ligand was confirmed by NMR, MS and IR, as performed 
for the previously synthesised click ligands. 
 
2.3.5.11. Attempted synthesis of [Pd2L
Click-Glycol
4][(BF4)4] 
Unfortunately, complexation of ligand LClick-Glycol to a palladium(II) metal centre did 
not occur or could not be detected. 
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2.4. Closing remarks 
This chapter has explored four different strategies to improve the solubility of the 
first generation of Hannon’s tetra-stranded palladium(II) supramolecular cylinders. 
Modification of the spacer unit has led to four novel palladium(II) complexes that 
are soluble in acetonitrile, acetone and dimethyl sulfoxide. Exchanging the 
counter-ion of the complex only led to a solubility improvement in acetonitrile with 
triflate anions. Ligands were functionalised at the edges and three new cylinders 
were synthesised. The best results were obtained when adding a glycol chain at 
position 3 of the pyridine ring, resulting in a new cylinder that is highly soluble in 
methanol. Unfortunately, water solubility has not yet been achieved, as none of the 
synthesised complexes were soluble in 100% aqueous buffer. A new different 
ligand system was also explored. The pyridine rings were substituted by triazoles, 
however pure complexes could not be isolated. 
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Chapter 3: DNA Binding Studies of 
Palladium(II) Tetra-Stranded Cylinders 
 
 
3.1. Introduction 
The DNA binding properties of the synthesised complexes in chapter 2 were 
explored and will be reported in this chapter. The interaction between the 
tetra-stranded complexes and DNA was studied via different spectroscopic 
techniques, such as circular and linear dichroism and ethidium bromide 
displacement, as well as agarose and polyacrylamide gel electrophoresis. 
Initially, the interaction between the newly synthesised cylinders and duplex 
DNA was investigated, in order to evaluate the binding affinity of these complexes 
to DNA. Then, more specific DNA four-way junction experiments were carried out. 
In this chapter, preliminary cytotoxicity data of the synthesised palladium(II) 
cylinders against different breast and ovarian cancer cell lines will also be 
presented. 
 
3.2. Circular dichroism studies 
Circular dichroism (CD) is a well known electronic spectroscopic technique that 
can be used to study the interaction between DNA and ligands, and to observe the 
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DNA conformation itself. CD measures the difference in absorption of left (AL) and 
right (AR) circularly polarized light (eq. 1) and is only sensitive to chiral molecules.  
CD () = AL () – AR ()   (eq. 1) 
DNA is a chiral molecule and therefore absorbs left and right circularly 
polarized light differently. This is measured as a wavelength function and gives 
rise to a CD signal under absorption bands.(169) DNA chirality arises from the 
right-handed chiral sugar moieties (C1’ carbon atom) that form the DNA phosphate 
backbone. However, the specific CD spectrum of DNA depends on the 
orientations of the DNA bases (chromophores) as these present characteristic 
bands in the UV region that result from -* transitions. These DNA bases are not 
chiral, however they are held within the chiral environment created by the DNA 
backbone.(170) Every chiral molecule shows a particular CD spectrum. The B-DNA 
form of ct-DNA presents a positive band around 280 nm and a negative band 
around 245 nm, with the intersection point at 260 nm. Over 300 nm the CD 
spectrum of DNA does not present any signal or band (Figure 3.1).(171) 
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Figure 3.1: CD spectrum of B-form of DNA. 
(300 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
If a DNA-binding molecule is achiral, no CD signal is observed in the 
absence of DNA. However, it could acquire an induced chirality upon binding to 
DNA, giving rise to an induced CD (ICD) signal. Intercalators present weak and 
negative ICD signals if the transitions are polarized along the long axis of the 
intercalation pocket; and positive if perpendicular transitions occur. ICD signals for 
groove binders are generally positive and an order of magnitude stronger than 
those observed for intercalators.(172) 
In this study, the interaction between the newly synthesised complexes and 
calf thymus DNA (ct-DNA) is assessed via CD titrations of the complexes into an 
aqueous buffered ct-DNA solution. The DNA concentration is kept constant during 
the experiment and aliquots of complexes are added, after which a CD spectrum is 
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measured. The overlay of the CD spectrum of each titration can be used to 
interpret the interactions between the complex and the DNA. 
None of the synthesised palladium(II) cylinders has an intrinsic CD signal 
as they are not helical or, if they are, they exist as a racemic mixture of M and P 
enantiomers. As a result, any CD signal observed in the spectroscopic regions of 
the complexes is due to their interaction with DNA. 
Since all the synthesised palladium(II) complexes are white or pale yellow, 
the major challenge for the evaluation of the DNA binding interaction was to be 
able to detect the ICD signal, as the spectroscopy of the complexes overlays or is 
very close to that of the DNA. 
The CD experiment was first attempted with the [Pd2L
OMe
4][(BF4)4] 
complex. As this complex is not water soluble, a concentrated dimethyl sulfoxide 
solution of the complex was prepared, which was then diluted with water to give a 
15% dimethyl sulfoxide solution. The percentage of dimethyl sulfoxide present in 
the titration was 3% at most. A control experiment where DNA is titrated with 
increasing concentrations of a 15% dimethyl sulfoxide solution was performed. 
Only changes below 225 nm were observed on the CD spectra, due to the 
absorbance of dimethyl sulfoxide in this region, manifested by high tension spectra 
which produces unreliable data. Therefore, this region will not be considered 
during the analysis of the CD spectra of the different palladium(II) complexes.  
Initially, titrations of a 500 M stock solution of [Pd2L
OMe
4][(BF4)4] complex 
over a 300 M ct-DNA solution were performed, as these are the experimental 
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conditions most commonly used by Hannon and co-workers. However, it was 
observed that precipitation of DNA at this concentration occurred even at low 
complex loading, hence CD data was unreliable. Therefore, the experiment 
concentrations were reduced by one order of magnitude. A stock solution of 50 M 
of [Pd2L
OMe
4][(BF4)4] complex was prepared by dissolving it in DMSO and diluting 
with water to obtain a 1.5% DMSO solution. At the end of the titration, the DMSO 
percentage in the cuvette will be of 0.3%. The stability of the complex at 1.5% 
DMSO was assessed during the course of the CD experiment by UV-vis scans. 
Scans from the start and end of the experiment were superimposable. The CD 
spectra corresponding to the titrations of a 50 M stock solution of 
[Pd2L
OMe
4][(BF4)4] complex over a 30 M ct-DNA solution are shown in Figure 3.2. 
These CD spectra present an ICD signal at around 318 nm, which increases its 
intensity with increasing concentrations of [Pd2L
OMe
4][(BF4)4] complex. This 
indicates that the palladium(II) complex is interacting with the DNA. It is also 
observed that the B-conformation of DNA is retained upon cylinder binding as the 
DNA signature is maintained. A small decrease in intensity is observed, probably 
due to ligand transitions in this region. 
Chapter 3 
DNA Binding Studies of Palladium(II) Tetra-Stranded Cylinders 
155 
 
 
Figure 3.2: CD spectra of ct-DNA with increasing concentrations of [Pd2L
OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
A greater interaction is observed when performing CD titrations for 
[Pd2L
O-OMe
4][(BF4)4] in the same conditions reported above (Figure 3.3). An ICD 
signal is observed around 312 nm which indicates binding of the complex to the 
DNA. The characteristic DNA signal between 200-300 nm is lost at high loading, 
from a ratio of DNA base:complex of 4:1. This could mean that either the 
palladium(II) complex has perturbed the B-DNA upon binding at high loadings, or 
that an effect of the DNA and complex CD signals (from the ligands) being overlaid 
is being observed. 
Chapter 3 
DNA Binding Studies of Palladium(II) Tetra-Stranded Cylinders 
156 
 
 
Figure 3.3: CD spectra of ct-DNA with increasing concentrations of [Pd2L
O-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
CD titrations with [Pd2L
NH-OMe
4][(BF4)4] were also performed, however it 
was known that the complex degrades or forms different supramolecular 
structures in the presence of DMSO (as seen by 1H NMR experiments). Since a 
small percentage of DMSO is used to solubilise the complexes, the fact that a 
different structure might be interacting with the DNA needs to be considered. 
Nevertheless, once the complex (or mixture) was in a DMSO/water solution, it 
seemed to be stable as observed via UV-vis scans during the CD experiment. The 
CD spectra presented an ICD signal around 376 nm that increases in magnitude 
with increasing concentrations of complex, indicating binding of the complex to the 
DNA (Figure 3.4). This complex is yellow in colour, consequently this band is 
shifted to the visible. The overall B-conformation of DNA is retained upon cylinder 
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binding, with small changes in the 200-300 nm region due to the ligands electronic 
transitions. 
 
Figure 3.4: CD spectra of ct-DNA with increasing concentrations of [Pd2L
NH-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
An induced CD signal around 344 nm is observed for the titration of 
[Pd2L
S-OMe
4][(BF4)4] into ct-DNA. Since the complex on its own did not have a CD 
signal, this ICD signal is due to the interaction of the palladium(II) complex with 
DNA (Figure 3.5). 
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Figure 3.5: CD spectra of ct-DNA with increasing concentrations of [Pd2L
S-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.6% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
The parent palladium(II) complex [Pd2L4][(BF4)4] was also synthesised
‡ in 
order to determine its DNA binding ability, as this was not previously studied. A 
higher dimethyl sulfoxide percentage was required to solubilise this complex (3%), 
since this parent complex presents a much poorer solubility compared to the newly 
synthesised palladium(II) complexes. Circular dichroism titrations were performed 
using the same conditions applied to all palladium(II) cylinders. An ICD signal 
cannot be observed, suggesting a lack of interaction between the complex and 
DNA (Figure 3.6).  
                                            
‡
 Ligand L was synthesised according to the Suzuki coupling protocol used for the rest of the 
ligands. [Pd2L4][(BF4)4] complex was synthesised by mixing ligand and [Pd(CH3CN)4][(BF4)2] at 
high temperature, instead of at room temperature as previously reported. Characterization and full 
experimental procedures can be found in Chapter 5. 
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Figure 3.6: CD spectra of ct-DNA with increasing concentrations of [Pd2L4][(BF4)4] parent 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
CD titrations of complex [Pd2L
OH
4][(BF4)4] into a 30 M solution of ct-DNA 
also produced no changes in the CD spectra (see Appendix). No ICD signal is 
observed in the spectroscopic region of the complex, which indicates no 
interaction between the cylinder and DNA. 
DNA binding of complex [Pd2L
O-OH
4][(BF4)4] was not investigated as it 
proved very difficult to solubilise as mentioned in Chapter 2. 
The last complex to be studied via CD was the [Pd2L
O-Glycol
4][(BF4)4] 
complex.  
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Figure 3.7: CD spectra of ct-DNA with increasing concentrations of [Pd2L
O-Glycol
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
Titrations were initially performed in 1.5% DMSO as for the previous 
complexes, in order to directly compare all of them (Figure 3.7). A very intense 
ICD signal around 312 nm is observed which indicates a strong interaction 
between the complex and DNA. As for the [Pd2L
O-OMe
4][(BF4)4] complex the DNA 
signature between 200 and 300 nm is lost at 4:1 and 3:1 DNA base:complex 
concentrations, most probably due to ligand transitions in this region. 
Since [Pd2L
O-Glycol
4][(BF4)4] is methanol soluble, CD titrations of this 
complex in a 1.5% methanol solution were also performed (Figure 3.8).  
Chapter 3 
DNA Binding Studies of Palladium(II) Tetra-Stranded Cylinders 
161 
 
 
Figure 3.8: CD spectra of ct-DNA with increasing concentrations of [Pd2L
O-Glycol
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. MeOH. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
The ICD signal that arises from the binding event is even greater than that 
observed for the 1.5% DMSO titration. Controls of the effect of methanol on DNA 
were also performed and no effect was observed as the CD spectra remained the 
same. 
 
Comparison of the magnitude of the ICD signals produced by the DNA 
binding of each complex is presented in Figure 3.9.  
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Figure 3.9: Normalized ICD signal vs complex concentration for all palladium(II) cylinder 
studied. 
 
The much greater magnitude of the ICD signal with the 
[Pd2L
O-Glycol
4][(BF4)4] cylinder is striking and it is also considerably larger if 
compared to previously reported iron(II), ruthenium(II) and rhodium(III) cylinders. 
Given that the cylinder electronic transitions should be similar between the glycol 
complex and the methoxy analogues, it would be tempting to ascribe this effect to 
a higher binding affinity. However, the CD experiment cannot be used to confirm 
this, and indeed a subsequent displacement assay (see section 3.4.) does not 
support this as a conclusion. 
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3.3. Linear dichroism studies 
Linear dichroism (LD) is another spectroscopic technique that can be used to 
study DNA conformation and the effect that DNA binding drugs have on the DNA 
orientation upon binding. Linear dichroism is defined as the difference in 
absorption of light polarized parallel (A||) and perpendicular (A) to an orientation 
axis (eq. 2).(169) 
LD () = A|| () – A ()   (eq. 2) 
In flow oriented linear dichroism, shear forces can align polymeric DNA of at 
least 200 base pairs in length. The apparatus that generates these shear forces is 
a rotating cuvette cell, also called a Couette cell. The light path through the 
Couette cell is made of quartz (uv transparent) and can either have a rotating inner 
and a fixed outer cylinder or a rotating outer and a fixed inner cylinder.(173) 
The LD spectrum of DNA presents a negative signal at 260 nm (Figure 
3.10). This signal arises from the absorption of linearly polarized light by the DNA 
bases. These are situated perpendicular to the DNA axis, which is also the 
orientation axis in the LD experiment, hence the negative LD signal. If the Couette 
cell does not rotate, the LD spectrum will be zero.(174) 
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Figure 3.10: LD spectrum of B-form of DNA. 
(300 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
Since most of the DNA binding drugs are too small to be oriented 
themselves via viscous drag, they are unaligned and therefore do not have their 
own LD spectrum. However, they become oriented if bound to DNA, which gives 
rise to an induced LD (ILD) signal. As intercalators sandwich between DNA bases, 
their absorbance dipoles are also oriented perpendicularly to the DNA axis. This 
results in a negative ILD signal. In contrast, groove binders can present positive 
ILD signals, since the chromophores of the groove binder can be aligned parallel 
to the helical axis. Therefore, linear dichroism can give information about the DNA 
binding modes of drug molecules.(172) 
In the work presented in this thesis, the effect on aqueous buffered ct-DNA 
conformation when titrating aliquots of the newly synthesised palladium(II) 
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cylinders is investigated. The DNA concentration is kept constant throughout the 
experiment and an LD spectrum is recorded after each titration. The overlay of the 
LD spectrum of each titration can be used to assess the interactions between 
complex and DNA. 
Circular dichroism titrations informed on the DNA and complex 
concentrations that are necessary to not precipitate the DNA. This information is 
important as precipitation of DNA cannot readily be detected in the Couette cell 
but will provide inaccurate data. Therefore, titrations of a 50 M stock solution of 
[Pd2L
OMe
4][(BF4)4] complex over a 30 M ct-DNA solution were performed. As for 
the CD experiments, the 50 M stock solution of complex [Pd2L
OMe
4][(BF4)4] was 
prepared by dissolving it in DMSO and diluting with water to obtain a 1.5% DMSO 
solution. At the end of the titration, the DMSO percentage in the Couette will be 
0.3%. Control experiments to evaluate the effect of DMSO on the LD spectra of 
ct-DNA were carried out and no changes were observed.  
As the concentration of the [Pd2L
OMe
4][(BF4)4] complex increases, the 
characteristic DNA LD signal at 260 nm decreases in magnitude. This indicates 
that the DNA is being coiled or bent upon binding. This coiling or bending effect is 
observed upon addition of very small complex concentrations, indicating an 
immediate effect of the cylinder on the DNA. No ILD signal is apparent in this 
titration, which suggests either that the binding of the [Pd2L
OMe
4][(BF4)4] complex 
is not oriented or that the angle of orientation is such that it is not detected (Figure 
3.11). 
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Figure 3.11: LD spectra of ct-DNA with increasing concentrations of [Pd2L
OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
LD titrations of [Pd2L
O-OMe
4][(BF4)4], [Pd2L
NH-OMe
4][(BF4)4] and 
[Pd2L
O-Glycol
4][(BF4)4] complexes produced similar outcomes, with the 
[Pd2L
O-OMe
4][(BF4)4] complex producing the largest amount of coiling of the DNA. 
The negative LD signals at 260 nm for these complexes decrease in magnitude 
with increasing concentrations of the complexes, indicating coiling or bending of 
the DNA and therefore DNA binding (see Appendix). 
The full LD titration of [Pd2L
S-OMe
4][(BF4)4] could not be recorded as 
precipitation of the DNA occurred from a 30:1 DNA base:complex ratio 
(see Appendix). 
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The LD spectra of [Pd2L4][(BF4)4] showed a smaller coiling or bending 
effect compared to the other studied complexes. This is observed by a smaller 
decrease in the magnitude of the LD signal at 260 nm (Figure 3.12).  
 
Figure 3.12: LD spectra of ct-DNA with increasing concentrations of [Pd2L4][(BF4)4] parent 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. 
(30 M ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
This is not surprising since this complex did not show a remarkable DNA 
interaction in the circular dichroism studies. However, the small decrease of the 
DNA band indicates coiling or bending, suggesting some sort of weak interaction 
between the complex and the DNA. Similar results were found for the 
[Pd2L
OH
4][(BF4)4] complex (see Appendix). 
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The coiling or bending effect of all palladium(II) cylinders studied can be 
compared by plotting the magnitude of the LD signal at 260 nm versus the 
complex concentration (Figure 3.13).  
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Normalized LD signal at 260 nm vs complex concentration for all palladium(II) 
cylinders studied (left) and percentage loss of LD signal at 260 nm for 0.5 M (60:1 DNA 
base:complex) and 5 M (6:1 DNA base: complex) concentrations. 
 
Complexes [Pd2L
OH
4][(BF4)4] and [Pd2L4][(BF4)4] produce smaller coiling 
effects on the DNA. The other complexes present similar orientation effects, 
except for that of [Pd2L
O-OMe
4][(BF4)4] where the coiling effect is considerably 
higher from an 8:1 DNA base:complex ratio. The percentage loss of the LD signal 
of DNA at 260 nm gives a quantitative value of the coiling effect of all of the 
palladium(II) cylinders studied. At the smallest concentration of cylinder (0.5 M or 
60:1 DNA base:complex), little difference is observed between the different 
complexes. However, when the concentration of complex is increased by one 
order of magnitude (5 M or 6:1 DNA base:complex), the coiling effect produced 
% LD loss 0.5 M 5 M 
 
[Pd2L
OMe
4][(BF4)4] 
 
17% 
 
71% 
 
[Pd2L
O-OMe
4][(BF4)4] 18% 96% 
 
[Pd2L
NH-OMe
4][(BF4)4] 17% 67% 
 
[Pd2L
OH
4][(BF4)4] 16% 31% 
 
 [Pd2L
O-Glycol
4][(BF4)4] 10% 73% 
 
[Pd2L4][(BF4)4] 5% 27% 
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by [Pd2L
O-OMe
4][(BF4)4] is 96%, while the other complexes produce a 27-73% loss 
of the negative LD signal. 
 
3.4. Ethidium bromide displacement experiments 
Ethidium bromide is a well known fluorescent intercalating drug (see section 
1.2.3.). However, its fluorescence can be greatly enhanced when bound to DNA, 
giving rise to a band at around 600 nm (Figure 3.14).  
 
Figure 3.14: Emission spectra of ethidium bromide and its complex with DNA. 
 
Ethidium bromide displacement is a competition binding assay where the 
binding affinity of ethidium bromide and another molecule is assessed. The 
competition will be greater if the two binders are competing for the same position, 
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that is if the molecule being studied is an intercalator. However, simple 
electrostatic interaction will ensure a DNA binding competition.(175) 
In the work reported in this thesis, an ethidium bromide displacement assay 
is performed to evaluate the interaction between DNA and the newly synthesised 
palladium(II) complexes. A solution of aqueous buffered ct-DNA fully loaded with 
ethidium bromide molecules is excited at 500 nm and the emission spectrum 
produced is recorded. Aliquots of palladium(II) complexes are then titrated into this 
solution and the emission spectra measured. If the emission is quenched as a 
result of the titration, this is evidence of ethidium bromide being displaced from the 
DNA by the palladium(II) cylinder. However, interactions between the palladium(II) 
complexes and free or bound ethidium bromide can also be present and these 
may also decrease the emission intensity.(176)  
Aliquots of a 100 M stock solution of [Pd2L
OMe
4][(BF4)4] complex were 
progressively added over a solution of 30 M ct-DNA and 10 M ethidium 
bromide. The 100 M stock solution of the [Pd2L
OMe
4][(BF4)4] complex was 
prepared by dissolving it in DMSO and diluting with water to obtain a 1.5% DMSO 
solution. At the end of the titration, the DMSO percentage in the cuvette will be 
0.15%. The concentrations of DNA and ethidium bromide were kept constant 
during the experiment. The emission spectra of the titrations performed for the 
[Pd2L
OMe
4][(BF4)4] complex are shown in Figure 3.15. 
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Figure 3.15: Emission spectra of displacement of ethidium bromide (10 M) from ct-DNA 
with increasing concentrations of [Pd2L
OMe
4][(BF4)4] complex (exc=500 nm). 
Legend shows ct-DNA base:complex ratios. 0.15% max. DMSO. 
(30 M ct-DNA in 50 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
The emission of the complex formed by ethidium bromide and DNA is 
quenched upon addition of increasing concentrations of the complex, indicating 
displacement of ethidium bromide by the cylinder. All the palladium(II) complexes 
studied are able to displace ethidium bromide, suggesting higher binding 
constants for these than that of ethidium bromide. Quenching of the luminescence 
was not detected in free ethidium bromide solutions upon titration of complex 
solutions. Therefore, the decrease in luminescence of the ethidium bromide-DNA 
solution must be due to the interaction between the complex and DNA, and 
therefore displacement of the bound ethidium bromide. A comparison of all the 
complexes where the relative emission intensity at the emission maximum 
(606 nm) is plotted against complex concentration is shown in Figure 3.16.  
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Figure 3.16: Relative emission intensity at 606 nm maximum vs complex concentration for 
all palladium(II) cylinder studied using an ethidium bromide displacement experiment. 
 
Most of the complexes appear to have similar binding constants as they 
quench the emission of the complex between DNA and ethidium bromide by 
similar magnitudes. The [Pd2L
NH-OMe
4][(BF4)4] complex can displace ethidium 
bromide from ct-DNA more efficiently than the other complexes, suggesting a 
higher binding constant. However, this can be due to the formation of other 
structures or decomposition of the complex in DMSO solutions, as seen by 
1H NMR. The [Pd2L
O-Glycol
4][(BF4)4] complex is less efficient at displacing ethidium 
bromide compared with its analogues. This can be due to its bigger size and the 
long chains at either side of the complex, which might require a larger binding site. 
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3.5. Agarose gel electrophoresis unwinding experiments 
Gel electrophoresis is one of the most widely used techniques by biochemists and 
molecular biologists. By employing this technique, macromolecules that differ in 
size, charge or conformation can be separated. DNA is such a molecule and will 
migrate to the positive pole when placed in an electric field, as the DNA phosphate 
backbone is negatively charged. Interactions between ligands and DNA can also 
be assessed by gel electrophoresis.(177) 
In the work presented herein, interactions between the newly synthesised 
palladium(II) complexes and plasmid DNA are investigated. Plasmid DNA is a 
double-stranded circle that can exist in two topologically different conformations: 
supercoiled and open circular (Figure 3.17).  
 
 
 
Figure 3.17: Plasmid DNA forms: negatively supercoiled (left), open circular (centre) and 
positively supercoiled (right). 
 
negatively supercoiled 
plasmid DNA 
open circular 
plasmid DNA 
positively supercoiled 
plasmid DNA 
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 The open circular form is relaxed duplex DNA, while the supercoiled form 
occurs when the duplex twists around itself. The latter is extensively found in 
nature in replication and transcription processes, where opening of the double 
helix is required. Depending on the direction of the twisting, it can be negatively 
supercoiled (right handed) or positively supercoiled (left handed). It is the 
negatively supercoiled form which causes torsional stress to the DNA favouring 
unwinding of the duplex, while the positively supercoiled form favours winding up 
of the double helicate. Conformational changes of the duplex can result from 
interactions with bound molecules.(178,179) 
 In this work, gel electrophoresis is used to study the effect caused by 
different concentrations of palladium(II) complexes and pBR322 plasmid DNA, 
which is negatively supercoiled DNA consisting of 4 361 base pairs. This form of 
plasmid DNA will travel faster through the gel pores, as it is smaller than the open 
circular DNA. 1% agarose gels were used and immersed in Tris-Acetate-EDTA 
(TAE) buffer, which provides ions to carry the applied current and maintains the 
pH at a constant value.(180) If the complexes bind to supercoiled DNA, it will unwind 
and therefore its size and volume will increase, resulting in a slower migration of 
the supercoiled bands, suggesting that the complex is binding to the DNA.(181) 
Once the two plasmidic forms have been separated the gel can be stained with 
ethidium bromide, which intercalates between the DNA base pairs and is then 
visible under UV light. When the supercoiled and open circular forms of the 
plasmid DNA co-migrate, the unwinding angle of the supercoiled form can be 
calculated (eq. 3). 
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     (eq. 3) 
 The unwinding angle () is defined as the number of degrees by which the 
DNA is unwound about its helical axis per molecule bound. The superhelicity 
constant () of the plasmid DNA has been determined to be -0.059 using cisplatin, 
since the unwinding angle of cisplatin is known (13º).(182) r(c) is the number of 
molecules bound per plasmid and is taken to be equal to the mixing ratios, as it is 
assumed that all the binders present in the sample are bound to the plasmidic 
DNA. 
 The unwinding experiment was performed for all synthesised palladium(II) 
complexes in 1% agarose gels. Sample solutions of DNA and complex at different 
ratios were incubated for two hours at 37 ºC. These solutions contained a 1% 
DMSO, required to solubilise the complexes. Controls with and without DMSO 
were performed to ensure that the DMSO had no effect on the DNA. Table 3.1 
indicates the DNA base pairs:complex ratios used on every gel run. 
Table 3.1: Relation between DNA base pairs:complex ratios and lanes in agarose gels. 
 
Lanes 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
Base 
pairs: 
complex 
 
Control 
(1% DMSO) 
 
20:1 
 
15:1 
 
10:1 
 
8:1 
 
6:1 
 
5:1 
 
4:1 
 
3:1 
 
2:1 
 
Control 
 
 The agarose gel for the [Pd2L
OMe
4][(BF4)4] complex is shown in Figure 3.18. 
The band corresponding to the supercoiled DNA starts to migrate more slowly with 
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increasing concentrations of complex, indicating unwinding of the negatively 
supercoiled DNA and therefore binding to the DNA. This binding lengthens and/or 
stiffens the DNA structure. 
 
 
 
Figure 3.18: 1% Agarose gel showing changes in the electrophoretic mobility of open 
circular (oc) and supercoiled (sc) plasmid DNA for [Pd2L
OMe
4][(BF4)4] complex. 
 
The rest of the palladium(II) complexes studied behave in a similar manner, 
except for [Pd2L
NH-OMe
4][(BF4)4] which does not seem to have any effect on 
plasmidic DNA, as the open circular (oc) and supercoiled (sc) forms of plasmid 
DNA migrate at the same speed at any given concentration of this complex (Figure 
3.19). This can be due to the formation of other structures or decomposition of this 
palladium(II) cylinder in DMSO solutions, as seen by 1H NMR. 
Unwinding angles can only be calculated when the supercoiled and open 
circular forms co-migrate across the gel. For all the gels performed in this study, 
either both bands co-migrate at a 2:1 DNA base pairs:complex ratio or they do not 
co-migrate at any point, even if the complexes interact with the supercoiled form. 
Therefore the unwinding angle is assumed to be smaller or equal to 4º. 
  1        2        3       4        5        6        7        8        9       10      11 
oc 
 
sc 
- 
 
+ 
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Figure 3.19: 1% Agarose gels showing changes in the electrophoretic mobility of open 
circular (oc) and supercoiled (sc) plasmid DNA for [Pd2L
O-OMe
4][(BF4)4], [Pd2L
NH-
OMe
4][(BF4)4], [Pd2L
S-OMe
4][(BF4)4], [Pd2L
OH
4][(BF4)4], [Pd2L
O-Glycol
4][(BF4)4] and 
[Pd2L4][(BF4)4] complexes (from left to right and top to bottom). 
 
 
3.6. Polyacrylamide gel electrophoresis: DNA junction 
recognition experiments 
Polyacrylamide is another polymer that can be used to perform gel electrophoresis 
experiments. Polyacrylamide gel electrophoresis (PAGE) is normally used to 
separate smaller DNA fragments that cannot be separated by agarose gels, since 
the pore size is considerably smaller. The main advantage of PAGE is that low 
concentrations can be used and high resolution between bands is observed.  
 1      2      3      4      5      6      7      8      9     10    11    1      2      3      4      5      6      7      8       9    10    11 
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In this work, PAGE has been used to evaluate whether the synthesised 
palladium(II) cylinders are able to recognize DNA junctions, such as three-way and 
four-way DNA junctions. In order to do this, DNA oligonucleotide strands were 
designed so that a non-palindromic three-way junction and a four-way junction can 
be formed. One of these strands was radiolabelled at the 5’ terminus end with 
-32P ATP, so that the gel could be visualized and quantified. This experiment is 
based on that reported by Hannon and co-workers for the recognition of DNA and 
RNA three-way junctions by iron(II) supramolecular helicates.(81,121)  
Initially, a PAGE DNA three-way junction experiment was performed. In 
principle, the bigger size of a tetra-stranded cylinder compared to a triple-stranded 
cylinder will prevent binding to a DNA three-way junction and thus the stabilization 
of the structure, and this was the result observed. The three DNA strands were 
incubated with the synthesised palladium(II) tetra-stranded complexes, and also 
Hannon’s iron(II) triple-stranded cylinder, at room temperature for one hour (Figure 
3.20). Formation of DNA three-way junction was observed for the triple-stranded 
cylinder as expected, however none was observed for the tetra-stranded cylinders. 
This result emphasises the perfect fit observed between Hannon’s iron(II) 
triple-stranded cylinder and DNA three-way junctions and that not every metal 
complex can fit and bind at the central cavity of a DNA three-way junction, so that 
size and shape are crucial for the molecular design of DNA junction binders. It also 
confirms that it is not purely electrostatic stabilization of the DNA three-way 
junction by a tetracation. 
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1 S3* 7 S3*+S2+S1+ [Pd2L
S-OMe
4][(BF4)4] (3:1) 
2 S3*+S2 8 S3*+S2+S1+ [Pd2L
OH
4][(BF4)4] (3:1) 
3 S3*+S2+S1 9 S3*+S2+S1+ [Pd2L
O-Glycol
4][(BF4)4] (3:1) 
4 S3*+S2+S1+ [Pd2L
OMe
4][(BF4)4] (3:1) 10 S3*+S2+S1+ [Pd2L4][(BF4)4] (3:1) 
5 S3*+S2+S1+ [Pd2L
O-OMe
4][(BF4)4] (3:1) 11 S3*+S2+S1+ [Pd2L
OMe
4][(BF4)4] (3:1) 
6 S3*+S2+S1+ [Pd2L
NH-OMe
4][(BF4)4] (3:1) 12 S3*+S2+S1+ [Fe2L
im
3][Cl4] (3:1) 
    
 
Figure 3.20: Autoradiogram of 15% polyacrylamide gel run at 25 ºC, 120 V, 4 h. S3* 32P 
radiolabelled, incubation of samples at room temperature for 1 h. Lanes as indicated in 
table. 
 
As previously mentioned, the design of DNA four-way junction binders is 
not as straightforward, as DNA four-way junctions can exist in two 
conformations.(87) DNA four-way junctions are normally the target of proteins that 
are involved in the homologous recombination process and little work has been 
focused on the binding of synthetic molecules. Initial efforts in targeting DNA 
four-way junctions were performed by Kallenbach and co-workers. In 1989 they 
reported the cleavage of a DNA four-way junction near the branch point by 
intercalation of methidiumpropyl-EDTA-FeII or MPE-FeII (Figure 3.21), as seen by 
32P radiolabelled PAGE.(183) 
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Figure 3.21: Structure of MPE-FeII four-way junction binder. 
 
Segall et al. have reported a hexapeptide, WRWYCR, that is able to inhibit 
DNA repair intermediates by selectively interacting with the DNA four-way junction, 
as seen by radiolabelled gel mobility shift assays.(184) Peptide WRWYCR and its D 
stereoisomer, wrwycr, act as dimers via a disulfide bond and are able to inhibit 
bacterial cell growth, as seen by MIC assays.(185) The McAlpine group continued 
with this strategy and designed more rigid cyclic peptides with C-2 symmetry that 
mimic the symmetry of the DNA four-way junction binding site (Figure 3.22). 
Hydrophobic residues are thought to stack with the nucleotides at the centre of the 
junction, while hydrophilic residues might form hydrogen bonds with either bound 
proteins or the DNA junction itself.(186) 
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Figure 3.22: McAlpine cyclic hexapeptide with C-2 symmetry. 
 
More recently, Cardin and co-workers presented the crystal structure of a 
bis-acridine intercalator bound at the centre of the junction (see section 
1.2.6.4.).(94) 
The last example of a DNA four-way junction binder reported to date is the 
9-propargylaminoacridine click ligand reported by Searcey’s group (Figure 3.23). It 
was shown that this compound is able to recognize the DNA four-way junction, 
without evidence of binding to single stranded DNA, at a concentration of 50 M 
when the DNA strands (one of them doubly labelled with two fluorophores) and the 
compound are annealed at 80 ºC. The same result was obtained after incubation 
at room temperature for four hours.(187) These results were also confirmed by 
fluorescence assays and circular dichroism spectroscopy. 
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Figure 3.23: 9-propargylaminoacridine click ligand reported by Searcey’s group. 
 
In the work reported herein, radiolabelled PAGE has been performed with 
the synthesised palladium(II) complexes reported in Chapter 2. Initially, complexes 
and DNA oligonucleotides were annealed at 80 ºC for five minutes followed by 
slow cooling for four hours. The gel was run in the same conditions used in the 
Hannon group for DNA three-way junction PAGE (15% polyacrylamide gel, 120 V, 
4 h). These conditions produced a gel with wide bands for the single stranded 
band (Figure 3.24), not seen in Searcey’s gels. Formation of the four-way junction 
was observed with all the complexes, however it was also present in the control in 
the absence of magnesium cations and palladium(II) complexes (45% of Holliday 
junction formation in all cases). Well precipitation with the [Pd2L
OMe
4][(BF4)4] 
complex is also observed. 
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1 S4* 7 S4*+S3+S2+S1+ 6 mM MgCl2 
2 S4*+S3 8 S4*+S3+S2+S1+ 25 M [Pd2L
OMe
4][(BF4)4] 
3 S4*+S3+S2 9 S4*+S3+S2+S1+ 50 M [Pd2L
OMe
4][(BF4)4] 
4 S4*+S3+S2+S1 10 S4*+S3+S2+S1+ 100 M [Pd2L
OMe
4][(BF4)4] 
5 S4*+S3+S2+S1+ 2 mM MgCl2 11 S4*+S3+S2+S1+ 25 M [Pd2L
O-Glycol
4][(BF4)4] 
6 S4*+S3+S2+S1+ 4 mM MgCl2 12 S4*+S3+S2+S1+ 50 M [Pd2L
O-Glycol
4][(BF4)4] 
    
 
Figure 3.24: Autoradiogram of 15% polyacrylamide gel run at 25 ºC, 120 V, 4 h. S4* 32P 
radiolabelled, incubation of samples at 80 ºC. Lanes as indicated in table. 
 
A second gel was then performed with Searcey’s conditions (12% 
polyacrylamide gel, 50 V, 2 h). Samples were incubated at room temperature for 
24 hours. In principle, DNA four-way junction should not be formed under these 
conditions unless a divalent metal or a four-way junction binder is present. 
Searcey has reported that 60% Holliday junction is formed after 24 hours 
incubation of the DNA oligonucleotides in the presence of 2 mM MgCl2. The gel 
shown in Figure 3.25 shows 80% and 78% four-way junction formation for 2 mM 
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and 4 mM MgCl2 concentrations respectively. 74% and 72% four-way junction 
formation is observed for [Pd2L
OMe
4][(BF4)4] and [Pd2L
O-Glycol
4][(BF4)4] complexes 
at 25 M concentration respectively. At higher concentrations, precipitation or 
condensation of the DNA is observed. This latter observation is in full agreement 
with the circular dichroism studies. 
1 S4* 6 S4*+S3+S2+S1+ 50 M [Pd2L
OMe
4][(BF4)4] 
2 S4*+S3+S2+S1+ 2 mM MgCl2 7 S4*+S3+S2+S1+ 100 M [Pd2L
OMe
4][(BF4)4] 
3 S4*+S3+S2+S1+ 4 mM MgCl2 8 S4*+S3+S2+S1+ 25 M [Pd2L
O-Glycol
4][(BF4)4] 
4 S4*+S3+S2+S1+ 6 mM MgCl2 9 S4*+S3+S2+S1+ 50 M [Pd2L
O-Glycol
4][(BF4)4] 
5 S4*+S3+S2+S1+ 25 M [Pd2L
OMe
4][(BF4)4] 10 S4*+S3+S2+S1+ 100 M [Pd2L
O-Glycol
4][(BF4)4] 
    
 
Figure 3.25: Autoradiogram of 12% polyacrylamide gel run at 25 ºC, 50 V, 2 h. S4* 32P 
radiolabelled, incubation of samples at room temperature for 24 h. Lanes as indicated in 
table. 
 
Another experiment using the same conditions was performed, however the 
four-way junction on its own was also loaded as a control (Figure 3.26). Lower 
concentrations of cylinders were also used. Four-way junction appears to be 
formed in the absence of any cation after incubation for 24 hours at room 
temperature. This result makes the detection and therefore confirmation of the 
formation of DNA four-way junction upon incubation of the DNA oligonucleotides 
with the synthesised cylinders difficult. 
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1 S4* 6 S4*+S3+S2+S1+ 0.1 M [Pd2L
O-OMe
4][(BF4)4] 
2 S4*+S3+S2+S1 7 S4*+S3+S2+S1+ 1 M [Pd2L
O-OMe
4][(BF4)4] 
3 S4*+S3+S2+S1+ 2 mM MgCl2 8 S4*+S3+S2+S1+ 10 M [Pd2L
O-OMe
4][(BF4)4] 
4 S4*+S3+S2+S1+ 10 M [Pd2L
OMe
4][(BF4)4] 9 S4*+S3+S2+S1+ 25 M [Pd2L
O-OMe
4][(BF4)4] 
5 S4*+S3+S2+S1+ 25 M [Pd2L
OMe
4][(BF4)4]   
    
 
Figure 3.26: Autoradiogram of 12% polyacrylamide gel run at 25 ºC, 50 V, 2 h. S4* 32P 
radiolabelled, incubation of samples at room temperature for 24 h. Lanes as indicated in 
table. 
 
It was then explored whether incubation of the DNA oligonucleotides for 
only one hour at room temperature might not be sufficient for the formation of DNA 
four-way junction, and whether therefore the four-way junction might appear only 
when bound to magnesium cations or cylinders under these conditions (Figure 
3.27). However, this was not successful: the DNA four-way junction was again 
formed in the absence of cations. Well precipitation was again observed at high 
complex loadings and for any given concentration of the [Pd2L
O-Glycol
4][(BF4)4] 
cylinder. 
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1 S4* 7 S4*+S3+S2+S1+ 25 M [Pd2L
OMe
4][(BF4)4] 
2 S4*+S3+S2+S1 8 S4*+S3+S2+S1+ 10 M [Pd2L
O-Glycol
4][(BF4)4] 
3 S4*+S3+S2+S1+ 0.5 mM MgCl2 9 S4*+S3+S2+S1+ 25 M [Pd2L
O-Glycol
4][(BF4)4] 
4 S4*+S3+S2+S1+ 2 mM MgCl2 10 S4*+S3+S2+S1+ 10 M [Pd2L
O-OMe
4][(BF4)4] 
5 S4*+S3+S2+S1+ 6 mM MgCl2 11 S4*+S3+S2+S1+ 25 M [Pd2L
O-OMe
4][(BF4)4] 
6 S4*+S3+S2+S1+ 10 M [Pd2L
OMe
4][(BF4)4]   
    
 
Figure 3.27: : Autoradiogram of 12% polyacrylamide gel run at 25 ºC, 50 V, 2 h. S4* 32P 
radiolabelled, incubation of samples at room temperature for 1 h. Lanes as indicated in 
top table. 
 
It can be concluded from the gel experiments performed that there is not a 
dramatic shift from single strand to four-way junction when incubating the DNA 
oligonucleotides with the different cylinders. However, most of the DNA present 
seems to have already formed four-way junction, and perhaps the single stranded 
DNA observed is either excess or for some reason cannot form a four-way 
junction. These results are also inconclusive as magnesium does not seem to 
affect this ratio either. It is unclear why despite apparently using the same 
conditions as Searcey, different four-way junction stability is observed 
 
3.7. Cytotoxicity Tests 
In order to explore the anti-cancer activity of the synthesised palladium(II) 
cylinders, preliminary cytotoxicity tests were performed by Hannah Pritchard from 
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the Hannon group. The cytotoxicity was determined using the 
3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) assay.(188) The 
A2780 ovarian and the T47D breast cancer cell lines were grown in 96 well plates 
in the presence of the palladium(II) complexes at different concentrations. After 
72 hours of incubation at 37 ºC and 5% CO2, the amount of living cells present 
was determined by the addition of MTT. The mitochondrial enzyme succinate 
dehydrogenase is able to convert the yellow water soluble MTT into blue formazan 
crystals in viable cells (Scheme 3.1). 
 
 
Scheme 3.1: Reduction of yellow MTT to blue formazan by succinate dehydrogenase. 
 
These blue crystals are then dissolved in DMSO to give a purple solution 
and the absorbance is measured at 590 nm. An IC50 value can be determined from 
a dose response curve. The IC50 is the concentration of complex required to inhibit 
50% of cell growth.(189) 
Three cylinders were initially tested against A2780 and T47D cells. Each 
assay was performed in duplicate. Table 3.2 summarizes the obtained IC50 values. 
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Table 3.2: Preliminary IC50 values (M) for some of the synthesised palladium(II) cylinders 
and cisplatin 
 
 
A2780 
 
T47D 
 
[Pd2L
OMe
4][(BF4)4] 
87 53 21 34 
 
[Pd2L
O-OMe
4][(BF4)4] 
11 5 9 26 
 
[Pd2L
NH-OMe
4][(BF4)4] 
10 8 >100 >100 
 
Cisplatin 
2 1 15 29 
 
The [Pd2L
OMe
4][(BF4)4] complex does not seem to be very toxic against the 
A2780 ovarian cancer cell line, however it shows good cytotoxicity against the 
T47D breast cancer cell line. The [Pd2L
O-OMe
4][(BF4)4] complex is the most toxic of 
all the compounds tested, presenting good cytotoxicity in both ovarian and breast 
cancer cell lines. The [Pd2L
NH-OMe
4][(BF4)4] complex is not active against T47D 
cells, although it is quite toxic against the ovarian A2780 cancer cell line.  
These results are only preliminary and need to be repeated to obtain more 
accurate data with the corresponding standard deviation. The other synthesised 
palladium(II) complexes need to also be tested. Nevertheless, it can be concluded 
that in general the modifications performed on the cylinders in order to acquire 
better solubility have not quenched their cytotoxic activity, however it may have 
conferred some selectivity. The reason for this possible selectivity has not yet 
been explored. 
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3.8. Closing remarks 
In this chapter DNA binding studies of the newly synthesised palladium(II) 
cylinders have been presented. Circular dichroism gave information on the DNA 
binding properties of the methoxy cylinders, as well as the [Pd2L
O-Glycol
4][(BF4)4] 
complex. A binding event was indicated by the presence of an ICD signal in the 
spectroscopic region of the complexes. An ethidium bromide displacement assay 
also confirmed the binding of these complexes to duplex DNA. Quenching of the 
luminescence of the DNA-ethidium bromide complex upon addition of increasing 
concentrations of cylinder indicates the displacement of the ethidium bromide 
intercalator by the complex. Linear dichroism showed the coiling or bending effect 
caused by the synthesised palladium(II) cylinders, confirming the DNA interaction 
of all complexes. Agarose gel electrophoresis was also performed and this 
technique showed that all the synthesised complexes, except 
[Pd2L
NH-OMe
4][(BF4)4], are able to unwind supercoiled DNA and retard its migration 
in a 1% agarose gel. The interaction of these complexes with a DNA four-way 
junction was also investigated in a radiolabelled PAGE experiment. Unfortunately, 
the results are inconclusive and this subject needs further investigation. 
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The work described in this thesis has been focused on the design and synthesis of 
novel palladium(II) tetra-stranded supramolecular cylinders that might be capable 
of recognizing a DNA four-way junction. Tetra-stranded cylinders were previously 
synthesised by Hannon, Ryabova and Kaur, however their poor water solubility 
prevented detailed DNA binding studies.(133,134) These palladium(II) complexes are 
highly toxic against different ovarian and breast cancer cell lines, suggesting a 
possible use of these cylinders as anti-cancer drugs. In this work, four different 
strategies to increase the water solubility of these complexes have been explored. 
This was to allow DNA binding studies to be carried out to give a better 
understanding of the mode of action of these supramolecular cylinders.  
Modification of the central spacer unit provided an increase in the solubility 
of the first generation of complexes; when exchanging the carbon spacer by 
oxygen, the palladium(II) complex became more soluble in organic solvent/water 
mixtures.(133,134) Therefore, this was the first strategy that was explored in this 
work. The carbon spacer unit was substituted by oxygen, nitrogen and sulfur. 
These changes were performed in a newly synthesised ligand with methyl ether 
groups at the 3 position of the pyridine rings (LOMe). This functional group was 
chosen as 3-bromo-5methoxypyridine is commercially available, it could be 
cleaved in a later stage and would provide an easy synthetic route while protected. 
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All spacer-modified ligands (LO-OMe, LNH-OMe and LS-OMe), as well as the carbon 
analogue (LOMe), were formed via Suzuki coupling of smaller molecules. Formation 
of the palladium(II) complex of ligand LOMe was initially performed at room 
temperature overnight. This yielded two supramolecular species of different size, 
as seen by DOSY NMR spectroscopy. These two products were identified as the 
desired tetra-stranded dinuclear palladium(II) cylinder and a double walled 
triangle. The complexation reaction at 80 ºC yielded the desired tetra-stranded 
cylinders as the only products. These four new complexes were soluble in 
dimethyl sulfoxide, acetone, acetonitrile and organic solvent/water mixtures, with a 
smaller percentage of organic solvent required compared with the first generation 
of complexes.  
Deprotection of the methyl ether groups of the synthesised ligands yielded 
three new ligands (LOH, LO-OH and LNH-OH), which were more soluble in protic 
solvents. The tetra-stranded palladium(II) complexes of ligands LOH and LO-OH 
were successfully formed, however they tend to form gelatinous solutions and this 
made the characterization complicated. Nevertheless, the [Pd2L
OH
4][(BF4)4] 
complex could be solubilised in dimethyl sulfoxide/water mixtures. Ligand LNH-OH 
presented water solubility properties, however the formation of its palladium(II) 
complex could not be achieved since the yield for the formation of this ligand was 
low.  
A short glycol chain was introduced at the edges of the pyridine rings, which 
gave the [Pd2L
O-Glycol
4][(BF4)4] complex methanol solubility. Other motifs, such as 
alkyl-chained pyrrolidines were also added at position 3 of the pyridine rings, 
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however formation of the palladium(II) complex of ligand LPyr could not be 
achieved in its pure form.  
Exchange of the tetrafluoroborate counter-ion of the [Pd2L
OMe
4][(BF4)4] 
complex was also explored. Triflate anions considerably increased the solubility of 
this complex in acetonitrile, while nitrate counter-ions yielded a complex more 
soluble in organic solvents. When treating [Pd2L
OMe
4][(BF4)4] complex with a 
saturated solution of chloride anions, ligand LOMe was obtained as the complex fell 
apart. Two of the four tetrafluoroborate counter-ions were observed to be located 
in the central cavity of [Pd2L
OMe
4][(BF4)4] and [Pd2L
NH-OMe
4][(BF4)4] complexes via 
X-ray diffraction. Therefore, triflate and tosilate anion titrations monitored by 
1H NMR were performed. These experiments revealed that the outer anions are 
exchanged first as these are more readily available.  
An increase in the overall charge of the cylinder was also investigated. This 
led to the formation of the doubly charged LN+ ligand, in which the central 
phenylene spacer units were replaced by pyridine rings. Unfortunately, formation 
of the tetra-stranded complex could not be achieved. A single charged ligand 
might be more suitable as the overall charge of the complex will be 8+ instead of 
12+. This might allow a better interaction between the charged ligands and the 
metal ions.  
In summary, four different modifications of the basic structure of the parent 
palladium(II) cylinder have been explored. An increase in solubility in organic 
solvent/water mixtures has been observed and has allowed detailed DNA binding 
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studies to be performed. A highly methanol-soluble complex has also been 
synthesised, however solubility in aqueous buffer could not be obtained. Four 
different changes at four different positions were investigated and no aqueous 
solubility was achieved.  
Changing the metal ion was not explored in this study as this did not 
improve the water solubility of the first generation of compounds and yielded other 
structures, such as polymeric structures for silver ions and complex mixtures for 
platinum complexes, that needed to be purified with two consecutive HPLC runs. 
However, if a water soluble palladium(II) cylinder could be synthesised, the 
synthesis of its platinum(II) analogue would be interesting due to its higher stability 
and the numerous existing platinum anti-cancer drugs, so that cytotoxic activities 
between platinum complexes could be compared.  
Ishikawa has reported that by disrupting the molecular planarity and 
symmetry of drug molecules, an improvement in water solubility is achieved.(190) 
The high symmetry and the square planar conformation of the palladium(II) 
complexes could be the reason for their poor water solubility. Therefore, disruption 
of the symmetry could be investigated in future studies (e.g. singly charged 
ligands). However, this could lead to mixtures that might be challenging to purify. 
Even though the synthesised complexes were not water soluble, their DNA 
binding properties were studied via circular and linear dichroism, ethidium bromide 
displacement and agarose and polyacrylamide gel electrophoresis. Sample 
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solutions were prepared by dissolving the complexes in a small percentage of 
DMSO.  
The methoxy cylinders and the [Pd2L
O-Glycol
4][(BF4)4] complex showed 
affinity for duplex DNA as seen by circular dichroism, while [Pd2L
OH
4][(BF4)4] and 
the parent [Pd2L4][(BF4)4] complexes did not seem to bind DNA. However, an 
ethidium bromide displacement assay confirmed the DNA binding properties of all 
of the synthesised complexes.  
Oriented binding to ct-DNA was not observed for any of the studied 
complexes, however coiling or bending effects were observed via linear dichroism 
spectroscopy. The [Pd2L
O-OMe
4][(BF4)4] complex produced the greatest loss of 
DNA LD signal, with the rest showing similar coiling effects.  
Unwinding angles of 4º or lower were determined by agarose gel 
electrophoresis of plasmid DNA. All the complexes, except the 
[Pd2L
NH-OMe
4][(BF4)4] complex, were shown to interact with the supercoiled form of 
plasmidic DNA, indicating DNA binding.  
From these experiments, it can be concluded that the newly synthesised 
palladium(II) complexes are able to recognize and bind to duplex DNA. In terms of 
DNA junction recognition, the results reported herein are inconclusive, as the DNA 
four-way junction is quantitatively formed in the absence of divalent cations or 
cylinder. Therefore, detection of stabilization or binding of the cylinder to a DNA 
four-way junction is difficult to confirm. Further investigations might involve either 
the detection of palladium via ICP-MS on four-way junction bands, or cylinder 
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detection via MALDI spectroscopy. This issue needs to be addressed as the 
palladium(II) cylinders may only be duplex binders or coiling agents. 
Preliminary cytotoxicity tests showed that in general the synthesised 
cylinders remain toxic against breast and ovarian cancer cell lines, and some 
selectivity can be observed. However, these are only initial results and need to be 
further investigated. Future work may also involve the study of cellular uptake 
mechanisms, as well as detection of the localization of the complexes in cells. 
Distribution of the complexes in the cell (cytoplasm or nuclei) could be detected by 
ICP-MS. 
A new ligand system was also explored in this study, however formation of 
a dinuclear, tetra-stranded palladium(II) complex has not yet been achieved. This 
new ligand system replaced the coordinating pyridines by 1,2,3-triazoles moieties 
that are shown to coordinate metal ions. These triazole ligands can be easily 
synthesised via the click chemistry reaction, in one step with high yields and with a 
wide variety of functionalization groups. This could allow the synthesis of large 
libraries of compounds and metallo-supramolecular structures. Initial studies 
towards the application of this new ligand system in Hannon’s iron(II) triple 
stranded cylinder have been explored. The coordinating pyridine group was also 
replaced by a 1,2,3-triazole unit (Scheme 4.1). However, ligand Lim-click could not 
be obtained. 1H NMR indicated a mixture of species with the aldehyde present, 
and mass spectrometry confirmed the presence of the aldehyde and half ligand. A 
one pot synthesis was performed with the immediate formation of an orange 
solution, however this coloration faded with time. NMR and mass spectrometry 
Chapter 4 
Conclusions and Future Work 
196 
 
studies were inconclusive in determining whether the complex had been formed. 
The synthesis of mononuclear iron(II) complexes might give a better 
understanding of this new ligand system. 
 
Scheme 4.1: Synthesis of ligand Lim-click. 
 
Although much has been learnt from the design and synthesis of the novel 
palladium(II) cylinders, some questions remain unanswered. Several modifications 
of the parent palladium(II) cylinder have been performed and water solubility could 
not be obtained. A new ligand system was also explored, however it was not 
possible to obtain the dinuclear palladium(II) complexes. Future work might involve 
a completely new molecular design in order to acquire water solubility.  
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Even though the synthesised complexes were not soluble in 100% aqueous 
buffer, DNA binding studies could be performed with small percentages of organic 
solvents. In this regard, this is a success as these DNA binding studies could not 
be performed for the first generation of complexes. Binding of the complexes to 
duplex DNA has been observed and it is likely they do so by binding in the major 
groove, due to their large size. However, further confirmation is needed and this 
could be investigated by NMR, computer modelling or by crystallization of the 
complex with duplex DNA. AFM studies could also be performed in order to 
confirm the coiling observed by linear dichroism 
Four-way junction studies were unfortunately inconclusive and this needs 
further investigation. Detection of palladium in four-way junction bands in gels or 
study of the stabilization of the four-way junction via circular dichroism 
spectroscopy upon addition of aliquots of complex could be explored. 
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Chapter 5. Experimental 
 
 
5.1. General materials and methods for synthetic protocols 
All solvents and reagents were purchased from Sigma Aldrich, Fisher Scientific, 
Alfa Aesar and Fluorochem and were used without further purification. Anhydrous 
tetrahydrofuran, dichloromethane, toluene, methanol, diethyl ether and acetonitrile 
were collected from a Pure Solv-MD Solvent Purification System. Reaction 
temperatures refer to the temperature measured in an external oil bath. NMR 
spectra were recorded on AV300, AVIII300, AV400, AVIII400 and DRX500 Bruker 
spectrometers in the deuterated solvents indicated, which were purchased from 
Goss Scientific. NMR spectra were processed using MestReNova 6.0.2 software 
with calibration on residual solvent peaks given by reported values.(191) Chemical 
shifts () are quoted in ppm and coupling constants (J) are quoted in Hz. Progress 
of reactions was monitored by thin layer chromatography using Merck Silica Gel 
60 F254 aluminium plates which were visualized with UV light or potassium 
permanganate. Flash column chromatography was carried out using 60 Å Silica 
Gel or activated neutral aluminium oxide in the solvent systems indicated. Infrared 
spectra were recorded on a Perking Elmer Spectrum 100 FTIR spectrometer as 
neat films, wavelengths () are quoted in cm-1. Electrospray Ionisation (ESI+) 
spectra were recorded on a Micromass LCT Time of Flight mass spectrometer in 
positive ionization mode. Electron impact (EI) spectra were recorded on a Waters 
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Micromass Zabspec/Magnetic sector mass spectrometer. Matrix-Assisted Laser 
Desorption Ionization (MALDI) spectra were recorded on a Bruker Bi-flex MALDI 
Time of Flight mass spectrometer. X-ray diffraction data was collected either at the 
National Crystallography Service at the University of Southampton in a Rigaku 
FR-E Ultra High Flux diffractometer or at the University of Birmingham in a Bruker 
Smart 6000 CCD diffractometer. COLLECT was used for data collection and 
DENZO for data refinement. Experimental absorption correction was performed 
with SADABS. Crystal structures were solved by direct methods using SIR92, and 
refinement was performed by a full-matrix least-squares procedure on F2 in 
SHELXL-97. All non-hydrogen atoms were refined with anisotropic displacement 
parameters. All hydrogen atoms (except NH on LNH-OH) were fixed as riding 
models. Mercury 3.0(192) and Chimera 1.6rc(193) were used to process .cif and .pdb 
files of crystal structures solved by Dr. Louise Male or downloaded from the 
Cambridge Crystallographic Data Centre (CCDC)(194) or from the Protein Data 
Bank (PDB)(195). High Performance Liquid Chromatography (HPLC) analyses were 
performed using a Dionex HPLC system with Chromeleon software. UV-Vis 
spectra were recorded using a Varian Cary 5000 UV-Vis spectrometer in 1 cm 
quartz cuvettes. 
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5.1.1. Synthesis of (5-methoxypyridin-3-yl)boronic acid (1) 
 
 
Dry toluene (12 mL) was placed in a dry flask under argon atmosphere at -78 ºC. 
n-Butyllithium (7.30 mL, 11.70 mmol, 1.6 M in hexanes) followed by 3-bromo-5-
methoxypyridine (2.00 g, 10.64 mmol) in dry toluene (6 mL) were added and the 
reaction mixture was left to stir for 30 minutes. A brown precipitate was formed 
and dry THF (6 mL) was added slowly, keeping the temperature below -78 ºC. 
After stirring for an additional 15 minutes, triisopropylborate (3.00 mL, 12.76 mmol) 
was added and the dark brown solution was allowed to warm to -15 ºC. 2 M HCl 
(15 mL) was then added and the reaction mixture left to warm to room temperature 
forming a biphasic light brown solution that was partitioned. The acidic water 
phase was neutralized with saturated NaHCO3 solution and extracted with ethyl 
acetate (3 X 30 mL). Sodium chloride was added to the water phase and it was 
extracted again with ethyl acetate (3 X 30 mL). The combined organic phases 
were evaporated to give a brown oil that was dissolved in a mixture of 
THF:methanol (1:1) and filtered to remove the inorganic salts. The filtrate was then 
evaporated giving a brown solid (1.26 g, 76% yield). 1H NMR (300 MHz, MeOD): 
8.20 (s br, 1H, H2), 8.19 (s br, 1H, H6), 7.99 (s br, 1H, H4), 3.96 (s, 3H, H7). 
LRMS (EI+): m/z (%) 165 (20) [M-2H+CH3(
10B)]+, 167 (80) [M-2H+CH3(
11B)]+. IR 
(Neat): max 2942 (m), 1578 (m), 1412 (s), 1313 (s), 1254 (s), 1018 (s), 1049 (s), 
904 (m), 830 (m), 721 (s). 
 
1 
C6H8BNO3 
FW: 153.06 
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Alternative “in situ” protocol: 
3-Bromo-5-methoxypyridine (0.50 g, 2.66 mmol) dissolved in THF (20 mL) was 
placed in a dry flask under argon atmosphere at -78 ºC. Triisopropylborate 
(0.63 mL, 2.71 mmol) was added followed by dropwise addition of n-butyllithium 
(1.83 mL, 2.92 mmol, 1.6 M in hexanes).The reaction mixture was left stirring at 
-78 ºC for 1 hour, after which it was allowed to warm to room temperature 
overnight. 2 M HCl (7 mL) was added and the mixture stirred for 20 minutes. The 
crude mixture was evaporated to dryness, redissolved in water and extracted with 
ethyl acetate (3 X 30 mL). The combined aqueous phases were evaporated under 
reduced pressure to yield a yellow solid (0.20 g, 48% yield). 1H NMR (300 MHz, 
D2O):  8.47 (s br, 1H, H2), 8.41 (d, J = 2.6 Hz, 1H, H6), 8.34 – 8.31 (m, 1H, H4), 
3.99 (s, 3H, H7). LRMS (EI+): m/z (%) 189 (20) [M+HCl(11B)]+. IR (Neat): max 
3194 (m, br), 1612 (m), 1566 (s), 1451 (s), 1433 (s), 1395 (m), 1339 (s), 1321 (m), 
1275 (s), 1261 (s), 1117 (m), 1022 (s), 1006 (s), 865 (m), 773 (m), 693 (s). 
 
5.1.2. Synthesis of bis(4-bromophenyl)methanol (3)(140) 
 
 
 
 
1,4-Dibromobenzene (0.83 g, 3.52 mmol) dissolved in dry THF (8 mL) was placed 
in an argon purged dry flask at -78 ºC. n-Butyllithium (2.00 mL, 3.20 mmol, 1.6 M 
in hexanes) was added dropwise to the solution, keeping the rate of addition 
 
3 
C13H10Br2O 
FW: 342.03 
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constant to maintain the temperature at -78 ºC. The cream slurry was stirred under 
an argon atmosphere for 1 hour before adding it to a solution of 
4-bromobenzylaldehyde (0.53 g, 2.87 mmol) in THF (8 mL) which had also been 
cooled to -78 ºC. The resulting solution was kept at that temperature for 1 hour 
after which it was allowed to warm to room temperature. It was then stirred 
overnight before being poured into ice (50 g). The suspension was extracted with 
ethyl acetate (3 X 30 mL), washed with water (2 X 20 mL) and brine (1 X 20 mL) 
and dried over magnesium sulfate. The solvent was removed in vacuo and the 
yellow oil material precipitated and washed with hexane to yield the required 
product as a white solid (0.61 g, 82% yield). 1H NMR (300 MHz, CDCl3): 7.49 – 
7.44 (m, 4H, H2), 7.25 – 7.21 (m, 4H, H3), 5.76 (d, J = 3.4 Hz, 1H, H5), 2.21 (d, J 
= 3.4 Hz, 1H, OH). 13C NMR (100 MHz, CDCl3): 142.4 Cq, 131.9 C2, 128.3 C3, 
121.9 Cq, 75.2 C5. LRMS (EI+): m/z (%) 342 (26) [M]
+, 261 (14) [M-Br]+, 185 (100) 
[M-2Br]+. HRMS (EI+) calculated for C13H10Br2O [M]
+ 339.9098, found 339.9087. 
FTIR (film): max 3327 (s, br), 2890 (w), 1645 (w), 1589 (m), 1482 (s), 1404 (m), 
1328 (w), 1188 (m), 1115 (m), 1069 (s), 1038 (s), 1008 (s), 790 (s), 693 (m). 
 
5.1.3. Synthesis of bis(4-bromophenyl)methane (2)(140) 
 
 
 
To a solution of bis(4-bromophenyl)methanol (1.60 g, 4.70 mmol) in TFA (40 mL), 
sodium borohydride (1.79 g, 47.00 mmol) was slowly added. The white slurry was 
 
2 
C13H10Br2 
FW: 326.03 
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stirred for 2 hours and then poured into ice (50 g). 2 N Sodium hydroxide was then 
carefully added to make the suspension alkaline. The mixture was extracted with 
diethyl ether (3 X 30 mL) and the combined fractions washed with water 
(2 X 30 mL) and brine (1 X 30 mL) and dried over magnesium sulfate. Diethyl 
ether was removed under reduced pressure. The residue was then purified by 
column chromatography on silica gel with hexane as eluent to yield a white solid 
(1.42 g, 93% yield). 1H NMR (300 MHz, CDCl3):  7.43 – 7.38 (m, 4H, H2), 7.05 – 
7.00 (m, 4H, H3), 3.88 (s, 2H, H5). 13C NMR (100 MHz, CDCl3):  139.6 Cq, 131.8 
C2, 130.7 C3, 120.4 Cq, 40.8 C5. LRMS (EI+): m/z (%) 326 (100) [M]
+, 245 (77) 
[M-Br]+, 165 (84) [M-2Br]+. HRMS (EI+) calculated for C13H10Br2 [M]
+ 323.9149, 
found 323.9150. FTIR (film): max 2920 (w), 2852 (w), 1484 (s), 1437 (m), 1400 
(m), 1201 (w), 1111 (w), 1067 (s), 1010 (s), 858 (s), 806 (s), 776 (s). 
 
5.1.4. General Suzuki Coupling Procedure 
Pyridineboronic acid or ester (3.92 mmol), bis(4-bromophenyl) (1.78 mmol), 
tricyclohexylphosphine (0.086 mmol) and tris(dibenzylideneacetone)dipalladium(0) 
(0.036 mmol) were placed in a Schlenk flask. The Schlenk flask was evacuated 
and refilled with argon five times. Dioxane (10 mL) followed by an aqueous 
solution (5 mL) of potassium phosphate tribasic (6.06 mmol) were added via 
syringe followed by three evacuation/refill cycles. The sealed flask was heated in 
an oil bath at 100 ºC for 48 hours. The mixture was then filtered and washed with 
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ethyl acetate (100 mL), dried over sodium sulfate and evaporated under reduced 
pressure. The residue was then purified by column chromatography. 
 
5.1.5. Synthesis of ligand LOMe 
 
 
 
The title compound was prepared according to the General Suzuki Coupling 
Procedure with (5-methoxypyridin-3-yl)boronic acid (0.60 g, 3.92 mmol) and 
bis(4-bromophenyl)methane (0.58 g, 1.78 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.45 g, 66% yield).1H NMR (300 MHz, CDCl3):  8.45 (d, J = 1.8 Hz, 2H, H6), 8.28 
(d, J = 2.8 Hz, 2H, H2), 7.56 – 7.50 (m, 4H, H8), 7.37 – 7.31 (m, 6H, H9 and H4), 
4.09 (s, 2H, H11), 3.92 (s, 6H, H12). 13C NMR (100 MHz, CDCl3):  155.9 Cq, 
141.1 Cq, 140.9 C6, 137.2 Cq, 136.1 C2, 135.9 Cq, 129.8 C9, 127.6 C8, 119.2 C4, 
55.8 C12, 41.4 C11. LRMS (ES+): m/z (%) 383.2 (23) [M+H]+, 405.2 (100) 
[M+Na]+, 406.2 (11) [M+Na+H]+. HRMS (ES+) calculated for C25H22N2O2Na 
[M+Na]+ 405.1579, found 405.1581. FTIR (film): max 3041 (w), 2971 (w), 1579 (s), 
1515 (m), 1431 (s), 1398 (s), 1313 (s), 1218 (s), 1189 (m), 1157 (m), 1064 (m), 
1015 (s), 910 (m), 875 (m), 807 (s), 708 (s). 
 
 
LOMe 
C25H22N2O2 
FW: 382.45 
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5.1.6. General Tetrafluoroborate Tetra-Stranded Palladium(II) Cylinder 
Procedure 
Tetrakis(acetonitrile)palladium(II) tetrafluoroborate (0.038 mmol) was added to a 
suspension of ligand LX (0.076 mmol) in acetonitrile (5 mL) at 80 ºC. The resulting 
mixture was stirred at 80 ºC for 6 hours after which it was filtered to remove a 
suspended solid. Diethyl ether (50 mL) was added to precipitate a solid which was 
further washed with diethyl ether (50 mL) and dried in vacuo. 
 
5.1.7. Synthesis of [Pd2L
OMe
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LOMe (28.9 mg, 
0.076 mmol) to yield a white solid (31.0 mg, 78% yield). 1H NMR (300 MHz, 
CD3CN):  8.83 (d, J = 1.5 Hz, 8H, H6), 8.72 (d, J = 2.4 Hz, 8H, H2), 7.70 (dd, J = 
 
[Pd2(C25H22N2O2)4][BF4]4 
FW: 2088.49 
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2.4, 1.5 Hz, 8H, H4), 7.47 – 7.44 (m, 16H, H8), 7.33 – 7.30 (m, 16H, H9), 4.12 (s, 
8H, H11), 3.99 (s, 24H, H12). 13C NMR (100 MHz, CD3CN):  158.8 Cq, 143.3 Cq, 
142.1 Cq, 141.8 C6, 138.0 C2, 134.1 Cq, 130.8 C9, 128.8 C8, 124.7 C4, 57.7 C12, 
41.1 C11. 19F NMR (282 MHz, CD3CN):  -150.35 (s, 2F), -150.40 (s, 8F). LRMS 
(ES+): m/z (%) 383.4 (1) [LOMe+H]+, 435.9 (2) [Pd2L
OMe
4]
4+, 610.1 (43) 
[Pd2L
OMe
4(BF4)]
3+, 958.2 (100) [Pd2L
OMe
4(BF4)2]
2+, 2003.5 (3) [Pd2L
OMe
4(BF4)3]
+. 
FTIR (film): max 3086 (w), 1589 (s), 1516 (w), 1464 (m), 1439 (m), 1403 (m), 1332 
(m), 1263 (w), 1226 (s), 1185 (w), 1055 (s), 1032 (s), 1002 (s), 878 (m), 799 (s), 
764 (w), 700 (s), 627 (m), 576 (m). UV-Vis (CH3CN): max (max/dm
3mol-1cm-1) 294 
(61 000), 256 (81 900) nm. 
 
5.1.8. Synthesis of ligand LO-OMe 
 
 
 
 
The title compound was prepared according to the General Suzuki Coupling 
Procedure with (5-methoxypyridin-3-yl)boronic acid (0.60 g, 3.92 mmol) and 
bis(4-bromophenyl) ether (0.58 g, 1.78 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.49 g, 71% yield).1H NMR (300 MHz, CDCl3):  8.46 (d, J = 1.8 Hz, 2H, H6), 8.30 
(d, J = 2.7 Hz, 2H, H2), 7.62 – 7.54 (m, 4H, H8), 7.36 (dd, J = 2.7, 1.8 Hz, 2H, H4), 
7.20 – 7.13 (m, 4H, H9), 3.93 (s, 6H, H11). 13C NMR (100 MHz, CDCl3):  157.4 
 
LO-OMe 
C24H20N2O3 
FW: 384.43 
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Cq, 140.8 C6, 136.8 Cq, 136.1 C2, 133.7 Cq, 133.2 Cq, 128.9 C8, 119.7 C9, 119.1 
C4, 55.8 C11. LRMS (ES+): m/z (%) 385.3 (100) [M+H]+, 407.3 (46) [M+Na]+, 
406.2 (10) [M+Na+H]+. HRMS (ES+) calculated for C24H21N2O3 [M+H]
+ 385.1552, 
found 385.1546. FTIR (film): max 3041 (w), 2973 (w), 2955 (w), 2850 (w), 1912 
(w), 1599 (w), 1584 (m), 1507 (m), 1470 (w), 1450 (w), 1430 (m), 1396 (m), 1335 
(w), 1312 (m), 1259 (m), 1219 (s), 1175 (m), 1163 (m), 1112 (m), 1062 (m), 1015 
(m), 913 (w), 882 (m), 834 (s), 709 (m), 687 (m), 642 (w), 578 (m). 
 
5.1.9. Synthesis of [Pd2L
O-OMe
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LO-OMe (29.1 mg, 
0.076 mmol). A white solid was yielded after washing with chloroform (50 mL) that 
was dried in vacuo (18 mg, 46% yield). 1H NMR (300 MHz, CD3CN):  9.02 (d, J = 
 
[Pd2(C24H20N2O3)4][BF4]4 
FW: 2096.41 
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1.5 Hz, 8H, H6), 8.88 (d, J = 2.4 Hz, 8H, H2), 7.70 (dd, J = 2.4, 1.5 Hz, 8H, H4), 
7.65 – 7.60 (m, 16H, H8), 7.28 – 7.23 (m, 16H, H9), 4.03 (s, 24H, H11). 13C NMR 
(100 MHz, CD3CN):  159.1 Cq, 159.0 Cq, 141.7 Cq, 141.3 C6, 137.8 C2, 131.5 Cq, 
130.4 C8, 124.3 C4, 120.7 C9, 57.8 C11. 19F NMR (282 MHz, CD3CN):  -150.35 
(s, 2F), -150.41 (s, 8F). LRMS (ES+): m/z (%) 611.2 (91) [Pd2L
O-OMe
4(BF4)]
3+, 
959.8 (100) [Pd2L
O-OMe
4(BF4)2]
2+. FTIR (film): max 3088 (w), 1593 (s), 1507 (s), 
1454 (m), 1439 (m), 1401 (w), 1321 (m), 1224 (s), 1178 (m), 1154 (m), 1055 (s), 
1032 (s), 1004 (s), 871 (m), 832 (s), 698 (m), 600 (w), 578 (w). UV-Vis (CH3CN): 
max (max/dm
3mol-1cm-1) 292 (66 000), 274 (53 600) nm. 
 
5.1.10. Synthesis of ligand LNH-OMe 
 
 
 
The title compound was prepared according to the General Suzuki Coupling 
Procedure with (5-methoxypyridin-3-yl)boronic acid (0.60 g, 3.92 mmol) and 
bis(4-bromophenyl)amine (0.58 g, 1.78 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.58 g, 85% yield). 1H NMR (300 MHz, CDCl3):  8.46 (s br, 2H, H6), 8.26 (d, J = 
1.9 Hz, 2H, H2), 7.58 – 7.47 (m, 4H, H8), 7.35 (dd, J = 2.7, 1.9 Hz, 2H, H4), 7.25 – 
7.17 (m, 4H, H9), 6.12 (s br, 1H, NH), 3.92 (s, 6H, H11). 13C NMR (100 MHz, 
 
LNH-OMe 
C24H21N3O2 
FW: 383.44 
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CDCl3):  156.0 Cq, 143.0 Cq, 140.5 C6, 137.1 Cq, 135.6 C2, 130.6 Cq, 128.4 C8, 
118.7 C4, 118.4 C9, 55.8 C11. LRMS (ES+): m/z (%) 384.2 (100) [M+H]+, 385.3 
(11) 406.2 (20) [M+Na]+, 438.2 (9) [M+Na+MeOH]+. HRMS (ES+) calculated for 
C24H22N3O2Na [M+H+Na]
+ 384.1712, found 384.1711. FTIR (film): max 3427 (w), 
2974 (w), 1605 (m), 1581 (m), 1521 (m), 1472 (w), 1422 (m), 1404 (w), 1387 (w), 
1310 (m), 1250 (w), 1216 (s), 1185 (m), 1160 (w), 1064 (w), 1025 (m), 908 (w), 
873 (m), 828 (s), 819 (m), 708 (m), 694 (w), 645 (w), 581 (m). 
 
5.1.11. Synthesis of [Pd2L
NH-OMe
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LNH-OMe (29.0 mg, 
0.076 mmol) to yield a yellow solid (20.2 mg, 51% yield). 1H NMR (300 MHz, 
CD3CN):  9.28 (d, J = 1.4 Hz, 8H, H6), 8.81 (d, J = 2.4 Hz, 8H, H2), 7.74 – 7.71 
 
[Pd2(C24H21N3O2)4][BF4]4 
FW: 2092.47 
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(m, 16H, H8), 7.70 – 7.68 (m, 8H, H4), 7.33 – 7.30 (m, 16H, H9), 7.27 (s br, 4H, 
NH), 4.00 (s, 24H, H11). 13C NMR (100 MHz, CD3CN):  159.0 Cq, 151.8 Cq, 145.4 
Cq, 141.0 C6, 137.0 C2, 129.2 C8, 127.4 Cq, 122.6 C4, 119.5 C9, 57.6 C11. 
19F 
NMR (282 MHz, CD3CN):  -150.46 (s, br, 10F). LRMS (ES+): m/z (%) 611.1 (69) 
[Pd2L
NH-OMe
4(BF4)]
3+, 960.2 (100) [Pd2L
NH-OMe
4(BF4)2]
2+. FTIR (film): max 3380 (w, 
br), 3088 (w), 1585 (s), 1524 (s), 1455 (m), 1409 (w), 1317 (m), 1270 (w), 1222 
(s), 1188 (m), 1156 (m), 1057 (s), 1032 (s), 1003 (s), 874 (m), 820 (s), 762 (w), 
698 (m), 602 (w), 576 (w). UV-Vis (CH3CN): max (max/dm
3mol-1cm-1) 351 (107 
900), 278 (78 500) nm. 
 
5.1.12. Synthesis of bis(4-bromophenyl)sulfide (4) 
 
 
To a solution of diphenyl sulfide (1.00 mL, 5.98 mmol) in dichloromethane (25 mL), 
bromine (1.20 mL, 23.9 mmol) was added followed by water (25 mL). The red 
solution was stirred for 6 hours. Saturated sodium thiosulfate aqueous solution 
was added to quench the excess bromine. The two phases were extracted. The 
organic phase was washed with water (50 mL) and brine (50 mL), dried over 
magnesium sulfate and evaporated to dryness. The residue was then purified by 
column chromatography on silica gel with hexane as eluent to yield a white solid 
(1.65 g, 80% yield). 1H NMR (300 MHz, CDCl3):  7.46 – 7.40 (m, 4H, H2), 7.21 – 
7.16 (m, 4H, H3). 13C NMR (100-MHz, CDCl3):  134.7 Cq, 132.7 C2, 132.6 C3, 
C12H8Br2S 
FW: 344.06  
4 
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121.7 Cq. LRMS (EI+): m/z (%) 344 (100) [M]
+, 265 (44) [M-Br+2H]+, 184 (62) 
[M-2Br]+. HRMS (EI+) calculated for C12H8Br2S [M]
+ 341.8713, found 341.8716. 
FTIR (film): max 3066 (m), 2934 (w), 1893 (m), 1779 (w), 1646 (w), 1553 (w), 1467 
(s), 1391 (m), 1348 (w), 1235 (w), 1104 (w), 1079 (m), 1066 (s), 1005 (s), 955 (m), 
805 (s), 724 (s), 692 (m), 625 (m). 
 
5.1.13. Synthesis of ligand LS-OMe 
 
 
 
The title compound was prepared according to the General Suzuki Coupling 
Procedure with (5-methoxypyridin-3-yl)boronic acid (0.60 g, 3.92 mmol) and 
bis(4-bromophenyl)sulfide (0.61 g, 1.78 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.33 g, 46%). 1H NMR (300 MHz, CDCl3):  8.45 (d, J = 1.8 Hz, 2H, H6), 8.31 (d, 
J = 2.8 Hz, 2H, H2), 7.59 – 7.52 (m, 4H, H8), 7.52 – 7.45 (m, 4H, H9), 7.35 (dd, J 
= 2.8, 1.8 Hz, 2H, H4), 3.93 (s, 6H, H11). 13C NMR (100 MHz, CDCl3):  156.0 Cq, 
140.7 C6, 136.8 Cq, 136.6 Cq, 136.5 C2, 136.0 Cq, 131.8 C9, 128.2 C8, 119.1 C4, 
55.8 C11. LRMS (ES+): m/z (%) 401.3 (38) [M+H]+, 423.3 (100) [M+Na]+. HRMS 
(ES+) calculated for C24H20N2O2SNa [M+Na]
+ 423.1143, found 423.1153. FTIR 
(film): max 3038 (w), 2968 (w), 2845 (w), 1789 (w), 1578 (s), 1547 (w), 1495 (m), 
 
LS-OMe 
C24H20N2O2S 
FW: 400.49 
Chapter 5 
Experimental 
212 
 
1426 (s), 1391 (m), 1314 (s), 1218 (s), 1188 (m), 1157 (m), 1090 (m), 1063 (m), 
1017 (m), 967 (w), 910 (w), 881 (m), 874 (m), 834 (m), 817 (s), 757 (w), 707 (s), 
653 (m), 582 (s). 
 
5.1.14. Synthesis of [Pd2L
S-OMe
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LS-OMe (28.9 mg, 
0.076 mmol) to yield a white solid (20.0 mg, 49% yield). 1H NMR (300 MHz, 
CD3CN):  8.96 (d, J = 1.6 Hz, 8H, H6), 8.82 (d, J = 2.4 Hz, 8H, H2), 7.71 (dd, J = 
2.4, 1.6 Hz, 8H, H4), 7.64 – 7.59 (m, 16H, H8), 7.55 – 7.51 (m, 16H, H9), 4.01 (s, 
24H, H11). 19F NMR (282 MHz, CD3CN):  -150.67 (s, br, 10F). LRMS (ES+): m/z 
(%) 612.1 (27) [Pd2L
S-OMe
4(BF4)]
3+, 725.0 (43) [Pd2L
OMe
3F2]
2+. FTIR (film): max 
3094 (w), 1591 (s), 1499 (w), 1452 (m), 1440 (m), 1394 (w), 1321 (m), 1269 (w), 
 
[Pd2(C24H20N2O2S)4][BF4]4 
FW: 2160.32 
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1226 (s), 1188 (w), 1153 (m), 1056 (s), 1032 (s), 1005 (s), 878 (m), 820 (s), 778 
(w), 698 (s), 607 (m), 577 (m). UV-Vis (DMSO): max (max/dm
3mol-1cm-1) 303 (109 
500) nm. 
 
5.1.15. Synthesis of [Pd2L
OMe
4][NO3]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with precipitation occurring with a 
saturated solution of tetrabutylammonium nitrate. The white solid was washed with 
acetonitrile (10 mL) and diethyl ether (50 mL) and dried in vacuo (29.0 mg, 76% 
yield). Alternatively, excess tetrabutylammonium nitrate was added to a solution of 
pure [Pd2L
OMe
4][BF4]4 in acetonitrile to precipitate the nitrate salt of the complex. 
The solid was washed with acetonitrile (2 mL) and diethyl ether (10 mL) and dried 
in vacuo. 1H NMR (300 MHz, DMSO-d6):  9.32 (s br, 2H, H6), 8.99 (d, J = 2.4 Hz, 
 
[Pd2(C25H22N2O2)4][NO3]4 
FW: 1988.43 
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2H, H2), 7.90 (s br, 2H, H4), 7.64 – 7.62 (m, 4H, H8), 7.37 – 7.34 (m, 4H, H9), 
4.16 (s, 2H, H11), 4.00 (s, 6H, H12). FTIR (film): max 3072 (w), 1588 (s), 1517 (w), 
1456 (m), 1438 (m), 1391 (m), 1317 (s), 1265 (w), 1225 (s), 1187 (w), 1153 (m), 
1070 (w), 1033 (s), 1005 (s), 886 (m), 811 (s), 798 (s), 700 (s), 626 (m), 578 (m). 
UV-Vis (DMSO): max (max/dm
3mol-1cm-1) 291 (63 600), 264 (70 800) nm. 
 
5.1.16. Synthesis of [Pd2L
OMe
4][CF3SO3]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with precipitation occurring with a 
saturated solution of tetrabutylammonium trifluoromethanesulfonate. The white 
solid was washed with acetonitrile (10 mL) and diethyl ether (50 mL) and dried in 
vacuo (21.7 mg, 67% yield). Alternatively, excess tetrabutylammonium 
trifluoromethanesulfonate was added to a solution of pure [Pd2L
OMe
4][BF4]4 in 
 
[Pd2(C25H22N2O2)4][CF3SO3]4 
FW: 2336.29 
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acetonitrile to precipitate the nitrate salt of the complex. The solid was washed 
with acetonitrile (2 mL) and diethyl ether (10 mL) and dried in vacuo. 1H NMR 
(300 MHz, CD3CN):  8.93 (s br, 2H, H6), 8.90 (d, J = 2.4 Hz, 2H, H2), 7.69 (dd, J 
= 2.4, 1.7 Hz, 2H, H4), 7.48 – 7.46 (m, 4H), 7.32 – 7.29 (m, 4H), 4.13 (s, 2H), 4.00 
(s, 6H). LRMS (ES+): m/z (%) 630.3 (100) [Pd2L
OMe
4(CF3SO3)]
3+, 1019.9 (87) 
[Pd2L
OMe
4(CF3SO3)2]
2+. FTIR (film): max 3086 (w), 1590 (m), 1518 (w), 1464 (m), 
1441 (m), 1404 (m), 1333 (m), 1320 (m), 1269 (m), 1244 (s), 1224 (s), 1155 (s), 
1027 (s), 1006 (s), 880 (w), 850 (w), 814 (m), 799 (m), 760 (w), 699 (m), 636 (s). 
UV-Vis (CH3CN): max (max/dm
3mol-1cm-1) 293 (63 300), 231 (172 200) nm. 
 
5.1.17. General Deprotection Procedure 
Ethanethiol (74.27 mmol) was added to aluminium chloride (8.63 mmol) in dry 
dichloromethane (10 mL) in a cooling ice-salt bath. Ligand LX-OMe (0.52 mmol) 
dissolved in dry dichloromethane (10 mL) was then added dropwise to the slurry 
mixture to form a red solution. The reaction mixture remained in the cooling bath 
for one hour and was then left to warm to room temperature for two days. The 
reaction was quenched with water and neutralized with sodium hydroxide. The 
crude mixture was evaporated under reduce pressure. The residue was then 
purified by column chromatography on silica gel. 
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5.1.18. Synthesis of LOH 
 
 
 
The title compound was prepared according to the General Deprotection 
Procedure with ligand LOMe (0.20 g, 0.52 mmol). Purification by column 
chromatography on silica gel with ethyl acetate:methanol (9:1) as eluent yielded a 
yellow solid (0.12 g, 62% yield). 1H NMR (300 MHz, MeOD):  8.25 (d, J = 1.9 Hz, 
2H, H6), 8.05 (d, J = 2.6 Hz, 2H, H2), 7.60 – 7.53 (m, 4H, H8), 7.44 (dd, J = 2.6, 
1.9 Hz, 2H, H4), 7.39 – 7.33 (m, 4H, H9), 4.09 (s, 2H, H11). 1H NMR (300 MHz, 
DMSO-d6):  10.33 (s br, 2H, OH), 8.29 (d, J = 1.8 Hz, 2H, H6), 8.14 (d, J = 2.6 
Hz, 2H, H2), 7.59 – 7.57 (m, 4H, H8), 7.44 – 7.41 (m, 2H, H4), 7.39 – 7.36 (m, 4H, 
H9), 4.03 (s, 2H, H11). 13C NMR (100 MHz, DMSO-d6):  154.0 Cq, 141.1 Cq, 
138.2 C6, 136.8 C2, 136.1 Cq, 135.0 Cq, 129.4 C9, 127.0 C8, 119.8 C4, 42.3 C11. 
LRMS (ES+): m/z (%) 355.3 (100) [M+H]+, 356.3 (11) [M+2H]+, 377.3 (11) 
[M+Na]+. HRMS (ES+) calculated for C23H19N2O2 [M+H]
+ 355.1447, found 
355.1440. FTIR (film): max 3029 (w), 2918 (w), 1734 (w), 1584 (s), 1515 (m), 1440 
(s), 1401 (s), 1322 (m), 1302 (s), 1145 (s), 1018 (m), 908 (m), 854 (m), 811 (s), 
792 (s), 747 (w), 705 (w). 
 
 
 
LOH 
C23H18N2O2 
FW: 354.40 
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5.1.19. Synthesis of [Pd2L
OH
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LOH (28.9 mg, 
0.076 mmol) to yield a white solid (26.0 mg, 70% yield). 1H NMR (300 MHz, 
DMSO-d6):  11.39 (s br, 8H, OH), 8.89 (s br, 8H, H6), 8.80 – 8.79 (m, 8H, H2), 
7.60 (s br, 8H, H4), 7.45 – 7.41 (m, 16H, H8), 7.33 – 7.30 (m, 16H, H9), 4.13 (s, 
8H, H11). LRMS (ES+): m/z (%) 659.9 (30) [Pd2L
OH
3+F2]
2+, 870.9 (5) 
[Pd2L
OH
4+BF4+F]
2+. FTIR (film): max 3088 (w), 1590 (s), 1517 (w), 1482 (m), 1444 
(s), 1403 (m), 1337 (m), 1300 (w), 1225 (w), 1152 (m), 1052 (s), 1029 (s), 999 (s), 
921 (m), 875 (w), 856 (w), 799 (s), 763 (w), 699 (s), 623 (m). UV-Vis (DMSO): max 
(max/dm
3mol-1cm-1) 306 (48 900) nm. 
 
 
[Pd2(C23H18N2O2)4][BF4]4 
FW: 1976.37 
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5.1.20. Synthesis of LO-OH 
 
 
 
 
The title compound was prepared according to the General Deprotection 
Procedure with ligand LO-OMe (0.20 g, 0.52 mmol). Purification by column 
chromatography on silica gel with ethyl acetate:methanol (9:1) as eluent yielded a 
yellow solid (0.13 g, 72% yield). 1H NMR (300 MHz, MeOD):  8.31 (s br, 2H, H6), 
8.08 (d, J = 1.8 Hz, 2H, H2), 7.72 – 7.64 (m, 4H, H8), 7.51 (dd, J = 2.5, 1.8 Hz, 2H, 
H4), 7.21 – 7.14 (m, 4H, H9). 13C NMR (75 MHz, MeOD):  158.9 Cq, 156.2 Cq, 
139.1 Cq, 138.7 C6, 136.4 C2, 133.8 Cq, 129.8 C8, 122.8 C4, 120.6 C9. LRMS 
(ES+): m/z (%) 357.3 (100) [M+H]+, 358.3 (6) [M+2H]+, 379.3 (2) [M+Na]+. HRMS 
(ES+) calculated for C22H17N2O3 [M+H]
+ 357.1239, found 357.1232. FTIR (film): 
max 3063 (w), 2924 (w), 1582 (s), 1506 (s), 1492 (s), 1443 (s), 1397 (m), 1310 (s), 
1261 (s), 1216 (s), 1170 (m), 1149 (m), 1104 (m), 1059 (w), 1029 (m), 1013 (m), 
909 (m), 850 (s), 827 (s), 784 (m), 716 (s), 698 (s), 624 (m), 595 (m). 
 
 
 
 
C22H16N2O3 
FW: 356.37  
LO-OH 
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5.1.21. Synthesis of [Pd2L
O-OH
4][BF4]4 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LO-OH (28.9 mg, 
0.076 mmol) to yield a white solid (27.0 mg, 72% yield). 1H NMR (300 MHz, 
MeOD):  9.19 (d, J = 1.4 Hz, 8H, H6), 8.75 (d, J = 2.3 Hz, 8H, H2), 7.67 – 7.64 
(m, 16H, H8), 7.60 (dd, J = 2.3, 1.4 Hz, 8H, H4), 7.23 – 7.16 (m, 16H, H9). LRMS 
(ES+): m/z (%) 409.7 (21) [Pd2L
O-OH
4-H]
4+, 662.9 (100) [Pd2L
O-OH
3+F2]
2+, 840.9 (26) 
[Pd2L
O-OH
4+F2]
2+. FTIR (film): max 3072 (w), 1593 (s), 1504 (s), 1447 (s), 1401 (m), 
1338 (m), 1282 (w), 1227 (s), 1177 (s), 1153 (s), 1051 (s), 1025 (s), 1011 (s), 923 
(m), 872 (m), 850 (w), 829 (s), 697 (m), 600 (m). 
 
 
 
[Pd2(C22H16N2O3)4][BF4]4 
FW: 1984.28 
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5.1.22. Synthesis of LNH-OH 
 
 
 
The title compound was prepared according to the General Deprotection 
Procedure with ligand LNH-OMe (0.20 g, 0.52 mmol). Purification by column 
chromatography on silica gel with ethyl acetate:methanol (9:1) as eluent yielded a 
yellow solid (0.01 g, 5% yield). 1H NMR (300 MHz, MeOD):  8.26 (d, J = 2.0 Hz, 
2H, H6), 8.00 (d, J = 2.6 Hz, 2H, H2), 7.58 – 7.53 (m, 4H, H8), 7.44 (dd, J = 2.6, 
2.0 Hz, 2H, H4), 7.29 – 7.24 (m, 4H, H9). 1H NMR (300 MHz, DMSO-d6):  10.72 
(s br, 2H, OH), 8.80 (s br, 1H, NH), 8.46 (d, J = 1.6 Hz, 2H, H6), 8.16 (d, J = 2.5 
Hz, 2H, H2), 7.74 – 7.58 (m, 6H, H8 & H4), 7.27 – 7.24 (m, 4H, H9). 13C NMR 
(100 MHz, DMSO-d6):  156.4 Cq, 144.1 Cq, 139.4 Cq, 130.6 C6, 128.3 C8, 127.9 
Cq, 126.6 C2, 125.3 C4, 117.4 C9. LRMS (ES+): m/z (%) 356.3 (100) [M+H]
+, 
378.4 (6) [M+Na]+. HRMS (ES+) calculated for C22H18N3O2 [M+H]
+ 356.1399, 
found 356.1393. FTIR (film): max 3285 (w), 2943 (w), 1592 (s), 1564 (m), 1478 (s), 
1369 (s), 1348 (s), 1224 (s), 1193 (s), 1003 (m), 907 (m), 809 (s), 705 (m), 656 (s), 
593 (s). 
 
C22H17N3O2 
FW: 355.39 
 
LNH-OH 
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5.1.23. General Mitsunobu Coupling Procedure 
To a solution of 3-bromo-5-hydroxypyridine (5.75 mmol) in dry THF (70 mL) cooled 
in an ice bath, 1,1’-(azodicarbonyl)-dipiperidine (8.62 mmol) in THF (30 mL), 
tri-n-butylphosphine (8.62 mmol) and primary alcohol (6.90 mmol) were added 
under an argon atmosphere. After one hour of stirring, the ice bath was removed 
and the reaction was stirred at room temperature overnight. The resulting mixture 
was added to a saturated aqueous solution of sodium bicarbonate and ethyl 
acetate. The two layers were extracted and the organic layer was washed with 
water (50 mL) and brine (50 mL), dried over sodium sulfate and evaporated under 
reduce pressure. The crude residue was then purified by column chromatography. 
 
5.1.24. Synthesis of 3-bromo-5-(2-(2-methoxyethoxy)ethoxy)pyridine (5) 
 
 
 
 
The title compound was prepared according to the General Mitsunobu Coupling 
Procedure with 2-(2-methoxyethoxy)ethanol (0.81 mL, 6.90 mmol). Purification by 
column chromatography on silica gel with ethyl acetate:hexane (9:1) as eluent 
yielded a yellow oil (1.42 g, 90% yield). 1H NMR (300 MHz, CDCl3):  8.28 (d, J = 
1.9 Hz, 1H, H2), 8.25 (d, J = 2.5 Hz, 1H, H6), 7.40 (dd, J = 2.5, 1.9 Hz, 1H, H4), 
4.18 (dd, J = 5.4, 4.0 Hz, 2H, H7), 3.87 (dd, J = 5.4, 4.0 Hz, 2H, H8), 3.75 – 3.68 
(m, 2H, H9), 3.61 – 3.55 (m, 2H, H10), 3.39 (s, 3H, H11). 13C NMR (100 MHz, 
 
5 
C10H14BrNO3 
FW: 276.13 
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CDCl3):  155.5 Cq, 143.3 C2, 136.8 C6, 124.4 C4, 120.4 Cq, 72.1 C10, 71.0 C9, 
69.7 C8, 68.4 C7, 59.3 C11. LRMS (ES+): m/z (%) 276.1 (5) [M]+, 278.1 (5) 
[M+2H]+, 298.1 (100) [M+Na]+,  300.1 (98) [M+Na+2H]+. HRMS (ES+) calculated 
for C10H14NO3BrNa [M+Na]
+ 298.0055, found 298.0048. FTIR (film): max 2933 (w), 
2876 (w, br), 2828 (w), 1574 (s), 1555 (m), 1445 (m), 1430 (s), 1356 (w), 1310 
(m), 1262 (s), 1221 (m), 1107 (s), 1053 (m), 1008 (s), 937 (m), 858 (s), 695 (s), 
611 (m). 
 
5.1.25. General Pyridine Boronate Ester Procedure 
3-bromo pyridine (2.09 mmol), bis(pinacolato)diboron (2.51 mmol), 
[1,1’-bis(diphenylphosphino)ferrocene]dichloropalladium(II) complex with 
dichloromethane (0.063 mmol) and potassium acetate (6.28 mmol) in dry DMF 
(2 mL) were heated to 160 ºC under an argon atmosphere for 1 hour. The reaction 
mixture was concentrated and tert-butyl methyl ether was added to produce a 
brown precipitate which was filtered. The filtrate was concentrated to yield a 
red-brown oil, which was used in the next reaction step without further purification. 
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5.1.26. Synthesis of 3-(2-(2-methoxyethoxy)ethoxy)-5-(4,4,5,5-tetramethyl-
1,3,2-dioxaborolan-2-yl)pyridine (6) 
 
 
 
The title compound was prepared according to the General Pyridine Boronate 
Ester Procedure with 3-bromo-5-(2-(2-methoxyethoxy)ethoxy)pyridine 5 (0.58 g, 
2.09 mmol). 1H NMR (300 MHz, CDCl3):  8.54 (d, J = 1.2 Hz, 1H, H6), 8.39 (d, J = 
3.1 Hz, 1H, H2), 7.56 (dd, J = 3.1, 1.2 Hz, 1H, H4), 4.20 (dd, J = 5.4, 4.2 Hz, 2H, 
H7), 3.87 (dd, J = 5.4, 4.2 Hz, 2H, H8), 3.76 – 3.68 (m, 2H, H9), 3.64 – 3.53 (m, 
2H, H10), 3.39 (s, 3H, H11), 1.34 (s, 12H, H13). 13C NMR (100 MHz, CDCl3):  
154.6 Cq, 148.1 Cq, 146.5 C6, 141.5 C2, 126.1 C4, 84.4 Cq, 72.1 C7, 71.0 C8, 
69.8 C9, 67.9 C10, 59.25 C11, 25.0 C13. LRMS (ES+): m/z (%) 324.2 (40) [M+H]+, 
346.2 (100) [M+Na]+. HRMS (ES+) calculated for C16H26NO5Na
11B [M+Na]+ 
346.1802, found 346.1813. FTIR (film): max 2977 (m), 2930 (w), 2878 (w), 1578 
(w), 1518 (w), 1453 (m), 1420 (m), 1360 (m), 1301 (m), 1254 (m), 1141 (s), 1108 
(s), 1053 (m), 1025 (m), 971 (m), 883 (w), 849 (m), 803 (w), 743 (w), 713 (m), 675 
(m), 578 (w). 
 
 
 
6 
C16H26BNO5 
FW: 323.19 
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5.1.27. Synthesis of LO-Glycol 
 
 
 
The title compounds was prepared according to the General Suzuki Coupling 
Procedure with 3-(2-(2-methoxyethoxy)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pyridine 6 (1.27 g, 3.92 mmol) and bis(4-bromophenyl) ether 
(0.58 g, 1.78 mmol). Purification by column chromatography on silica gel with ethyl 
acetate:methanol (9:1) as eluent yielded a white solid (0.62 g, 70% yield). 1H NMR 
(300 MHz, CDCl3):  8.45 (d, J = 1.8 Hz, 2H, H6), 8.30 (d, J = 2.7 Hz, 2H, H2), 
7.63 – 7.52 (m, 4H, H8), 7.40 (dd, J = 2.7, 1.8 Hz, 2H, H4), 7.20 – 7.10 (m, 4H, 
H9), 4.27 (dd, J = 5.4, 4.1 Hz, 4H, H11), 3.91 (dd, J = 5.4, 4.1 Hz, 4H, H12), 3.80 – 
3.71 (m, 4H, H13), 3.65 – 3.55 (m, 4H, H14), 3.40 (s, 6H, H15). 13C NMR 
(100 MHz, CDCl3):  157.4 Cq, 155.3 Cq, 140.8 C6, 136.7 Cq, 136.5 C2, 133.1 Cq, 
128.8 C8, 120.0 C4, 119.6 C9, 72.1 C14, 71.0 C13, 69.8 C12, 68.1 C11, 59.2 
C15. LRMS (ES+): m/z (%) 583.3 (100) [M+Na]+. HRMS (ES+) calculated for 
C32H36N2O7Na [M+Na]
+ 583.2420, found 583.2432. FTIR (film): max 2877 (m), 
2816 (w),, 1910 (w), 1582 (m), 1509 (m), 1455 (w), 1434 (m), 1397 (m), 1314 (m), 
1276 (m), 1261 (m), 1243 (m), 1221 (m), 1201 (m), 1130 (s), 1111 (s), 1054 (m), 
1015 (w), 966 (w), 940 (m), 914 (w), 876 (m), 834 (s), 829 (s), 709 (m), 693 (m), 
604 (m), 589 (m). 
 
LO-Glycol 
C32H36N2O7 
FW: 560.64 
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5.1.28. Synthesis of [Pd2L
O-Glycol
4][(BF4)4] 
 
 
 
 
 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand LO-Glycol (42.4 mg, 
0.076 mmol) to yield a white solid (37 mg, 70% yield). 1H NMR (300 MHz, 
CD3CN):  9.02 (s br, 8H, H6), 8.85 (d, J = 2.3 Hz, 8H, H2), 7.79 – 7.71 (m, 8H, 
H4), 7.69 – 7.57 (m, 16H, H8), 7.34 – 7.20 (m, 16H, H9), 4.37 – 4.35 (m, 16H, 
H11), 3.91 – 3.80 (m, 16H, H12), 3.70 – 3.58 (m, 16H, H13), 3.54 – 3.42 (m, 16H, 
H14), 3.25 (s, 24H, H15). 19F NMR (282 MHz, CD3CN):  -150.87 (s, 2F), -150.92 
 
[Pd2(C32H36N2O7)4][BF4]4 
FW: 2800.83 
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(s, 8F). LRMS (ES+): m/z (%) 561.4 (19) [LO-Glycol]+, 583.4 (34) [LO-Glycol+Na]+, 
847.1 (52) [Pd2L
O-Glycol
4(BF4)]
3+, 1314.6 (100) [Pd2L
O-Glycol
4(BF4)2]
2+. FTIR (film): 
max 3088 (w), 2878 (w), 1591 (s), 1508 (s), 1446 (s), 1403 (m), 1323 (m), 1283 
(w), 1245 (s), 1223 (s), 1180 (w), 1158 (w), 1057 (s), 1035 (s), 1012 (s), 956 (w), 
875 (w), 833 (s), 799 (w), 699 (s), 599 (w). UV-Vis (MeOH): max (max/dm
3mol-1cm-
1) 293 (75 500), 245 (98 400) nm. 
 
5.1.29. Synthesis of 3-bromo-5-(2-(pyrrolidin-1-yl)ethoxy)pyridine (7) 
 
 
The title compound was prepared according to the General Mitsunobu Coupling 
Procedure with 1-(2-hydroxyethyl)pyrrolidine (0.81 mmol, 6.90 mmol). Purification 
by column chromatography on neutral aluminium oxide with ethyl acetate as 
eluent yielded a yellow oil (0.92 g, 59% yield). 1H NMR (300 MHz, CDCl3):  8.27 
(d, J = 1.9 Hz, 1H, H2), 8.26 (d, J = 2.5 Hz, 1H, H6), 7.38 (dd, J = 2.5, 1.9 Hz, 1H, 
H4), 4.13 (t, J = 5.8 Hz, 2H, H7), 2.91 (t, J = 5.8 Hz, 2H, H8), 2.71 – 2.55 (m, 4H, 
H9), 1.88 – 1.77 (m, 4H, H10). 13C NMR (100 MHz, CDCl3):  155.5 Cq, 143.2 C2, 
136.7 C6, 124.2 C4, 120.5 Cq, 68.1 C7, 54.9 C9, 54.9 C8, 23.7 C10. LRMS (ES+): 
m/z (%) 271.2 (100) [M]+, 273.2 (93) [M+2H]+. HRMS (ES+) calculated for 
C11H16N2OBr [M+H]
+ 271.0446, found 271.0440. FTIR (film): max 2962 (w), 1668 
(m), 1575 (s), 1557 (s), 1429 (s), 1311 (s), 1264 (s), 1222 (m), 1166 (m), 1140 (w), 
1010 (m), 863 (m), 697 (s). 
 
7 
C11H15BrN2O 
FW: 271.15 
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5.1.30. Synthesis of 3-(2-(pyrrolidin-1-yl)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pyridine (8) 
 
 
 
The title compound was prepared according to the General Pyridine Boronate 
Ester Procedure with 3-bromo-5-(2-(pyrrolidin-1-yl)ethoxy)pyridine 7 (0.57 g, 
2.09 mmol). 1H NMR (300 MHz, CDCl3):  8.54 (d, J = 1.2 Hz, 1H, H6), 8.39 (d, J = 
3.1 Hz, 1H, H2), 7.55 (dd, J = 3.1, 1.2 Hz, 1H, H4), 4.17 (t, J = 5.8 Hz, 2H, H7), 
2.93 (t, J = 5.8 Hz, 2H, H8), 2.76 – 2.57 (m, 4H, H9), 1.92 – 1.77 (m, 4H, H10), 
1.35 (s, 12H, H12). 13C NMR (100 MHz, CDCl3):  154.6 Cq, 147.9 C6, 141.2 C2, 
126.2 C4, 84.4 Cq, 83.1 Cq, 67.3 C7, 54.9 C8, 54.7 C9, 25.0 C12, 23.6 C10. LRMS 
(ES+): m/z (%) 319.3 (76) [M+H]+, 341.2 (100) [M+Na]+. HRMS (ES+) calculated 
for C17H27N2O3Na
11B [M+Na]+ 341.2012, found 341.2020. FTIR (film): max 2975 
(m), 1577 (w), 1518 (w), 1474 (m), 1454 (s), 1362 (s), 1273 (m), 1145 (s), 1097 
(w), 1035 (m), 981 (m), 882 (w), 850 (m), 805 (w), 714 (m), 675 (s), 578 (w). 
 
 
 
 
 
8 
C17H27BN2O3 
FW: 318.22 
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5.1.31. Synthesis of LO-Pyrr: 
 
 
 
The title compounds was prepared according to the General Suzuki Coupling 
Procedure with 3-(2-(pyrrolidin-1-yl)ethoxy)-5-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)pyridine 8 (1.25 g, 3.92 mmol) and bis(4-bromophenyl) ether 
(0.58 g, 1.78 mmol). Purification by column chromatography on activated neutral 
aluminium oxide with ethyl acetate:acetone:methanol (8:1.5:0.5) as eluent yielded 
a white solid (0.52 g, 53% yield). 1H NMR (300 MHz, CDCl3):  8.45 (d, J = 1.8 Hz, 
2H, H6), 8.30 (d, J = 2.7 Hz, 2H, H2), 7.60 – 7.54 (m, 4H, H8), 7.40 (dd, J = 2.7, 
1.8 Hz, 2H, H4), 7.19 – 7.11 (m, 4H, H9), 4.23 (t, J = 5.8 Hz, 4H, H11), 2.96 (t, J = 
5.8 Hz, 4H, H12), 2.70 – 2.61 (m, 8H, H13), 1.85 – 1.81 (m, 8H, H14). 13C NMR 
(100 MHz, CDCl3):  157.4 Cq, 155.2 Cq, 140.7 C6, 136.8 Cq, 136.4 C2, 133.1 Cq, 
128.8 C8, 119.9 C4, 119.6 C9, 67.6 C11, 55.1 C12, 54.9 C13, 23.6 C14. LRMS 
(ES+): m/z (%) 551.4 (100) [M+H]+. HRMS (ES+) calculated for C34H39N4O3 
[M+H]+ 551.3022, found 551.3024. FTIR (film): max 3039 (w), 2953 (w), 2791 (w), 
1598 (m), 1582 (s), 1507 (s), 1455 (m), 1433 (s), 1396 (m), 1313 (m), 1273 (m), 
1258 (s), 1241 (s), 1214 (s), 1159 (s), 1111 (m), 1014 (m), 972 (w), 924 (w), 873 
(s), 833 (s), 710 (s), 617 (m), 589 (m). 
 
 
LO-Pyrr 
C34H38N4O3 
FW: 550.69 
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5.1.32. Synthesis of 3,4’-bipyridine (9)(141) 
 
 
 
 
The title compounds was prepared according to the General Suzuki Coupling 
Procedure with 3-pyridinylboronic acid (0.24 g, 1.96 mmol) and 4-bromopyridine 
(0.35 g, 1,78 mmol). Purification by column chromatography on silica gel with ethyl 
acetate:methanol (9:1) as eluent yielded a yellow oil (0.27 g, 97% yield). 1H NMR 
(300 MHz, CDCl3):  8.88 (d, J = 1.7 Hz, 1H, H2), 8.76 – 8.61 (m, 3H, H9 & H6), 
7.91 (ddd, J = 7.9, 2.3, 1.7 Hz, 1H, H4), 7.50 (dd, J = 4.6, 1.7 Hz, 2H, H8), 7.41 
(ddd, J = 7.9, 4.6, 0.8 Hz, 1H, H5). 13C NMR (100 MHz, CDCl3):  150.7 C9, 150.3 
C6, 148.3 C2, 145.3 Cq, 134.4 C4, 133.9 Cq, 123.9 C5, 121.7 C8. LRMS (ES+): 
m/z (%) 157.1 (100) [M+H]+. HRMS (ES+) calculated for C10H9N2 [M+H]
+ 
157.0766, found 157.0763. FTIR (film): max 2919 (w), 1596 (s), 1578 (m), 1544 
(w), 1474 (m), 1425 (m), 1401 (s), 1322 (w), 1221 (w), 1191 (w), 1071 (w), 1027 
(m), 1015 (m), 994 (m), 838 (m), 795 (s), 764 (m), 636 (s), 611 (m), 656 (s). 
 
 
 
 
 
9 
C10H8N2 
FW: 156.18 
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5.1.33. Synthesis of ligand LN+·2Br- 
 
 
 
 
 
3,4’-bipyridine (0.60 g, 3.86 mmol) and a 0.4 M DMF solution of dibromomethane 
(2.42 mL, 1.15 mmol) were stirred at 70 ºC overnight. A precipitate was formed 
and it was collected via filtration and washed with DMF (1 mL) and diethyl ether 
(20 mL) to yield an off-white solid (0.08 g, 16% yield). 1H NMR (300 MHz, D2O):  
9.36 – 9.34 (m, 4H, H9), 9.09 (dd, J = 2.4, 0.8 Hz, 2H, H2), 8.76 (dd, J = 5.0, 1.6 
Hz, 2H, H6), 8.63 – 8.55 (m, 4H, H8), 8.42 (ddd, J = 8.2, 2.4, 1.6 Hz, 2H, H4), 7.69 
(ddd, J = 8.2, 5.0, 0.8 Hz, 2H, H5), 7.41 (s, 2H, H10). 13C NMR (100 MHz, D2O):  
157.6 Cq, 152.3 C6, 148.2 C2, 145.1 C9, 137.3 C4, 129.8 Cq, 126.5 C8, 125.0 C5, 
77.1 C10. LRMS (ES+): m/z (%) 163.1 (100) [LN+]2+, 408.1 (3) [LN+·Br]+, 509.1 (3) 
[LN+·Br2+Na]
+. HRMS (ES+) calculated for C21H18N4Na
79Br81Br [LN+·Br2+Na]
+ 
508.9775, found 508.9777. FTIR (film): max 3423 (m), 3387 (m), 3032 (m), 1636 
(s), 1591 (s), 1581 (m), 1562 (m), 1473 (s), 1425 (s), 1353 (s), 1306 (m), 1184 (s), 
1132 (m), 1011 (s), 848 (s), 809 (s), 765 (m), 700 (s), 628 (w), 592 (m), 554 (s). 
 
 
 
LN+·2Br- 
C21H18N4Br2 
FW: 486.20 
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5.1.34. Synthesis of ligand LN+·2PF6
- 
 
 
 
 
 
Ligand LN+·2Br- was dissolved in the minimum amount of water and an aqueous 
saturated solution of ammonium hexafluorophosphate was added to precipitate a 
white solid. LRMS (ES+): m/z (%) 163.0 (100) [LN+]2+, 471.0 (53) [LN+·PF6]
+. FTIR 
(film): max 3628 (w), 3141 (w), 3078 (w), 1636 (s), 1590 (m), 1472 (m), 1419 (m), 
1345 (w), 1306 (w), 1179 (s), 1129 (w), 1015 (w), 822 (s), 805 (s), 742 (s), 707 (s), 
645 (w), 621 (w), 554 (s). 
 
5.1.35. Synthesis of ligand LN+·2NO3
- 
 
 
 
 
 
Ligand LN+·2PF6
- was dissolved in the minimum amount of acetonitrile and a 
saturated solution of tetrabutylammonium nitrate in acetonitrile was added to 
precipitate a white solid. FTIR (film): max 3130 (w), 3050 (m), 3032 (m), 1637 (s), 
 
LN+·2PF6
- 
C21H18N4P2F12 
FW: 616.32 
 
LN+·2NO3
- 
C21H18N6O6 
FW: 450.41 
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1592 (m), 1580 (m), 1558 (w), 1525 (w), 1475 (m), 1421 (w), 1370 (s), 1320 (s), 
1241 (w), 1193 (s), 1132 (m), 1098 (m), 1010 (m), 827 (m), 810 (s), 760 (w), 726 
(w), 702 (s), 644 (w), 626 (w), 553 (s). 
 
5.1.36. Synthesis of bis(4-iodophenyl)methane (13)(168) 
 
 
 
 
4,4’-Methylenedianiline (4.25 g, 21.43 mmol) was dissolved in sulfuric acid 
(75 mL). The brown solution was cooled to 0 - 5 ºC and sodium nitrite (4.25 g, 
61.59 mmol) dissolved in water (7.5 mL) was added dropwise, maintaining the 
temperature below 5 ºC. When the addition was concluded, the solution was kept 
below 5 ºC for 30 minutes and was then slowly poured into an aqueous solution 
(500 mL) of potassium iodide (25.00 g, 150.60 mmol) that was preheated to 55 ºC. 
The resulting mixture was stirred for 1 hour at 55 ºC. After cooling, 
dichloromethane (250 mL) was added to the mixture. 2 M sodium hydroxide 
aqueous solution was then added to neutralize the mixture and a saturated 
aqueous sodium bisulfate solution to decolorize it. The organic phase was 
extracted and washed successively with 2 M HCl aqueous solution (150 mL), 
water (150 mL), saturated aqueous sodium bicarbonate solution (150 mL) and 
water (150 mL). The organic phase was then dried over magnesium sulfate and 
the solvent removed in vacuo. The brown oil was purified by silica column 
C13H10I2 
FW: 420.03  
13 
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chromatography with hexane as eluent to obtain a white solid (4.20 g, 47%). 1H 
NMR (300 MHz, CDCl3):  7.64 – 7.57 (m, 4H, H2), 6.94 – 6.87 (m, 4H, H3), 3.85 
(s, 2H, H5). 13C NMR (100 MHz, CDCl3):  140.0 Cq, 137.7 C2, 131.0 C3, 91.7 Cq, 
40.9 C5. LRMS (EI+): m/z (%) 166 (6) [M-2I]+, 293 (13) [M-I]+, 420 (100) [M]+. 
HRMS (EI+) calculated for C13H10I2 [M]
+ 419.8872, found 419.8840. FTIR (film): 
max 3018 (w), 2914 (w), 2846 (w), 1903 (w), 1581 (w), 1479 (s), 1434 (m), 1395 
(s), 1202 (w), 1181 (w), 1108 (w), 1057 (s), 1006 (s), 961 (w), 857 (m), 804 (s), 
774 (s), 719 (w). 
 
5.1.37. Synthesis of bis(4-((trimethylsilyl)ethynyl)phenyl)methane (12)(168) 
 
 
 
Bis(4-iodophenyl)methane (4.00 g, 9.50 mmol), ethynyltrimethylsilane (3.43 mL, 
24.30 mmol), palladium(II) acetate (21.3 mg, 0.10 mmol), triphenylphosphine 
(0.07 g, 0.29 mmol) and copper(I) iodide (18.1 mg, 0.01 mmol) were placed in a 
Schlenk flask and deaerated with argon. Triethylamine (50 mL) and toluene 
(25 mL) were added and the flask was deaerated again. The yellow solution was 
heated at 86 ºC for 16 hours. After the mixture was cooled to room temperature 
the grey precipitate that had formed was filtered off and washed with diethyl ether 
(100 mL). The filtrate was evaporated to yield a thick yellow oil which was 
C23H28Si2 
FW: 360.64 
 
12 
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redissolved in diethyl ether (100 mL) and washed with 10 % HCl (100 mL), water 
(100 mL), a saturated aqueous solution of sodium bicarbonate (100 mL) and water 
(100 mL). The ethereal phase was dried over magnesium sulfate and 
concentrated to an oil that crystallized on standing. Silica column chromatography 
was used to purify the crude, with hexane:ethyl acetate (50:1) as eluent, to obtain 
a pale yellow solid (3.30 g, 97%). 1H NMR (300 MHz, CDCl3):  7.43 – 7.41 (m, 
4H, H4), 7.11 – 7.08 (m, 4H, H5), 3.95 (s, 2H, H7), 0.29 (s, 18H, H8). 13C NMR 
(100 MHz, CDCl3):  141.2 Cq, 132.3 C4, 129.0 C5, 121.2 Cq, 105.2 Cq, 94.0 Cq, 
41.8 C7, 0.2 C8. LRMS (EI+): m/z (%) 345 (100) [M-CH3]
+, 360 (35) [M]+. HRMS 
(EI+) calculated for C23H28Si2 [M]
+ 360.1730, found 360.1749. FTIR (film): max 
3027 (w), 2957 (w), 2900 (w), 2157 (m), 1915 (w), 1605 (w), 1505 (m), 1410 (w), 
1246 (m), 1221 (w), 1106 (w), 1019 (w), 9194 (w), 836 (s), 810 (s), 755 (s), 697 
(m), 633 (m), 596 (m), 560 (m).  
 
5.1.38. Synthesis of bis(4-ethynylphenyl)methane (11)(168) 
 
 
 
A deaerated suspension of bis(4-((trimethylsilyl)ethynyl)phenyl)methane (2.80 g, 
7.76 mmol) and potassium carbonate (0.86 g, 6.21 mmol) in anhydrous methanol 
(30 mL) and anhydrous diethyl ether (30 mL) was stirred at room temperature 
under argon for 16 hours. The solvent was removed in vacuo and the crude solid 
C17H12 
FW: 216.28 
 
11 
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was purified by silica column chromatography with hexane:ethyl acetate (15:1) as 
eluent to give a yellow solid (1.38 g, 82%). 1H NMR (300 MHz, CDCl3):  7.49 – 
7.41 (m, 4H, H4), 7.18 – 7.09 (m, 4H, H5), 3.98 (s, 2H, H7), 3.07 (s, 2H, H1). 13C 
NMR (100 MHz, CDCl3):  141.5 Cq, 132.5 C4, 129.1 C5, 120.2 Cq, 83.7 Cq, 77.2 
C1, 41.8 C7. LRMS (EI+): m/z (%) 215.1 (100) [M-H]+, 216.1 (88) [M]+, 217.1 (8) 
[M+H]+. HRMS (EI+) calculated for C17H12 [M]
+ 216.0939, found 216.0943. FTIR 
(film): max 3274 (s), 3028 (w), 2927 (w), 2106 (w), 1917 (w), 1604 (m), 1502 (s), 
1444 (w), 1410 (m), 1240 (m), 1109 (m), 1019 (m), 867 (s), 819 (s), 797 (s), 758 
(s). 
 
5.1.39. General Click Reaction Procedure 
A bromo derivative (5.54 mmol) and sodium azide (11.1 mmol) were stirred for 
2 hours at 65 ºC in DMF (4 mL). After cooling the mixture to room temperature, 
copper(II) sulfate pentahydrate (1.84 mmol) dissolved in water (2 mL) was added, 
followed by L-ascorbic acid (1.84 mmol), sodium carbonate anhydrous 
(5.54 mmol), bis(4-ethynylphenyl)methane (1.84 mmol) and DMF (4 mL) were 
added. The resulting suspension was stirred at room temperature for 16 hours. 
The reaction mixture was then poured into a 0.1 M EDTA/NH4OH solution 
(100 mL) and stirred vigorously for 30 minutes. The resulting white precipitate was 
isolated via filtration and purified as indicated. 
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5.1.40. Synthesis of ligand LClick-Bn 
 
 
 
 
The title compound was prepared according to the General Click Reaction 
Procedure with benzyl bromide (0.66 mL, 5.54 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.72 g, 81% yield). 1H NMR (300 MHz, CDCl3):  7.73 – 7.70 (m, 4H, H7), 7.62 (s, 
2H, H5), 7.43 – 7.34 (m, 6H, H14 & H15), 7.32 – 7.27 (m, 4H, H13), 7.23 – 7.20 
(m, 4H, H8), 5.57 (s, 4H, H11), 4.00 (s, 2H, H10). 13C NMR (100 MHz, CDCl3):  
148.0 Cq, 140.9 Cq, 134.7 Cq, 129.4 C8, 129.2 C14, 128.8 C15, 128.6 Cq, 128.0 
C13, 125.9 C7, 119.3 C5, 54.2 C11, 41.4 C10. LRMS (ES+): m/z (%) 505.3 (100) 
[M+Na]+. HRMS (EI+) calculated for C31H26N6Na [M+Na]
+ 505.2117, found 
505.2115. FTIR (film): max 3134 (w), 3036 (w), 2910 (w), 1560 (w), 1494 (s), 1452 
(s), 1436 (s), 1416 (m), 1343 (m), 1222 (s), 1208 (m), 1184 (m), 1110 (m), 1070 
(s), 1049 (s), 976 (s), 915 (m), 865 (s), 815 (s), 792 (s), 704 (s), 692 (s), 665 (s), 
646 (s), 634 (s), 585 (s). 
 
 
 
 
LClick-Bn 
C31H26N6 
FW: 482.58 
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5.1.41. Synthesis of ligand LClick-OH 
 
 
 
The title compound was prepared according to the General Click Reaction 
Procedure with 2-bromoethanol (0.40 mL, 5.54 mmol). Purification via 
recrystallization in hot methanol yielded a white solid (0.55 g, 76% yield). 1H NMR 
(300 MHz, DMSO-d6):  8.48 (s, 2H, H5), 7.79 – 7.76 (m, 4H, H7), 7.34 – 7.31 (m, 
4H, H8), 5.07 (t, J = 5.4 Hz, 2H, OH), 4.42 (t, J = 5.4 Hz, 4H, H11), 3.99 (s, 2H, 
H10), 3.81 (q, J = 5.4 Hz, 4H, H12). 13C NMR (100 MHz, DMSO-d6):  146.0 C8, 
140.7 C7, 129.2 Cq, 128.8 C5, 125.3 Cq, 121.6 Cq, 59.8 C12, 52.4 C11, 39.7 C10. 
LRMS (ES+): m/z (%) 413.2 (100) [M+Na]+. HRMS (ES+) calculated for 
C21H22N6O2Na [M+Na]
+ 413.1702, found 413.1703. FTIR (film): max 3292 (w, br), 
3140 (w), 2926 (w), 1458 (m), 1428 (m), 1416 (m), 1357 (w), 1319 (w), 1220 (m), 
1156 (m), 1077 (s), 1062 (s), 1038 (s), 977 (m), 912 (w), 866 (m), 815 (s), 791 (s), 
727 (w), 666 (m), 630 (m). 
 
 
 
 
C21H22N6O2 
FW: 390.44 
 
LClick-OH 
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5.1.42. Synthesis of ligand LClick-Glycol 
 
 
 
 
 
The title compound was prepared according to the General Click Reaction 
Procedure with 1-bromo-2-(2-methoxyethoxy)ethane (0.75 mL, 5.54 mmol). 
Purification by column chromatography on silica gel with ethyl acetate:methanol 
(9:1) as eluent yielded a white solid (0.73 g, 78% yield). 1H NMR (300 MHz, 
CDCl3):  7.97 (s, 2H, H5), 7.78 – 7.76 (m, 4H, H7), 7.28 – 7.26 (m, 4H, H8), 4.63 
– 4.57 (m, 4H, H11), 4.04 (s, 2H, H10), 3.93 – 3.87 (m, 4H, H12), 3.65 – 3.59 (m, 
4H, H13), 3.56 – 3.48 (m, 4H, H14), 3.37 (s, 6H, H15). 13C NMR (100 MHz, 
CDCl3):  168.6 Cq, 165.0 Cq, 140.8 Cq, 129.4 C8, 125.9 C7, 120.8 C5, 71.8 C14, 
70.6 C13, 69.6 C12, 59.1 C15, 50.3 C11, 41.5 C10. LRMS (ES+): m/z (%) 529.3 
(100) [M+Na]+. HRMS (ES+) calculated for C27H34N6O4Na [M+Na]
+ 529.2539, 
found 529.2536. FTIR (film): max 3141 (w), 2888 (m), 2867 (m), 2811 (w), 1499 
(m), 1457 (s), 1429 (m), 1417 (m), 1348 (s), 1221 (m), 1200 (m), 1171 (m), 1102 
(s), 1071 (s), 1048 (s), 1023 (s), 978 (m), 930 (m), 912 (w), 864 (m), 850 (s), 814 
(m), 791 (s), 696 (m), 666 (m), 630 (s). 
 
 
LClick-Glycol 
C27H34N6O4 
FW: 506.60 
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5.1.43. Synthesis of ligand L 
 
 
 
 
The title compound was prepared according to the General Suzuki Coupling 
Procedure with 3-pyridinylboronic acid (0.60 g, 3.92 mmol) and 
bis(4-bromophenyl)methane (0.72 g, 2.22 mmol). Purification by column 
chromatography on silica gel with ethyl acetate as eluent yielded a white solid 
(0.66 g, 92% yield). 1H NMR (300 MHz, CDCl3):  8.84 (dd, J = 2.3, 0.6 Hz, 2H, 
H2), 8.58 (dd, J = 4.8, 1.7 Hz, 2H, H6), 7.86 (ddd, J = 7.9, 2.3, 1.7 Hz, 2H, H4), 
7.57 – 7.51 (m, 4H, H8), 7.40 – 7.31 (m, 6H, H5 & H9), 4.10 (s, 2H, H11). 13C 
NMR (100 MHz, CDCl3):  148.5 C6, 148.4 C2, 141.0 Cq, 136.5 Cq, 136.0 Cq, 
134.3 C4, 129.8 C9, 127.5 C8, 123.7 C5, 41.4 C11. LRMS (ES+): m/z (%) 323.2 
(100) [M+H]+. HRMS (ES+) calculated for C23H19N2 [M+H]
+ 323.1548, found 
323.1546. FTIR (film): max 3028 (w), 2916 (w), 2852 (w), 1900 (w), 1606 (w), 1576 
(m), 1515 (m), 1473 (s), 1440 (w), 1395 (m), 1283 (s), 1187 (w), 1134 (w), 1115 
(w), 1060 (m), 1023 (m), 1001 (s), 945 (s), 865 (m), 830 (s), 798 (s), 786 (s), 758 
(s), 710 (s), 630 (m), 611 (s). 
 
 
 
 
L 
C23H18N2 
FW: 322.40 
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5.1.44. Synthesis of [Pd2L4][BF4]4 
 
 
 
 
 
 
The title compound was prepared according to the General Tetrafluoroborate 
Tetra-Stranded Palladium(II) Cylinder Procedure with ligand L (29.1 mg, 
0.076 mmol) to yield a white solid after further washing with chloroform (50 mL) 
and dried in vacuo (18 mg, 46% yield). 1H NMR (300 MHz, CD3CN):  9.20 (d, J = 
1.4 Hz, 2H, H2), 8.96 (dd, J = 5.7, 0.9 Hz, 2H, H6), 8.23 – 8.14 (m, 2H, H4), 7.65 
(dd, J = 8.0, 5.7 Hz, 2H, H5), 7.48 – 7.40 (m, 4H, H8), 7.34 – 7.31 (m, 4H, H9), 
4.11 (s, 2H, H11). 13C NMR (100 MHz, CD3CN):  150.4 C6, 150.1 C2, 143.3 Cq, 
141.4 Cq, 140.1 C4, 134.2 Cq, 130.8 C9, 128.8 C8, 128.3 C5, 41.2 C11. 
19F NMR 
(282 MHz, CD3CN):  -150.52 (s, 2F), -150.57 (s, 8F). LRMS (ES+): m/z (%) 323.2 
(100) [L+H], 529.9 (81) [Pd2L4(BF4)]
3+, 817.4 (28) [Pd2L4(BF4)2]
2+, 1763.7 (3) 
[Pd2L4(BF4)3]
+ FTIR (film): max 3094 (w), 1606 (m), 1581 (w), 1518 (w), 1481 (s), 
1439 (s), 1403 (s), 1339 (w), 1287 (w), 1247 (w), 1194 (m), 1055 (s), 1037 (s), 
1015 (s), 919 (m), 857 (m), 798 (s), 763 (m), 703 (s), 666 (m), 621 (m). UV-Vis 
(CH3CN): max (max/dm
3mol-1cm-1) 259 (84 400), 235 (86 100) nm. 
 
[Pd2(C23H18N2)4][BF4]4 
FW: 1848.41 
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5.2. General materials and methods for spectroscopic DNA 
binding studies 
Solutions were prepared with ultrapure water (18.2 M) purchased from Fisher 
Scientific. Highly polymerized calf thymus DNA (ct-DNA) was purchased from 
Sigma Aldrich and was used without further purification. 3000 M stock solutions 
of ct-DNA were prepared and kept frozen until the day of the experiment, when 
they were diluted to the required concentration. The DNA concentration was 
determined by UV-Vis measurements using the known molar extinction coefficient 
of 258 = 6 600 mol
-1dm3cm-1 per DNA base. Stock solutions of sodium chloride 
(1 M) and sodium cacodylate (Na(CH2)2AsO2 · 3H2O) buffer (100 mM) were 
prepared and kept refrigerated until the day of the experiment, when both were 
diluted to the required concentration. 
 
5.2.1. Circular and linear dichroism experiments 
Circular dichroism (CD) measurements were recorded in a Jasco J-810 
spectropolarimeter operated with the following parameters: sensitivity, 100 mdeg; 
start wavelength, 450 nm; end wavelength, 200 nm; data pitch, 0.5 nm; scanning 
mode, continuous; scanning speed, 200 nm/min; response, 1 second; bandwidth, 
2; accumulation, 3. A 1 cm quartz cuvette was used to perform the CD 
measurements. 
Linear dichroism (LD) measurements were recorded in a Jasco J-810 
spectropolarimeter modified for LD spectroscopic measurement. The 
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spectropolarimeter was operated in LD mode with the following parameters: 
sensitivity, 0.1 dOD; start wavelength, 450 nm; end wavelength, 200; data pitch, 
0.5 nm; scanning mode, continuous; scanning speed, 500 nm/min; response, 
0.25 seconds; bandwidth, 2.0; accumulation, 3. A flow Couette cell (Krometek) 
with a 0.1 cm pathlength was used to perform the LD measurements. CD and LD 
titrations were carried out using three solutions; solution A (a 30 M ct-DNA 
solution, containing 20 mM NaCl and 1 mM sodium cacodylate); solution B (a 
50 M palladium(II) cylinder solution) and solution C (a 60 M ct-DNA solution, 
containing 40 mM NaCl and 2 mM sodium cacodylate). Initially, solution A was 
recorded and then equal aliquots of solutions B and C were added to ensure a 
constant concentration of DNA throughout the titration. DNA base:complex ratios 
of 60:1, 30:1, 20:1, 15:1, 10:1, 8:1, 6:1, 4:1 and 3:1 were used. Data was 
processed with Origin (OriginLab, Northampton, Massachusetts). 
 
5.2.2. Ethidium bromide displacement experiments 
The fluorescence spectra for ethidium bromide displacement experiments were 
recorded using a Shimadzu RF-5301 PC Fluorescence Spectrophotometer with 
the following parameters: exc = 500 nm; range emission = 520-750 nm; resolution 
= 0.4nm; speed = medium; excitation split = 5; emmision split = 5; sensitivity = 
high. Titrations were carried out using three solutions; solution A (a 30 M ct-DNA 
solution, containing 50 mM NaCl, 1 mM sodium cacodylate and 10 mM ethidium 
bromide); solution B (a 100 M palladium(II) cylinder solution) and solution C (a 
60 M ct-DNA solution, containing 100 mM NaCl, 2 mM sodium cacodylate and 
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20 mM ethidium bromide). Initially, solution A was recorded and then equal 
aliquots of solutions B and C were added to ensure a constant concentration of 
DNA throughout the titration. DNA base:complex ratios of 100:1, 60:1, 30:1, 15:1, 
8:1, 4:1, 3:1, 2:1, 1.5:1 and 1:1 were used. Data was processed with Origin 
(OriginLab, Northampton, Massachusetts). 
 
5.3. General materials and methods for agarose gel 
electrophoresis 
Solutions were prepared with ultrapure water (18.2 M) purchased from Fisher 
Scientific. pBR322 plasmid DNA was purchased from New England Biolabs and 
used without further purification. Agarose was purchased from USB Corporation 
and Tris-Acetate-EDTA (TAE) buffer was purchased from Sigma Aldrich. 
 
5.3.1. Agarose gel electrophoresis experiment 
1% Agarose gels were prepared by warming 2 g of agarose in 1x TAE buffer until 
a clear solution was obtained. This solution was poured into a gel tray 
(210 x 150 mm) fitted with a 15 toothed comb. The gel was left to set at room 
temperature for 30 minutes. Sample solutions of 16 μl were prepared from a 
1540 M pBR322 plasmid DNA stock solution and a 60 M complex stock solution 
to obtain plasmid:complex ratios ranging from 20:1 to 2:1. These sample solutions 
were incubated for 2 hours at 37 ºC, after which 4 l of loading buffer (30% 
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glycerol, 0.25% bromophenol blue) was added. The samples were mixed and 
16 μl of the samples were loaded into the gel wells. The gel was run for 2.5 hours 
in an Amersham Biosciences HE99X Maxi submarine kit with an electrophoresis 
Power Supply-EPS 301 system, at a constant voltage of 120 V and 400 mA, in 
1x TAE running buffer. The gel was then stained with an ethidium bromide solution 
(0.5 mg.ml-1) in 200 ml of water for 20 minutes and visualised using a 
UVtec-uvipro platinum 2.0 system (UVidoc, Cambridge, UK) at 312 nm. 
 
5.4. General materials and methods for polyacrylamide gel 
electrophoresis 
Solutions were prepared with ultrapure water (18.2 M) purchased from Fisher 
Scientific. Gel electrophoresis purified DNA oligonucleotides were purchased from 
Eurofins MWG Operon and used without further purification. 
DNA oligonucleotide sequences used for three-way junction recognition 
experiments: 
3WJ-S1: 5’ - CGG AAC GGC ACT CG - 3’ 
3WJ-S2: 5’ - CGA GTG CAG CGT GG - 3’ 
3WJ-S3: 5’ - CCA CGC TCG TTC CG - 3’ 
DNA oligonucleotide sequences used for four-way junction recognition 
experiments: 
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4WJ-S1: 5’ - GCC TAG CAT GAT ACT GCT ACC G - 3’ 
4WJ-S2: 5’ - CGG TAG CAG TAC CGT TGG TGG C - 3’ 
4WJ-S3: 5’ - GCC ACC AAC GGC GTC AAC TGC C - 3’ 
4WJ-S4: 5’ - GGC AGT TGA CGT CAT GCT AGG C - 3’ 
-32P labelled ATP (3 000 Ci/mmol) was purchased from PerkinElmer. 
Bacteriophage T4 polynucleotide kinase was purchased from New England 
Biolabs. A QIAquick nucleotide removal kit was purchased from QIAGEN. 40% 
Acrylamide (29:1) was purchased from Geneflow. 
 
5.4.1. Radioactive labelling of DNA 
3WJ-S3 and 4WJ-S4 DNA oligonucleotide strands were radio-labelled with -32P at 
the 5’ terminus by mixing 9.6 L of ultrapure water, 2 L of 10x bacteriophage T4 
polynucleotide kinase buffer, 2.4 L of 100 M oligonucleotide (3WJ-S3 or 
4WJ-S4), 2 L of bacteriophage T4 polynucleotide kinase and 4 L of -32P ATP 
(3 000 Ci/mmol). This solution was incubated at 37 ºC for 40 minutes, followed by 
3 minutes at 80 ºC in order to deactivate the polynucleotide kinase. A QIAquick 
nucleotide removal kit was used to purify the radioactive-labelled DNA 
oligonucleotide from any unreacted ATP fragments. 200 L of PN buffer was 
added to the reaction mixture. This solution was transferred to a QIAquick spin 
column with a 2 mL collection tube and the mixture was centrifuge at 6 000 rpm for 
1 minute. The flow-through was discarded after centrifugation and the QIAquick 
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spin column was placed in a new collection tube. 500 L of PE buffer was added 
to wash the radiolabelled-DNA oligonucleotide and the mixture was centrifuged at 
6 000 rpm for one minute. The flow-through was discarded and the washing 
process repeated one again. The spin column was then centrifuged at 13 000 rpm 
for 1 minute to remove any remaining buffer. 30 L of ultrapure water was added 
onto the column to elute the radioactive-labelled DNA oligonucleotide. The solution 
was allowed to stand for 5 minutes and then was centrifuged at 13 000 rpm for 2 
minutes to obtain an 8 M stock solution of radiolabelled DNA oligonucleotide. 
 
5.4.2. Polyacrylamide gel preparation 
A 15% native polyacrylamide solution was prepared by mixing 100 mL of 
10x Tris-Borate (TB) buffer, 375 mL of 40 % acrylamide (29:1) and 525 mL of 
HPLC grade water and was kept in the fridge until the day of the experiment. 
10x TB buffer was prepared by mixing 108 g of Tris-base and 55 g of boric acid in 
1 L of HPLC grade water. On the day of the experiment, 50 mL of 15% native 
polyacrylamide solution was mixed with 150 L of 10 % (w/v) ammonium 
persulfate and 25 L of tetramethylenediamine (TEMED). This solution was 
poured onto a set of glass plates and a 19 toothed comb was placed between 
them. The gel was left to polymerise for 30 – 40 minutes, after which it was placed 
in the fridge for 10 minutes. Wells were washed with water and TB running buffer 
and the gel was pre-run at 300 V for 10 minutes. 
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5.4.3. PAGE electrophoresis experiment 
Sample solutions of 10 L were prepared by mixing 2 M stock solutions of each 
oligonucleotide strand and 1 L of a (10x TB buffer + 1 M sodium chloride) 
solution, and 2 M complex stock solution to give final concentrations of 0.2 M for 
each DNA strand and 0.2 M of complex. The sample solutions were incubated for 
1 hour at room temperature and then placed on ice for 15 - 20 minutes. 5 L of 
30% glycerol solution was added to each sample and 13 L of the sample was 
loaded onto the gel. The gel was run for 4 hours at 120 V using Gel System 
equipment and then exposed on a phosphor imaging plate for 1 - 16 hours, 
depending on how fresh the radioactive ATP used was. A radiogel image was 
obtained using a Bio-Rad Molecular Imager FX and PDQuest software. 
Quantification was carried out using Quantity One software. 
 
5.5. General materials and methods for cell culture 
RPMI medium and FBS were purchased from Invitrogen. Antibiotic antimycotic 
solution, L-glutamine, trypsin-EDTA, HEPES buffer, sodium pyruvate, MTT and 
DMSO were purchased from Sigma-Aldrich. Tissue culture flasks and 96 well 
microtiter plates were purchased from Appleton Woods, UK. A2780 and T47D 
cancer cell lines were purchased from the Health Protection Agency, European 
collection of cell cultures (ECACC). All reagents and materials were autoclaved 
before use. Manipulations with cells were carried out in sterile conditions in a class 
1 tissue culture hood (Aura B4, Bio Air). 
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5.5.1. MTT assay 
Sample solutions of 200 M were prepared in a 1% DMSO solution in DMEM 
medium. After 24 hours incubation, cells were treated with 100 L of six different 
concentrations of the complex. Cells were incubated for 72 hours, after which 
50 L of MTT solution (5 mg/mL in PBS) was added and further incubated for 2 
hours. MTT was removed and the formazan crystals were dissolved by the 
addition of 200 L of DMSO. The absorbance was measured using a microplate 
reader (Bio Rad) set at 590 nm. 
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Appendix 
 
 
A.1. Crystallographic data for [Pd2L
OMe
4][(BF4)4] complex. 
Empirical formula  C100H88N8O8Pd2 4(BF4) 2(C2H3N) 4(H2O) 
Formula weight  2244.00 
Temperature (K)  100(2) 
Wavelength (Å) 0.71075 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 12.499(19) Å = 98.05(3)° 
 b = 13.844(19) Å = 106.056(16)° 
 c = 16.16(2) Å  = 97.392(19)° 
Volume (Å3) 2619(7) 
Z 1 
Calculated density (mg/m3) 1.423 
Absorption coefficient (mm-1) 0.436 
Crystal size (mm3) 0.07 x 0.05 x 0.01 
Reflections collected 23097 
Independent reflections 9233 [R(int) = 0.0955] 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9233 / 6 / 680 
Goodness-of-fit on F2 1.107 
Final R indices [I>2(I)] R1 = 0.1121, wR2 = 0.2801 
R indices (all data) R1 = 0.1475, wR2 = 0.3148 
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A.2. Crystallographic data for ligand LO-OMe. 
Empirical formula  C24H20N2 O3 
Formula weight  384.42 
Temperature (K) 120(2) 
Wavelength (Å) 1.54184 
Crystal system  Monoclinic 
Space group  C 2/c 
Unit cell dimensions a = 38.7788(7) Å = 90° 
 b = 6.6075(1) Å = 100.784(1)° 
 c = 7.3762(1) Å  = 90° 
Volume (Å3) 1856.63(5) 
Z 4 
Calculated density (mg/m3) 1.375 
Absorption coefficient (mm-1) 0.739 
Crystal size (mm3) 0.32 x 0.20 x 0.08 
Reflections collected 8642 
Independent reflections 1758 [R(int) = 0.0201] 
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1758 / 0 / 134 
Goodness-of-fit on F2 1.042 
Final R indices [I>2(I)] R1 = 0.0332, wR2 = 0.0894 
R indices (all data) R1 = 0.0338, wR2 = 0.0901 
Extinction coefficient 0.00135(17) 
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A.3. Crystallographic data for [Pd2L
NH-OMe
4][(BF4)4] complex. 
Empirical formula  C96H84N12O8Pd2 4(BF4) C4H10O 5.5(C2H3N) 
Formula weight  2393.71 
Temperature (K) 100(2)  
Wavelength (Å) 0.71075 
Crystal system  Triclinic 
Space group  P -1 
Unit cell dimensions a = 11.362(16) Å = 109.64(2)° 
 b = 16.33(2) Å = 104.52(2)° 
 c = 18.17(3) Å  = 92.287(16)° 
Volume (Å3) 3045(8) 
Z 1 
Calculated density (mg/m3) 1.305  
Absorption coefficient (mm-1) 0.379  
Crystal size (mm3) 0.20 x 0.14 x 0.07 
Reflections collected 18645 
Independent reflections 9949 [R(int) = 0.1040] 
Absorption correction Semi-empirical from equivalents 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 9949 / 79 / 809 
Goodness-of-fit on F2 1.513 
Final R indices [I>2(I)] R1 = 0.1260, wR2 = 0.3512 
R indices (all data) R1 = 0.1373, wR2 = 0.3691 
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A.4. Crystallographic data for ligand LNH-OH. 
Empirical formula  C22H17N3O2 
Formula weight  355.39 
Temperature (K) 100(2) 
Wavelength (Å) 0.71070 
Crystal system  Orthorhombic 
Space group  P nma 
Unit cell dimensions a = 7.094(8) Å = 90° 
 b = 38.24(4) Å = 90° 
 c = 5.921(7) Å  = 90° 
Volume (Å3) 1606(3)  
Z 4 
Calculated density (mg/m3) 1.470 
Absorption coefficient (mm-1) 0.096 
Crystal size (mm3) 0.34 x 0.24 x 0.03 
Reflections collected 5642 
Independent reflections 1529 [R(int) = 0.0542] 
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1529 / 0 / 127 
Goodness-of-fit on F2 1.055 
Final R indices [I>2(I)] R1 = 0.0543, wR2 = 0.1295 
R indices (all data) R1 = 0.0576, wR2 = 0.1327 
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A.5. Crystallographic data for ligand LClick-Bn. 
Empirical formula  C31H26N6 
Formula weight  482.58 
Temperature (K) 120(2) 
Wavelength (Å) 1.54184  
Crystal system  Orthorhombic 
Space group  P na21 
Unit cell dimensions a = 8.2284(5) Å = 90° 
 b = 5.6886(3) Å = 90° 
 c = 50.573(3) Å  = 90° 
Volume (Å3) 2367.2(2)  
Z 4 
Calculated density (mg/m3) 1.354 
Absorption coefficient (mm-1) 0.649 
Crystal size (mm3) 0.22 x 0.18 x 0.04 
Reflections collected 9849 
Independent reflections 2208 [R(int) = 0.0259] 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9745 and 0.8704 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2208 / 1 / 334 
Goodness-of-fit on F2 1.102 
Final R indices [I>2(I)] R1 = 0.0292, wR2 = 0.0747 
R indices (all data) R1 = 0.0302, wR2 = 0.0756 
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A.6. 13C NMR of [Pd2L
OMe
4][(BF4)4] (100 MHz, CD3CN).
 
 
 
A.7. 13C-1H HSQC NMR of [Pd2L
OMe
4][(BF4)4] (100 MHz-400 MHz, CD3CN). 
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A.8. 1H-1H COSY NMR of [Pd2L
OMe
4][(BF4)4] (400 MHz, CD3CN). 
 
 
A.9. 1H-1H NOESY NMR of [Pd2L
OMe
4][(BF4)4] (400 MHz, CD3CN). 
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A.10. 1H NMR spectra of titrations of NBu4OTf into [Pd2L
NH-OMe
4][(BF4)4] 
(300 MHz, CD3CN). 
 
 
 
 
 
 
 
 
 
 
[Pd2L
NH-OMe
4][(BF4)4] 
[Pd2L
NH-OMe
4][(BF4)4] + 1 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 2 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 3 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 4 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 5 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 6 eq.NBu4OTf 
[Pd2L
NH-OMe
4][(BF4)4] + 10 eq.NBu4OTf 
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A.11. CD spectra of ct-DNA with increasing concentrations of [Pd2L
OH
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
 
A.12. LD spectra of ct-DNA with increasing concentrations of [Pd2L
O-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
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A.13. LD spectra of ct-DNA with increasing concentrations of [Pd2L
NH-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
 
A.14. LD spectra of ct-DNA with increasing concentrations of [Pd2L
S-OMe
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
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A.15. LD spectra of ct-DNA with increasing concentrations of [Pd2L
OH
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. DMSO. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
 
 
A.16. LD spectra of ct-DNA with increasing concentrations of [Pd2L
O-Glycol
4][(BF4)4] 
complex. Legend shows ct-DNA base:complex ratios. 0.3% max. MeOH. (30 M 
ct-DNA in 20 mM NaCl and 1 mM Na(CH2)2AsO3·3H2O (pH 6.8)). 
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